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Summary  
Cadmium has been described as being toxic in all living species. At 
no level of intake does it appear to have a useful biological function. 
Although it was not recognised until 1817 as a separate element man has 
been polluting his environment with it for centuries - from the time the 
early Greek metallurgist began working with "bronzes". Widely distrib-
uted in the earths crust in low concentrations it remains "locked in" 
unless other more important resources are extracted and refined. 
Erosion and weathering of the earths crust contributes little to the 
level of environmental cadmium. 
In nature it is closely associated with zinc. It is also found in many 
other polymetallic ores, particularly those containing copper and lead. 
Fossil fuels, coal and oil, as well as phosphate rock also contain 
significant quantities of cadmium. When mankind refines and utilises 
and purifies these materials cadmium is released. It is a relatively 
unimportant resource, a by-product of far more important resources. 
Whether needed or not it is being separated and recovered in greater 
quantities annually. Many uses have been found to make it marketable. 
Little recycling of the end product occurs. Consequently an increasing 
quantity of "free" cadmium is available for contamination of the environ-
ment. Water, air, food chains, foodstuffs are providing an increasing 
load to all living things. It has been claimed it poses a threat to all 
life on earth. 
Almost 150 years passed from the time cadmium was recognised to the 
time it was generally accepted as a dangerous substance. 19th century 
industry provided many examples of its acute toxicity but it was the 
mid twentieth century before it was established that the metal could 
accumulate in the body over manyyears and ultimately reach a concent-
ration which interfered with the function of the host cell. 
Those most at risk are those who handle the material in their occupation. 
But heavy pollution of some Japanese waterways has resulted in death and 
chronic disability to the population living along the shores. Chronic 
obstructive airways disease and renal tubular disease are common in 
those whose working conditions expose them to high concentrations. 
Anaemia,bone disease, general malaise have also been found. 
Animal experimentation has shown that cadmium, though poorly absorbed, 
can enter the body via the skin, lungs and alimentary canal. Its 
entry stimulates the formation of a special protein, Metallothionein, 
which acts both as a carrier and a receptacle. Cells of many tissues 
take up cadmium - in particular the liver, kidney, pancreas, gonads, 
salivary and intestinal glands. Because of its environmental ubiquity 
and its slow excretion - mainly via the kidney, lifelong accumulation 
occurs. How much can the body accumulate before signs of toxicity 
appear? Just how toxic is it to various organs? 
I have compared the health of 34 workers at the Electrolytic Zinc 
Company of Australasia, Risdon, Tasmania who have spent many years 
working in a moderately contaminated atmosphere with fellow workers 
exposed only to environmental cadmium. I restricted my investigation 
to the clinical field and avoided invasive investigational procedures.. 
I found no evidence of any serious ill health specific to the exposed 
group. In particular this group did not manifest any of the disabilities 
found in similar surveys by others. My group of workers were different 
in that they were working in levels well below accepted tolerable 
levels. This group therefore could be used as representatives of a 
middle group between those environmentally at risk and those seriously 
at risk because of heavy occupational exposure. 
I found cadmium did cause chronic pulmonary symptoms even in these 
low concentrations but without objective pulmonary disease. Some of 
those with the longest exposure and presumably the largest body burden 
did show evidence of altered haemoglobin and protein synthesis without 
obvious clinical manifestations. 
I found no evidence of any of the conditions - hypertension, malignancy 
endocrine disorders speculatively linked to cadmium by epidemiologists 
using results of animal studies on environmental studies and disease 
patterns. Though definitely toxic to cells cadmium can be tolerated up 
to a certain body burden for a "no effect". I was not able to establish 
this burden but the study may provide areas for further research into 
this very important question. 
FOREWORD 
Scope and General Plan of Thesis  
This thesis reports on a once only survey of 34 workmen at the 
Electrolytic Zinc Company of Australasia's plant at Risdon who 
have been working in a cadmium contaminated atmosphere for long 
periods. It compares their health with 34 controls working in 
non cadmium contaminated sections of the plant. A survey of the 
literature dealing with cadmium, its environmental and occupat-
ional hazards is presented first followed by detailed analysis 
of the findings of the survey. 
Obligatory Statement  
This thesis contains no material which has been accepted for the 
award of any other degree or diploma in any University and, to 
the best of my knowledge and belief, contains no material prev-
iously published or written by another person, except where due 
reference is made in the text of the thesis. 
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CHAPTER 1. 
Cadmium and the Environment 
Historical Background  
Despite its wide distribution in the earth's crust, cadmium was not recog-
nised until the early 19th century. The ancient Greek metallurgists had 
noticed that certain "earths" lacking tin could produce a bronze when added 
to copper and that these earths resembled the flue dust of their zinc 
smelting furnaces but failed to detect a separate element. Pliny and 
Dioscorides (1st Century A.D.) named this earth Cadmia Fornacum in honour 
of Cadmos, son of the Phonecian king Agenon. The former was responsible for 
the introduction of zinciferous ores into metallurgy. (1) 
In 1817 Strohmeyer, a Gottingen metallurgist working with zinc carbonate, 
noted a brilliant yellow pigment which he attributed to a new element. 
Hermannfrom Schonebeck isolated this pigment and confirmed the presence 
of a new element. Other workers soon verified these findings and noted 
its close association and relationship to zinc. Many different names were 
proposed but finally Strohmeyer's suggestion that it be called cadmium in 
honour of the early Greek metallurgist was accepted. (1) 
Environmental Aspects  
Cadmium is unique amongst the chemical elements in that nearly always it 
is found in nature in close association with zinc. In addition, it is 
present in the polymetallic ore sources of lead and copper whilst traces 
are found in the fossil fuels, coal and oil, and phosphate rock. (2) 
Although closely associated in nature with zinc, cadmium, unlike zinc, 
serves no biological useful function at any level of intake or cellular 
(2) 
concentration. As more and more zinc, copper, lead, fossil fuels and 
fertiliser are consumed more and more cadmium is dispersed into the 
environment. Cadmium in low concentration can now be found as a constit-
uent of all living things. Yet it is not essential to life; on the 
contrary, in all its chemical forms it is toxic to all living species. (2) 
It is this ubiquitous toxicity and the increasing environmental concent-
ration of readily accessible cadmium which has prompted extensive studies 
into the societal flow of cadmium and its effect on various ecosystems. 
Cadmium is an unimportant by-product of the refining of zinc, copper or 
lead. Industry, both primary and secondary, has found many uses for it 
and is finding more as more and more cadmium is being separated and 
recovered because technology demands purer and purer zinc, lead, copper 
without even traces of impurities. (Figures 1 and 2, pages 3 and 4). 
Cadmium is not generally recycled and consequently is accumulating in the 
environment at an increasing rate. 
Some thirty different uses have now been developed for cadmium. In none 
does it appear to be essential or non substitionable. Adequate substi-
tutes already exist or could easily be developed. Cadmium, therefore, 
is an unimportant resource and could be stockpiled like other trace 
contaminants such as arsenic or thalium without serious loss to society 
as a whole. (2) 
Two different estimates of the material flow of cadmium in the U.S.A. in 
1968 are shown in Figures 1 and 2, as given by Davis et al. (3) and by 
Heindl (4). The values for miscellaneous or other uses (Fig. 1) include 
uses in fungicides, nuclear control rods, phosphors, ceramics, and others. 
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The Cadmium System  
Although relatively new to industrialists and chemists, cadmium has been 
entering the environment for many centuries - ever since man first started 
smelting zinc and working with copper and lead. Its flow through the 
environment is dependent on a multiplicity of factors. These include 
background levels due to natural occurrence and abundance; mining, re-
fining,use, recycling of zinc, lead and copper ores as well as metals; coal, 
oil and phosphate utilisation. Many gaps exist in our understanding of the 
importance of these factors either in isolation or combination. 
An ever increasing number of studies concerning cadmium in many biological 
areas have produced a wealth of data. Some is valuable in immediately 
increasing understanding in one area. Some is confusing and seemingly 
irrelevant whilst some is completely contradictory to existing accepted 
facts. 
Though widely distributed in the rocks of the earth's crust, cadmium is 
generally in low concentration averaging 0.15 - 0.2 parts per million. 
Uncultivated soils contain between 0.01 - 0.7 parts per million. Higher 
levels are found near ore bodies or zinc smelters. (5) 
Most fresh waters contain less than 1 Ug/litre. Sea water averages about 
0.15 Ug/litre. Erosion and weathering of rocks and soils apparently 
contribute little to these figures, the major proportion coming from man's 
activities - mining, sewage disposal, soil fertilisation. (5) 
In natural waters cadmium is found mainly in bottom sediments and suspended 
particles whilst that in solution is of low concentration. Decreasing the 
pH will increase the solubility. (5) 
(6) 
Studies in 1966 on 58 cities and 29 rural areas in the U.S.A. by the 
National Air Sampling Network showed a range of 2 - 370 nanograms/cubic 
metre for urban areas compared with 0.4 - 26 for rural. The higher concen-
trations were found in cities with considerable industry, especially 
metallurgical and smelting. Coal and oil burning plus exhaust gases, wear 
of cadmium plated bearings and tyres from automobiles, contribute to air-
borne cadmium. No accurate data is available on the fate of airborne 
cadmium. Presumably it is carried back to earth by rain and snow. (6) (7) 
Soils enriched with phosphate or sewage sludge fertiliser may contain ten 
times the cadmium level of uncultivated soil. Williams and Davis of the 
C.S.I.R.O. Division of Plant Industry have found that 80% of the cadmium 
applied in fertiliser is retained in the top portion of the soil from which 
crops and pasture plants take their nutrient. The remaining 20% is leached 
into waterways adding to the existing cadmium content of streams, lakes and 
bays. (8) 
Several controlled studies have shown that the cadmium content of crops 
and pastures rises proportionately to the soil cadmium content. Little is 
known about the exact mechanism of transfer from soil to plant. It is 
believed that micro organisms are involved, producing a readily assimable 
organic cadmium compound or compounds. So far no organism or organic 
compounds have been identified. Soil pH and the presence of other metals 
affect the transfer. Root systems concentrate the cadmium and so block the 
transfer to the plant. In this they resemble the human placenta - presumably 
protecting the growing structure (vide infra.). 
Atmospheric concentration of cadmium affects plant concentration - part-
icularly leaf crops. Lagerwerff, in a study of plants near highways showed 
( 7) 
that approximately 50% of the cadmium content came from airborne sources 
and this cadmium content decreased with the distance from the highway. (9) 
Plankton are able to concentrate cadmium by a factor of some 900. Though 
this is considerably less than for copper, lead and zinc, it does lead 
cadmium into the marine food chain. In addition, marine plants have a 
concentration factor of 1620 - again less than other heavy metals but 
significant enough to add to the cadmium content of marine life. (10) 
Shell fish, particularly oysters - are able to accumulate cadmium from 
water that has only a small cadmium content (Thrower and Eustace). Some 
oysters can obtain a high cadmium level from such waters. (11). 
Ayling has shown that it is the concentration of the metal in the mud of 
the bed site which determines this concentration emphasising the importance 
of the bottom sediment as well as the environmental water in the cadmium 
system. (12) 
Cadmium in Food and Water  
Cadmium is present in relatively small amounts in nearly all food and 
water used by man. Fish and meat show mean levels considerably higher 
than those for wheat, eggs, other cereals and vegetables. Oysters and 
anchovies have 3 - 5 times the concentration of other foodstuffs. (13) 
Normal Human intake of Cadmium from Environmental Sources  
Man is therefore exposed to cadmium from his food, water and air. The 
principal source would appear to be food though this may not be true of 
( 8 ) 
smokers. There have been few accurate comprehensive studies on total 
cadmium balance in humans and the more reliable estimates from these 
studies would suggest a daily intake of 20 - 50 Ug of which only a small 
proportion is retained. Absorption into the body varies with the mode 
of entry (vide infra) and probably totals 2 - 3 Ug per day. (14) 
Two studies of water supplies would indicate that, except in unusual 
circumstances of contamination, intake via water is negligible. (5) 
Another significant source of cadmium in human beings is cigarette 
smoking (14). About 1.4 Ug of cadmium is present in each cigarette. 
Some 70% of this volatilised in the smoke. The respiratory intake from a 
packet of cigarettes would be 2 - 4 Ug per day, some 10 - 20 times the 
intake estimated from the air of a large city. 
( 9 ) 
CHAPTER 2. 
Analysis for Trace Concentration of Cadmium  
Many methods can be used for the determination of cadmium in trace 
concentrations. Unfortunately none of these provide a sensitive, simple, 
accurate, reliable, inexpensive, rapidly reproducible result unaffected by 
the presence of other elements or compounds. Different observers have 
used different methods for the same or various types of material studied 
since cadmium became an important biological study. This lack of standard 
technique has produced confusing and conflicting data. This in turn has 
complicated interpretation and correlation of results. 
Traditionally trace elements analyses of biological samples involved the use 
of a well established analytical method in conjunction with a suitable 
separation mechanism to purify and concentrate the element. This was an 
expensive laborious approach requiring precision in sample handling at all 
stages. In recent years newer instrumental techniques have been evolved 
which provide maximum information with minimum sample preparation. These 
have simplified to some extent the analysis of traces of cadmium. Unfort-
unately no study has collaborated the results of various laboratories 
engaged in research on the biological effects of cadmium. Such a study 
would facilitate comparisons in the future of cadmium in food, urine or 
blood. 
Some of the more common methods used are:- 
1. Spectrophotometic colorimetry after dithizone extraction 
2. Emissions spectroscopy 
. 3. Atomic absorption spectrophotometry 
4. Neutron activation 
(10) 
5. Various electro-chemical techniques 
6. Spark source mass spectrometry 
7. Isotope dilution 
The most generally used method is atomic absorption spectrophotemetry 
preceeded by a reliable separation method. Phosphate and sodium chloride, 
both common biological constituents can cause errors. Some earlier invest-
igators using this method failed to appreciate this interference and their 
results have to be interpreted with caution. (14) This method is the 
basis for the cadmium analyses in this survey. (Chapter 7). 
Spectrophotometric Colorimetry  
The method is based on the measurement of the degree of absorption of 
light at a given wave length that is characteristic of a specific ion or 
complex. Thus, the maximum absorption of light by a solution of cadmium 
dithizonate (the most commonly used complex) occurs at the wave-length 
518 nm, and the intensity of absorption is related to the concentration 
of cadmium dithizonate in solution which can be determined by appropriate 
calibrations with standard solutions. 
Concentration by selective extraction by organic solvents of the cadmium 
dithizonate complex is a necessary step, which can remove many interfering 
elements with proper adjustment of pH during the extraction. The method 
is less sensitive than some of the others, except where concentration is 
comparatively easy, as for sea water, in which levels of parts per billion 
can be determined. 
Special modifications, such as the use of ultraviolet spectrophotometry 
or fluorometric methods give promise of increased sensitivity of deter-
mination of cadmium. 
Emission Spectroscopy  
When elements are vaporized by means of a spark or an electric arc, the 
atoms present are energized to excited energy states; return of these 
energized atoms to the ground state is accompanied by the emission of light, 
the frequency of which is characteristic of each element. Resolution of 
these spectral lines and the determination of their intensities serve as 
the basis for estimating the concentrations of the trace elements present. 
The method is most commonly used for direct analysis of solid samples, 
without pre-treatment, because it makes possible the determination of many 
elements simultaneously. The inherent variations due to varying composition 
of samples, variations of degree of volatility, etc. require careful stand-
ardization against known material of similar composition and the use of 
internal standards. The sensitivity for the direct method (generally 5 - 10 
ppm) is not as good as in most of the methods discussed; it can be improved 
by concentration methods, followed by spark emission on solutions, or by 
arc emission of the evaporated dried solids. Such methods have not however, 
been used extensively. 
Atomic Absorption Spectrophotometry  
The basic principle of the method is that vaporized elements will absorb 
radiation of their characteristic frequencies by being activated from the 
(12) 
ground energy state to a higher electronic energy state. The concentrat-
ion of the atomized element is measured by the degree of absorption of 
its characteristic frequency of light. 
Atomic absorption is one of the most widely used methods for determining 
traces of cadmium, because of its relative simplicity, speed, and sens-
itivity. It is commonly preceded by a concentration procedure, most 
often by dithizone extraction, to improve the sensitivity and to eliminate 
interferences, especially the serious interference caused by the presence 
of NaCl; some of the early data on cadmium in biological samples may be 
seriously in error because this source of error was not then known. 
Recent modifications of the method, such as atomic fluorescence flame 
spectrometry and flameless atomic absorption, give promise of lowering 
sensitivity limits for cadmium to well below 1 ppb Cd. 
Neutron Activation 
Many elements, when subjected to bombardment by neutrons in a reactor, 
form radioactive isotopes. The amount of a given isotope formed is pro-
portional to the concentration in the original sample of the specific 
element, the neutron flux used, and the crossection of the parent nuclide. 
Instrumental analysis of the energy of radiation and the decay curve is 
used to identify the desired radioactive isotope, the amount of which is 
determined by comparison with standards that are irradiated simultaneously 
with the unknowns and which have been carried through the identical sep-
aration and counting procedures. Rarely is direct counting possible; 
usually separations must be made from other radioactive isotopes that 
(13) 
might interfere in the final counting procedure. The chemical separations 
are made after adding a known, generally much larger amount of the non-
radioactive element after irradiation is completed. Although such 
separations may be quite complex, it is unnecessary to make quantitative 
recoveries of the element sought, because yields can be calculated from a 
knowledge of the amount of nonradioactive carrier added. 
The neutron activation method is extremely sensitive. For cadmium the 
115 isotope Cd is generally measured, with sensitivity in the ppb range if 
chemical separations are made. The principal disadvantage is the need for 
a nuclear reactor and a "hot" laboratory. 
Electrochemical Methods (Polarography, Anodic Stripping Voltammetry) 
The polarographic method is based on the current voltage curves obtained 
by the electrolysis of solutions under special conditions, using a dropping 
mercury electrode. With proper choice of electrolyte, it is possible 
to obtain separate steps in the curves for each element present, the height 
of each step (current) being proportional to the concentration of the ion, 
and the location (potential) being dependent on the ion and on the nature 
of the base electrolyte. 
The method in its conventional form can be used to analyze solutions for 
cadmium at about 10- 5M concentrations and with special techniques for 
concentrations down to 10- 7M. 
Anodic stripping voltammetry is essentially a polarographic method in 
which the element is slowly plated out of a small volume of solution on a 
(14) 
small electrode (usually mercury-plated graphite) under carefully 
controlled conditions. After electrolysis is complete, a reversed voltage 
is applied, causing rapid dissolution of the plated element from the 
amalgam and thus producing a relatively large signal on the plot of cur-
rent flow versus voltage. 
The method is extremely sensitive and is especially useful for natural 
waters; its use may yield information on the nature of binding of cations 
in waters. 
Spark Source Mass Spectrometry  
Analyses for traces of metals by this method involves the volatilization 
and ionization of the material being analyzed by applying a radio-
frequency spark, followed by measurement of the ions formed by their masses 
in a high-resolution mass spectrometer. The method is extremely sensitive, 
permits the simultaneous determination of many elements, and can be used 
for nearly all types of samples. The main problems are erratic variab-
ility of the emissions of ions from a spark source, which requires that 
an internal standard such as lutetium be used, and the formation of 
multiply charged ions. Precisions of about 1- 10% have been reported for 
rock samples; further research should improve this. 
Isotope Dilution  
The method of stable isotope dilution, applicable to the determination of 
traces of any element composed of two or more stable isotopes, is based 
on the mass spectrometric determination of the proportions of two stable 
isotopes in a sample to which a known amount has been added of a "spike", 
(15) 
i.e., of a sample of known isotopic composition enriched in one of the 
isotopes that is of low natural abundance. The procedure requires the 
complete solution of the sample, addition of the spike with thorough 
mixing, separation of the element from possible interfering elements, and 
determination of the isotopic composition. For cadmium, the spike might 
be enriched in 106Cd (normal abundance 1.22%) or 108Cd (normal abundance 
_, 0.88%) and the ratio measured against 112  La (24.07%) or 114Cd (28.86%). 
The method is extremely sensitive, with very high precision and accuracy. 
It has the advantage that quantitative recovery in separation is unneces-
sary; also the yield does not have to be determined, because a ratio, 
rather than an absolute amount, is measured. Contamination by reagents 
can be determined by parallel experiments. Although the method has not 
often been used for cadmium, probably because it is relatively slow and 
expensive, it is to be considered one of the ultimate means of monitoring 
faster and less expensive methods. (5) 
(16) 
CHAPTER 3 
The Metabolism of Cadmium  
Most of our knowledge of the absorption, distribution and excretion of 
cadmium is derived from animal experimentation. Many different mammals 
have been given cadmium either by injection, inhalation, orally or 
through the skin. Single, multiple or constant dosage regimes have been 
employed. Independent of dosage or source of entry cadmium can be found 
in blood, internal organs, skin, hair and excreta in all species. A 
detailed analysis of the behaviour of cadmium in the animal body has 
emerged from the vast amount of data that has come from the research efforts 
of many investigators. Only a small number of controlled experiments on a 
few human beings have been performed. These and past mortem studies cor-
roborate the suggestion that the metabolism of cadmium is the same in all 
animal species. 
Single Dose Studies  
There are numerous studies recording the fate of a single dose of radio-
active cadmium taken either orally or by the respiratory tract or given 
by injection. Walsh and Burch 1959 (15) working with dogs; Kench, Wells 
and Smith 1962 (16) using rabbits and Perry et al 1970 (17) using rats 
have all shown the initial high plasma level after a single intravenous 
dose clears rapidly - usually within 30 minutes. By the end of twelve 
hours there is little cadmium in the blood and this cadmium is now in 
equal concentration in the plasma and in the red cells attached to protein. 
Lucis, Lynn, Lucis 1969 (18) found equal blood and plasma concentration 
12 hours after mice were given a subcutaneous injection. 
(17) 
Miller, Blackmon and Martin 1968 (19) working with goats and Fern, 
Hanlon and Urban 1969 (20) using hamsters showed a secondary rise of 
blood cadmium occurred between day one and day seven. This suggests a 
release from the storage sites responsible for the initial high clear-
ance. 
Decker, Byerrum and Hoppert 1957 (21) found that in the rat there was 
an increasing concentration of cadmium in the liver and this peaked at 
8 hours. By 72 hours the concentration in liver and kidney were equal. 
Miller et al (19) following the fate of single dose of over a period of 
days in their goats found after 14 days most of the cadmium had moved to 
the kidney. 
These findings have been substantiated by many other workers using differ-
ent species. 
Although the liver and kidney are the major organs of cadmium storage, 
traces of the metal can be found in most body compartments at some time 
after a single dose. The pancreas, spleen, testis and bone have all been 
shown to be able to store significant amounts. 
Harrison et al 1947 (20) exposed dogs to atomised cadmium chloride as 
a 25% aerosol for 30 minutes and subsequently measured the cadmium con-
tent of various organs from serial autopsies. By day five, most cadmium 
had left the lungs and the storage pattern showed a marked similarity to 
that described above after dosage by injection. 
Single dose experiments also indicate a long biological half life for cad:. 
(18) 
mium in most species. Cotzias et al 1961 (21) found it to be at least 
100 days in mice, Friberg et al (14) 2 years in monkeys and Rahola 
et al 1971 (22) in one of the few human studies noticed a half time 
for body retention in excess of 100 days. 
This long biological half life is due to a small daily excretion of 
cadmium. Only traces of the metal can be found in urine, faeces and 
hair. Of these excretion routes the major one appears to be the aliment-
ary canal. The salivary glands - the glands of the stomach, duodenum, 
pancreas and small intestine all accumulate cadmium and ultimately 
excrete it into the gut - Berlin et Ullberg (23). The rates and routes 
of excretion will be discussed again both in the next section and in the 
section devoted to body burden. 
Multiple Dose or Constant Exposure  
There are no major differences in the distribution of cadmium when 
multiple dose or long exposure experiments are conducted. Cadmium can 
be found in the cells of many organs and the concentration - particularly 
in the kidney rises proportionately to the total dose. Despite the 
increasing kidney concentration there is no significant rise in cadmium 
excretion in the urine unless the kidney shows evidence of damage. 
Axelsson and Piscator 1966 (24). However, when renal dysfunction - as 
evidenced by proteinuria occurs, there is a sharp increase in urinary 
cadmium excretion. Friberg 1955 (25) gave rabbits firstly radioactive 
cadmium and then non-radioactive cadmium and compared renal excretion with 
that from a control group given radioactive cadmium for the full period. 
During the period of administration of non-radioactive cadmium the concen- 
(19) 
tration of radioactive cadmium in urine increased sharply when protein-
uria appeared. This clearly demonstrates that when kidney damage 
occurred urinary cadmium came from accumulated renal deposits. 
In some species there is 100% increase in urinary excretion associated 
with increasing renal concentration of cadmium and renal damage. 
Axelsson and Piscator 1970 (24). This finding has an important clinical 
significance which will be discussed in a later chapter. 
Metallothionein  
No matter the portal of entry cadmium ultimately achieves widespread 
tissue distribution. However, there is significant difference in the 
percentage amounts absorbed from each site. Despite this difference 
the mode of absorption is probably the same from each site. 
In 1957 Margoshes and Vallee (26) discovered a low molecular weight 
protein in the equine kidney. This protein contained cadmium and other 
workers soon found similar proteins present in many tissues from other 
species including human tissue. This protein has many unique properties 
including a lack of aromatic amino acids, a high content of cysteine and 
an ability to bind certain heavy metals e.g. zinc, cadmium and mercury; 
for these reasons it was named metallothionein. 
Nordberg et al 1972 (27) has shown that there are different forms of 
metallothionein associated with a different metal content. These are 
closely related structurally as are the various metallothioneins of the 
various species. 
(20) 
Cadmium and other heavy metals appear to stimulate the production of 
this protein in the liver. It is also found in the lung, intestinal 
mucosa, kidney, spleen and pancreas. The protein binds the metal, 
transports it to, and holds it in the storage sites. The exact mechanism 
of transfer from gut or lung to metallothionein is not known. It is 
presumed that the metal is temporarily converted into an organic form 
although no compound or organism capable of forming an organic cadmium 
compound have been isolated at these sites. Metallothionein has been 
identified in quantity in various organs in a male who suicided by 
swallowing large quantities of cadmium iodide - Wesniewska et al 1971 
(28). Syversen (29) found metallothionein like protein in post mortem 
liver and kidney samples of non occupationally exposed males. No-one 
has found these proteins in human blood but Nordberg has in mice. (30). 
The Absorption of Cadmium  
Absorption via the lungs depends on the solubility and physico-chemical 
properties of the cadmium particles. Initially particle size determines 
the fate of cadmium aerosol. Those greater than 5 - 7 micron size will 
be either trapped by nasal hairs or swept up out of the pulmonary compart-
ment by ciliary action into the alimentary canal. Subsequent digestion 
and absorption of these will occur complicating the assessment of primary 
lung absorption. 
Friberg attempted to assess the actual pulmonary absorption by analysing 
Harrison's 1974 (14) data on single dose exposure with dogs. He suggested 
a figure of 40%. This figure is higher than that found by others in other 
species. Prodan 1932 (31) found a 30% retention in cats. Potts et al 
(21) 
1950 (32) 10% in mice and Friberg himself 1950 (14) using rabbits a 
30% retention. There is no quantitative data on absorption and retention 
in the human and a range of 10% to 40% is possible. 
In contrast most workers investigating oral absorption in animals appear 
to agree that only 1 - 2% of the ingested cadmium is retained. Rahola 
1971 (22) found a 6% retention in human male volunteers given a single 
oral dose of radioactive cadmium. Many factors influence oral absorp-
tion. Larssons and Piscator (33), Kobayashi et al 1971 (14) found that 
when mice were given a low protein diet they had a higher absorption. 
Worker et al 1961 (34) found that Vitamin D increased cadmium absorption 
in chickens. Larssons and Piscator 1971 (33) noted a higher absorption 
when rats were on a low calcium diet. 
The only long term study on humans by Tipton, Stewart and Dickson 1969 
(35) has come in for considerable criticism on the ground of poor analy-
tical technique. No attempt was made to extract cadmium from the various 
samples analysed and other electrolytes present probably gave erroneous 
readings. The study by these workers suggested a very high 75% dietary 
absorption. Kitamura 1972 (36) carried out a short term balance study 
on a 55 year old Japanese male using both cadmium contaminated rice and 
water. He found an absorption of 5.35% from the water and 1.55 from the 
rice. 
Unknown aspects of Cadmium Metabolism and Toxicology  
Considerable ignorance still exists in certain vital areas of cadmium 
metabolism. Much more information is required on the precise mechanism 
of cadmium absorption, especially with respect to chemical or physio- 
(22) 
logical factors which either enhance or inhibit intake. Little is 
• known about how or in what molecular form the metal is transported from 
absorption site to tissue stores. In addition, we are ignorant on just 
how the metal traverses vascular endothelium just prior to tissue 
deposition. Some investigators believe specific organs possess innate 
biochemical systems which vary from one location to another. 
Information is lacking concerning the chemical form or forms in which 
cadmium is deposited in various tissues. The specific effects of the 
metal on intermediary metabolism both in vivo and in vitro are not yet 
understood. Much has to be learnt about the inter-relationship between 
cadmium and other toxic compounds - drugs, pesticides, specific carcin-
ogens within cells,on their metabolic processes. Until these and many 
other unknowns are understood, speculation on the exact role of cadmium 
in health and disease will predominate over scientific fact. 
(23) 
CHAPTER 4. 
The Body Burden of Cadmium  
Henke,Sachs and Bohn 1970 (14) from an analysis of kidney and liver samples 
of stillborn babies in West Germany found that the total cadmium content of 
the new born is less than 1 Ug. Piscator in Sweden noted that cadmium accumu-
lates in the placenta during pregnancy. He found that an average 500 Gm 
placenta has 5 Ug. cadmium. Schroeder 1961 (37) from post mortem tissue 
analyses concluded that the standard American man of 30 - 50 years weighing 
70 Kg. contains 30 milligrams of cadmium. There is therefore a huge increase 
in body cadmium during life. 
But not all workers agree with Schroeder's figures. Smith et al (38) working 
with post mortem liver and kidney from three occupationally unexposed males 
in the United Kingdom suggest a figure of 15 mgm as total body burden. 
Ishizaki et al (14) found the renal concentration from some Japanese men 
in the Kanazawa area indicated a high 80 mgm accumulation. This area is 
not considered to give an excess exposure to cadmium. 
About 50% of total body cadmium can be found in the kidneys and liver in 
normal non-exposed humans. Of this about 33% is present in kidneys if 
there is no renal damage. The remainder is in various organs - pancreas, 
spleen, testes, thyroid, muscle and fat. Many workers have shown a decreasing 
kidney content after 50 years. Several explanations have been offered. 
Schroeder et al (14) speculate that this might be due to an increased mortal-
ity for individuals with higher renal levels but Friberg et al (14) suggests 
it is due to increased exposure over the past 50 years with kidney damage and 
increased excretion of renal cadmium. 
(24) 
Liver and kidney content of cadmium of occupationally exposed subjects 
are much higher and suggest body burden of 100 to 1,200 mgm. Only 10% 
of this is usually found in the kidney if there is evidence of renal 
cortical damage. Friberg (39). Animal studies and studies on workers 
occupationally exposed to cadmium have repeatedly shown that there is 
probably a critical body burden beyond which overt tissue damage occurs. 
No study has conclusively established an exact figure for this burden. 
No study has yet suggested either an accurate method for establishing body 
burden or a reliable indication of it. Yet this is the most critical point 
in the relationship between cadmium and health. It is quite clear that 
body cadmium increases with age, that it is stored with increasing exposure 
and that increasing environmental exposure is occurring. It is equally clear 
that the body can tolerate a certain cadmium level without demonstrable 
effect. The social, medical, economical and environmental implications of 
this vital missing link in the cadmium story are immense and far reaching. 
Many attempts have been made to solve the dilemma. Animal studies have 
shown that blood cadmium does not reflect body content. Blood cadmium 
levels in exposed workers show that concentrations do increase with 
exposure, but only to a certain level. Friberg (39). These levels fluct-
uate and a single or group of readings may reflect recent or past exposure 
rather than tissue levels. 
Similarly urinary excretion is more dependent on renal damage than renal 
concentration or can be linked to intercurrent illness, Bonnell et al 
1959 (40), Smith et al 1960 (38). Faecal excretion is unreliable as it 
is not possible to distinguish between excreted cadmium and unabsorbed cad- 
(25) 
mium from the diet. 
Workers in U.S.A., Japan, Sweden and Yugoslavia - Friberg (14), have attemp-
ted to correlate the cadmium content of hair and body burden. Schroeder 
and Nason (41) found that sex, hair colour, dust, hair lotion or sprays 
all effected the analysis to such an extent as to render this an unreliable 
marker. 
Proteinuria and Cadmium 
One early sign of excessive absorption of cadmium is an increase in protein 
excretion in the urine. Initially this may be intermittent and therefore 
not always detected. Later it becomes constant and may remain for many 
years without change. Sensitive analytical techniques have shown that this 
protein resembles the small amount of protein normally excreted by the kid-
ney or urinary tract, but some fractions are in higher concentration. 
Electrophoretic examination following ultrafiltration reveals a distinct 
pattern with a low albumin content and a predominance of (2 andi3globulin 
components-Kazantis et al 1963 (42), Piscator 1966 (43). The proteinuria 
is also characterised by an abnormally high clearance of low molecular 
weight protein. 
Concentration of the urine by ultrafiltration followed by two dimensional 
electrophoretic separation may reveal the pattern of tubular proteinuria 
at a stage before proteinuria can be detected by the usual chemical tests. 
These tests must be based on precipitation with either salicylsulphonic 
acid - Henry 1964 (44), trichloracetic acid - Friberg 1950 (14) or other 
(26) 
reagents - Piscator 1962 (45). Impregnated paper strips e.g. Albustix 
may not be sensitive enough to detect these proteins nor will simple 
boiling of urine. 
Nevertheless the significance of a small increase in urinary protein is 
difficult to interpret and of no reliable value as an indicator of total 
body burden. It may appear in some exposed workers after a short exposure 
or fail to appear after many years or even appear long after exposure has 
ceased. 
A number of enzymes are also excreted with this protein which is believed 
to arise in the renal tubules - these include lysozyme, ribonuclease and 
muramidase. They correlate well with the proteinuria, so well that Adams 
et al 1969 (46) has suggested their presence indicates early biochemical 
change induced by cadmium. 
Cadmium and Zinc 
Zinc and cadmium are closely connected in nature. In the body their metab-
olism is similar. The one important difference is that zinc is an essent-
ial trace element and many enzymes are zinc dependent. Parisi and Vallee 
list 18 zinc metallo enzymes and 15 zinc enzyme complexes known in various 
biological systems. (47). 
Cadmium has the ability to exchange with zinc in these enzyme systems. 
When this happens tissue levels of zinc increase - Schroeder (37). The 
toxic or adverse effects of cadmium are almost certainly due to this 
exchange and in certain animal experiments some of the acute toxic effects 
(27) 
of cadmium can be prevented by doses of zinc - Gunn et al 1961 (48) 
without altering tissue cadmium concentration. 
The zinc to cadmium ratio relative to intake therefore may be important 
in finalising body burden. It is very probable also that the zinc-cadmium 
ratio in tissue is of importance in the total effect of the body burden 
of cadmium. As yet no research has produced a reliable method whereby 
changes in enzymatic or tissue zinc could be used as a marker of body 
cadmium despite the predominance of zinc enzymes available for study. 
Cadmium and other minerals  
Metals other than zinc and cadmium can be bound by metallothionein e.g. 
copper and mercury. Although it has been established that cadmium can 
displace copper readily from metallothionein in chickens - Starcher (49) 
no correlation between cadmium content and copper analysis has been dem- 
onstrated. Selenium and cobalt protect animal testes from damage by cadmium 
without effecting tissue content. Gunn et al (48). 
Other trace elements probably also have an important role in modifying 
the effects of tissue cadmium. As yet this interrelationship between essent-
ial and non essential trace elements is not completely understood. 
(28) 
CHAPTER 5. 
Cadmium and the Occupationally Exposed  
Little industrial use was found for cadmium for sixty years after its 
discovery - in 1817. But, by the end of the 19th century battery and pigment 
manufacturers were consuming increasing quantities with little realisation 
of the health hazards involved. Industrial consumption was given a great 
impetus in 1919 when M.J. Udy employed cadmium in the electroplating field. 
Today some thirty differing occupations in both primary and secondary indus-
ry provide exposure to cadmium and pan i passu with its increased industrial 
usage is the increased awareness of its established and potential effects 
on health. 
In 1858 Sovet (50) recorded the first cases of cadmium toxicity. He reported 
severe respiratory symptoms in three men using cadmium carbonate as a silver 
polish. The effect on a respiratory function of acute exposure to cadmium, 
either as dust or fume, was subsequently noted by many workers both in 
Europe and America. By 1920 medical literature documented abundant evidence 
that acute overexposure to the metal or its salts could lead to a severe 
chronic or sudden fatal respiratory illness. 
Initially the great majority of cases of acute cadmium toxicity reported 
were associated with absorption by inhalation but by 1940 it was well estab-
lished that acute ingestion also produced severe chronic systemic disease 
or sudden fatality. 
Acute exposure  
Brief exposure to high concentration of cadmium fume leads to severe pul- 
(29 ) 
monary oedema. The clinical picture is usually one of intense respiratory 
irritation, precordial pain and severe dyspnoea coming on some hours after 
exposure. Generally those affected did not suffer sufficient initial dis-
comfort to cause them to leave work - Bulmer and Rothwell (51). Death may 
be caused either by acute pulmonary oedema or later by acute renal failure. 
Dunphy (52), from a study of the literature has postulated three overlapping 
phases of pulmonary pathology - oedematous - proliferative-and fibrogenic. 
Death can occur in phase one or two from interference with blood gas exchange. 
Phase three is the chronic phase leading to emphysema and pulmonary vascular 
complications. 
Chronic exposure  
Occupational physicians, focusing on the effects of acute exposure, initially 
paid little heed to a suggestion in 1920 by Stephens (53) that constant 
exposure to cadmium in the working environment may lead to chronic ill health. 
It was not until 1940, when Mancioli (54) reported that men working in an 
electroplating shop suffered chronic rhinitis and pharyngitis, that the spot-
light fell on the effects of long term absorption. 
In 1942 Nicoud,Lafitte and Gros (55) investigated a group of workers in a 
French alkaline accumulator factory. No details are given about the number 
of people employed or the number investigated. Weight loss, iron deficiency, 
anaemia, and marked osteoporosis with pseudo fractures of long bones were 
ascribed to cadmium. The latter was cured with calcium and vitamin D sug-
gesting nutritional deficiencies, due to the war, were an associated 
factor. Chronic bronchitis and emphysema were found occasionally but were 
not associated with cadmium exposure by these workers. Blood and urine 
(30) 
cadmium levels and the cadmium concentration in the working environment 
are not given in their report. 
Princi, 1947 (56) studied twenty workers in an American cadmium smelter. 
a 
The length of exposure varied from six months to twenty two years. Atmos- 
pheric cadmium varied from 40 micrograms to 31.30 milligrams per cubic 
metre. Blood cadmium level varied between 10 and 65 micrograms/100 gm., 
urine cadmium between 11 and 125 micrograms per litre. 
Both blood and urine cadmium were established by Church's spectrophotemetric 
method. This is less sensitive than other methods. Vide chapter 2. 
A complete history and physical examination was performed on each worker. 
Despite the high urinary levels, marked symptoms and signs of ill health 
were absent though the haemoglobin levels were slightly lower than the 
average for the altitude. The most characteristic finding was a yellow 
staining of the teeth in those long exposed. Chest x-rays showed no sign-
ificant changes. Princi concluded exposure to cadmium did not cause chronic 
ill health. 
In contrast, Friberg, 1948 (57) looking at 38 workers in a Swedish alkali 
storage battery plant found evidence of renal damage in men exposed to between 
3 and 15 milligrams of cadmium per cubic metre for more than 8 years. He 
compared the health of nineteen workers exposed for less than 8 years to 
nineteen with 8 or more years exposure. Although both groups complained of 
fatigue, nervousness, irritability, thirst, cough and dyspnoea, he found 
(31) 
no pathological changes which could be definitely associated with 
cadmium exposure in the first group. The second group contained a sig-
nificant number of men with objective renal damage, as measured by a 
proteinuria and inulin clearance and lowered respiratory function when 
tested by spirometry. A significant number of these men also complained of 
anosmia. 
A subsequent report on an expanded group of forty three, 1950, (58) confi-
rmed these findings. In addition, Friberg found a raised erythrocyte 
sedimentation rate and some suggestion of impaired liver function. He 
noted a lower average haemoglobin level amongst workers and a mild anaemia 
in animals experimentally exposed to cadmium by injection. Proteinuria 
was only evident in the Heller test, being absent in a boiling only exam-
ination of urine. Electrophoretic study of this urinary protein suggested 
it was of a special type with a molecular weight between 20,000 and 30,000 
Baarder, 1951 (59) reported emphysema, proteinuria and weight loss amongst 
11 workers in an alkaline accumulator factory in Germany. One worker who 
came to autopsy subsequently had large deposits of cadmium in both his 
liver and kidneys. Neither Friberg nor Baarder reported on blood or urinary 
cadmium levels in their exposed workers. 
Bonne11,1949, (60) examined two groups of British workers in two separate 
factories producing copper cadmium alloys and compared them with controls 
of the same age distribution. In all, 100 workers with an exposure range 
of 5 to 26 years were investigated. 
(32) 
104 controls worked in the same factory in jobs not exposing them to 
cadmium. No figures are given for blood cadmium but those in the exposed 
group excreted between 0 and 800 micrograms of cadmium per day. The 
working environment averaged 270 micrograms of cadmium per cubic metre. 
No figures are given for control group exposure. 
Although 12 exposed workers had clinical and radiological evidence of 
emphysema, respiratory function, as measured by vital capacity, maximum 
ventilatory capacity, total lung volume and intrapulmonary mixing showed no 
significant differences between the groups. Haemoglobin, erythroctye sedim-
entation rate and haematocrit showed no significant differences either. 
None of the workers with emphysema had proteinuria. A further seven with-
out emphysema also had proteinuria. Three control workers showed protein-
uria. Bonnell found the boiling test unreliable. 25% trichoroacetic 
acid or 3% sulphosalicylic acid gave positive reactions when added to the 
urine before boiling. Electrophoretic examination of 4 random sera showed 
that theoLglobulin was raised in all cases and the globulin high in two. 
Electrophoresis of urinary protein in two cases showed a large number of 
electrophoretic components sedimented in the 20,000 to 30,000 range. 
Forty four men in the series (41 exposed - 3 controls) excreted more than 
30 micrograms of cadmium per day (polarograph method). Less than 50% of 
these showed clinical or biochemical abnormalities. Specific enquiries 
failed to reveal loss of smell, yellow discolouration of teeth or abdominal 
pain. 
Reporting on a follow up of these men Bonnell, 1954 (61) suggests that 
(33) 
symptoms and signs may develop and progress after a latent interval despite 
cessation of exposure. 
Kazantzis et al, 1962, (42) extensively investigated 12 employees of a 
U.K. pigment factory handling cadmium seleno-sulphide. Although atmospheric 
levels of cadmium are not given, urinary excretion measured on two occasions 
varied from 1 - 109 micrograms/24 hours. Ten of the 12 workers excreted 
more than 30 micrograms per litre. Subjective respiratory symptoms - 
dyspnoea,cough, wheeze, were frequent but pulmonary radiology was not ab-
normal except in one case. 25% showed a low FEVi. Other tests of respir-
atory function were normal. 
No evidence of sterility was found nor was any anaemia or anosmia. Five 
subjects, all with a low FEV1, had proteinuria indistinguishable on two 
dimensional electrophoresis from that found in renal tubular disorder. 
Two of this group had an increased aminoaciduria, creatinine clearance and 
calcium excretion was elevated in 7. 
Serum., sodium and potassium, protein, cholesterol, calcium and alkaline 
phosphatase were all within normal limits. The plasmas of those excreting 
protein generally showed a tendency to hypochloraemic acidosis. These 
workers concluded that chronic exposure to cadmium could produce emphysema 
and renal tubular dysfunction. 
Adams et al, 1969 (46) reported on a twelve year supervision of men exposed 
to cadmium in a British alkaline accumulator factory. Cadmium in air levels 
varied depending on the department (range 50 micrograms per.cubic metre to 5 
milligrams). Many men excreting more than 30 micrograms of cadmium per litre 
(34) 
had proteinuria and renal dysfunction. They reported no other significant 
abnormality. 
Horstowa et al, 1966 (62) attempted to develop diagnostic criteria for 
cadmium poisoning on the basis of observations made on plant operators in a 
Polish alkaline battery factory. Workers were exposed to an atmosphere of 
.13 to 1.17 milligrams cadmium/cubic metre. Of 80 workers involved, 26 
were selected for intensive study because of symptoms (20 female - 6 male). 
The exposure time varied between 1 to 12 years. 
The most frequent complaints were insomnia,anorexia,weakness, headaches and 
dyspnoea. Ten workers had a yellow discolouration of teeth. Twelve had a 
reduced vital capacity. The haemoglobin did not deviate from normal level 
but the erythrocyte sedimentation rate was elevated in 17. Proteinuria was 
present in 7 cases. Sodium and potassium in blood and urine were normal. 
Serum iron and cholesterol were normal but serum lipids elevated in 9 
patients. Electrophoresis of serum protein showed an elevatedocl and4 2 
globulin in 14 cases. Radiological examination showed emphysematous changes 
in 17 patients (although only 12 had a diminished vital capacity). Bone 
films showed osteoporosis in 10 patients. In summary, these workers suggest 
that non specific symptoms, whilst they cannot serve as a basis, for cadmium 
poisoning, occur frequently in long exposure workers. 
Not all investigations have confirmed respiratory illnesses associated 
with chronic cadmium inhalation. Suzuki et al, 1965 (63) found protein-
. 
uria in Japanese workers in a vinyl chloride film plant exposed to cadmium 
stearate dust in concentration varying from 30 to 690 micrograms of 
cadmium but no significant difference in pulmonary symptoms or lung function 
(35) 
studies when compared with a control group. 
Teculeseu and Stanescu, 1970 (64) in a Rumanian study of 11 workers with 
more than 7 years exposure to cadmium oxide fumes in concentration between 
1.21 and 270 milligrams/cubic metre found neither proteinuria nor signifi-
cant changes in extensive pulmonary function studies, blood gases or chest 
radiology. 
Despite a few contrary reports, by 1970 it was generally accepted that long 
term exposure to cadmium was associated with both pulmonary and renal 
dysfunction and threshold limit values for cadmium both as dust or fumes 
had been set in various countries, e.g. America 200 micrograms/cubic metre 
for dust and 100 micrograms for fume; 20 and 10 micrograms/cubic metre in 
Finland. It was not long before there was debate about these levels. In 
1973 Lauwerys et al (65) studied three groups in Belgium, one group - 31 
females exposed to 31 micrograms/cubic metre for a period of 1 - 12 years - 
a second, 27 men to 134 micrograms/cubic metre for six months to 191/2 years 
and a third group of 22 men to 66 micrograms/cubic metre for 21 to 40 years. 
Cadmium in urine and blood, various enzymes, respiratory function and 
proteinuria were measured and compared with a number of controls. Although 
some cases of proteinuria were found in the first of two groups with lower 
years of exposure there was no significant difference in respiratory 
function studies between the exposed and controls. But in the group• 
exposed for longer than 20 years both respiratory symptoms and respiratory 
function showed a significant difference when compared to the control. 
68% of the exposed group had an abnormal electrophoretic pattern. There 
was a weak, but significant, correlation between urinary cadmium excretion 
and proteinuria. 
(36) 
These workers, discussing their findings, point out that the major uncert-
ainty in any survey is the average concentration to which workers are 
exposed during their workday life. Isolated, or even repeated, samplings 
over a short time span probably do not fully represent total past exposure. 
Nevertheless, they concluded that the threshold limit value for cadmium 
dust in the working environment should be SO micrograms/cubic metre if 
respiratory and renal dysfunction from cadmium absorption is to be avoided 
or minimised. 
Smith et al, 1975 (66) conducted a study amongst workers in a cadmium prod-
uction plant in Denver (U.S.A.). They endeavoured to determine the relat-
ionship between pulmonary function, respiratory symptoms and chronic 
exposure in workers with ten or more years in a high cadmium concentration 
atmosphere. All workers excreted more than 50 Ug cadmium/litre on one or 
more occasions. Two matched control groups - one with low cadmium 
exposure in the same plant and another with no exposure from outside the 
plant - were also examined. Cadmium air concentrations varied between 20.4 
milligrams per cubic metre to 50 micrograms over the twenty year sampling 
period. 
Pulmonary function was measured by Forced Vital Capacity (FVC), Forced 
Expiratory Volume (FEV) at one second, mid maximum expiratory flow (MMEF) 
arterial blood gases and chest radiology. No significant differences were 
found in respiratory symptoms or morbidity. The high exposure group had 
a significantly lower FVC but although the mean FEV and MPEF here were not 
of significance, smoking apparently made no difference to their findings. 
Chest film showed 29% of exposed workers had mild or moderate fibrosis. 
(37) 
Cadmium air concentrations varied between 20.4 milligrams per cubic 
metre to 50 micrograms over the twenty year sampling period. Diminished 
respiratory function correlared with both a urinary excretion greater 
than 25 micrograms per litre and time exposed. Additionally there was 
correlation between exposed time, airborne cadmium and urinary cadmium 
excretion. Urinary cadmium was measured by atomic absorption spectroscopy 
after dithizone extraction. 
There are so many variables between the numerous surveys of the health of 
cadmium workers that it is difficult and perhaps not even relevant to 
compare one with another. Such factors as geographic and cultural sit-
uation, actual environmental exposure, chemical and physical form of 
cadmium involved, associated exposure to other toxins, analytical technique 
used for the assay of biological and atmospheric cadmium, are so diverse 
that it is not surprising there are considerable areas of disagreement in 
the various findings. Nevertheless cadmium has been associated with the 
following abnormalities detected in those occupationally exposed to it:- 
1. Urinary Tract  
Renal tubular dysfunction 
Deceased glomerular function 
Renal calculi 
Carcinoma of bladder and prostate 
Glycosuria 
2. Haemopoetic System  
Mild anaemia of the iron deficiency type 
Raised Erythrocyte Sedimentation rate 
(38) 
3. Respiratory System  
Emphysema 
Carcinoma of the lung 
Anosmia 
Chronic rhinitis and pharyngitis 
4. Skeletal System  
Osteomalacia 
5. Reproductive System  
Non specific histological change in testicular tissue. Smith et al 
1960. 	(67). 
6. Alimentary System  
Liver damage 
Gastritis 
Dental changes 
7. Vague ill health and reducted working capacity 
In 1975 I carried out a survey at the Risdon works of the Electrolytic 
Zinc Company of Australasia comparing the health, physical findings 
• and results of certain routine biochemical and other non invasive 
investigations of a group of workers exposed to cadmium with a matched 
group of controls. The survey was planned to be more extensive than any 
reported in this chapter being designed to look for all the known Or 
suggested cadmium effects listed above. 
No similar survey has been reported in the literature. My group of men, 
(39) 
in contrast to those discussed above were associated with the extraction 
and refining of cadmium. They were also exposed to other heavy metals 
at the same time. (Chapter 7). 
(40) 
CHAPTER 6. 
Cadmium and the Non-occupationally Exposed  
Itai-Itai Disease 
In 1955 at a meeting of the Japanese Society of Clinical Surgeons, Dr. 
Nobura Hokino, a general practitioner from Fuchu in the Toyoma Prefectune 
Japan and Dr. M. Rono, assistant professor at the Kikei medical school 
reported on a "new disease" the former had been studying since 1946. 
Dr. Hokino called the disease Itai-Itai (meaning ouch ouch) because those 
patients afflicted cried out in pain when their bones were examined. All 
sufferers lived in the region of the Jintsu River system. 
In 1961, Hokino and Yoshioka, an agricultural scientist, suggested that 
heavy metals, particularly cadmium, could play a part in the etiology. In 
1968 the Japanese Ministry of Health and Welfare declared "the Itai-Itai 
disease is caused by_chronic cadmium poisoning in the presence of other 
inducing factors, pregnancy, lactation, unbalanced internal secretion, 
ageing, deficiency of calcium etc." It also announced that the Kamika 
Mining Station of the Mitsui Mining Company polluted the Jintsu river and 
that cadmium pollution of the river caused polluted soil, rice, soybeans in 
areas irrigated by the river, as well as underground wells nearby. 
In 1971, a district court in central Japan ruled that this bone ailment 
was caused by cadmium and that the Mitsui Mining Company must compensate 
the victims of the disease. 
Because of several puzzling features of the disease as described by Hagino, 
Murata (14) and others these rulings have created considerable controversy 
and debate. 
(41) 
The disease was epidemic amongst elderly women who had borne many children 
(average 6). The outstanding features were lumbar pain and myalgia, 
spontaneous fractures with skeletal deformities. Pain was readily elicited 
when pressure was applied to bone. A hypochromic microctyic anaemia was 
present, serum calcium and phosphorus was low and the alkaline phosphatase 
level was high. Although serum proteins were normal there was proteinuria 
and glycosuria with increased amino acid excretion in the urine. Analysis 
of the proteins revealed them to be similar low molecular weight proteins to 
those described previously as being associated with industrial cadmium 
intoxication. 
Cadmium in blood and urine was increased and zinc levels lower when compared 
to controls - Friberg (14). Histological studies showed renal tubular 
epithelial atrophy and bone changes consistent with osteomalacia. The 
cadmium content of the liver was about 5 times that in control specimens 
but that in the kidney was lower. 
Epidemiological studies have shown that the disease is confined to a 
limited area around the Jintsu river and that it is not genetic but 
environmental. These studies have also revealed other contaminated river 
systems in Japan. There is a high incidence of the combination proteinuria 
plus glycosuria associated with high body cadmium levels in inhabitants 
of areas along all these rivers. But no cases of overt osteomalacia or 
Itai-Itai disease have been found elsewhere. This is the basis of the 
controvesy surrounding the findings of both the Health and Welfare Ministry, 
and the Court. Is there another factor besides cadmium? 
(42) 
Almost all cases of Itai-Itai disease have been females yet in the 
endemic area the incidence of proteinuria plus glycosuria has been 
almost as high in males as in females. Two French and two British reports 
on bone changes associated with industrial cadmium intoxication indicate 
that osteomalacia occurs in both sexes. Nicaud et al (55), Bonnell (60). 
Friberg (14) in discussing Itai-Itai disease suggests that vitamin D must 
also play a role. He postulates that either vitamin D deficient ricketts 
associated with certain cultural practices of the area or vitamin D resis-
tant ricketts following on renal tubular disease is the basic cause of the 
Itai-Itai disease. 
Professor Takeuchi from the Department of Internal Medicine, Kanazawa 
University has reviewed the debate in a long article in the Nippon Rhinso 
(68). He casts considerable doubt on the validity of the link between 
cadmium and the disease and also appears to doubt a link between cadmium 
contaminated water, soil and irrigated crops, and the high incidence of 
proteinuria and glycosuria in inhabitants of these regions. Initially he 
was a supporter of the hypothesis that cadmium is the responsible toxin 
but now he believes that Itai-Itai is ricketts and quotes many cures with 
vitamin D therapy. 
Despite the Japanese Ministry and the Courts ruling there is still con-
siderable scientific and emotional debate throughout the world on the 
environmental effects of cadmium. Within the past decade a number of 
investigators have theorised, based on acceptable scientific observations 
both in animals and man, that environmental cadmium may be intimately 
involved in various pathological processes in humans. 
(43) 
Toxicological Effects of Cadmium Poisoning on Experimental Animals  
Cadmium has been shown to be highly toxic in numerous animal experiments. 
Its toxicity rating, 5, on a scale of 1 to 6 puts it in the category of 
extremely toxic - Gleason et al (69). The acute lethal dose by ingestion 
for man based on animal experiments is estimated to be between 5 and 50 
micrograms per kilogram of body weight. 
The following is a list of effects noticed in animals exposed to varying 
doses of cadmium:- 
Amyloidosis 
Anaemia 
Cancer 
Cirrhosis 
Dental changes 
Enteritis 
Gastritis 
Hypertension 
Hypocalcaemia 
Life span shortening 
Nerve damage 
Ovarian changes 
Pancreatic atrophy 
Proteinuria 
Pulmonary emphysema 
(44) 
Renal damage 
Teratogenic and embryotic effects 
Testicular atrophy and lesions 
Toxaemia of pregnancy 
Weight loss 
Many of these conditions have been found in workers exposed to cadmium, 
(vide chapter 5). Some however, have not been detected and some though 
found in exposed workers are also found to the same extent in controls 
or the population generally. 
Epidemiological Speculations  
(a) Cardiovascular Disease  
Carroll 1966 (70) examined mortality ratios standardised for age, sex and 
race for heart disease except rheumatic disease in 28 cities in the 
United States and the concentration of cadmium in the air of these cities. 
The death categories included arteriosclerotic heart disease, hypertension 
with or without mention of heart, and other heart diseases attributed 
to non specific terms: congestive cardiac failure or myocardial degeneration. 
He found a positive correlation between the two but no correlation between 
vascular lesions of the central nervous system and atmospheric cadmium. 
Schroeder 1965 (71) from an examination of renal tissue from subjects 
living both in the U.S.A. and outside the U.S.A. concluded that most 
patients dying from hypertensive complications showed either an increased 
concentration of cadmium or an increased cadmium to zinc ratio compared to 
subjects dying of a variety of other major diseases. In another study 
1966 (72) he noted that soft or acid waters frequently contain cadmium in 
(45) 
excess of U.S. Public Health Standards and a positive correlation between 
soft water and hypertension. 
Morgan 1972 (73) in a careful assessment of cadmium tissue levels in 
hypertensive patients and controls found no excessive renal cadmium in 
the former. Hammer (74) in an epidemiological survey of people industrially 
exposed to cadmium found no rise in blood pressure in this group. It has 
been suggested that occupationally acquired zinc acted as a protective 
in this group. 
(b) Respiratory Disease  
Lewis et al 1969 (75) found, from autopsies carried out in Glascow, an 
elevated liver cadmium level in those dying from emphysema and or bron-
chitis. No data were given on occupation or smoking habits. 
(c) Malignant Disease  
Cadmium has relatively strong carcinogenic properties when administered 
to animals. Morgan 1970 (76) reported significantly higher renal and 
hepatic cadmium concentrations in tissues taken from the general popul-
ation dying of carcinoma of the lung. Earlier Tietz 1976 (77) had found 
increased liver and lung cadmium levels in persons with pulmonary, oesoph-
ageal, pancreatic and brain tumors. 
Potts 1965 (78) reported a high incidence of cancer in 74 men exposed to 
cadmium for 10 years. Eight of the men died, three from carcinoma of 
the prostate, one from the lung and one where the primary was not identified. 
(46) 
Other workers have recorded similar figures. Lemen et al, have reported 
in a paper presented at a meeting on Occupational Carcinogenesis sponsored 
by the New York Academy of Science in March 1975 that their retrospective 
survey of deaths of 280 workers in a cadmium plant showed a higher incid-
ence of lung and prostatic cancer as well as total malignancies than would 
have been expected in the general population. 
d) Testicular Damage 
Partizek 1957 (79) reported a rapid sterilising effect (within 4 - 6 hours) 
from a small injected dose of cadmium chloride or lactate in rats. 
Histological changes were seen, in the seminiferous epithelium but none in 
liver or renal cells. After about a month endocrine function returned. 
Higher doses produced permanent sterility. Chiquoine 1964 (80) reviewing 
all the studies on various animals concluded that cadmium had a sterilising 
effect on species with scrotal testes but not on those possessing abdominal 
testes. Gunn et al (48) reported that zinc, selenium and thiols, e.g. 
cystein and British - Anti Lewesite prevented necrosis. 
Favino et al 1965 (14) analysed the fertility of ten cadmium workers and 
their hormonal levels. He found no evidence of infertility and one case • 
of low androgen level. 
e) . Teratogenesis  
Pregnant experimental animals fed cadmium either abort, produce small 
litters, abnormal offspring, or small offspring - Schroeder (81). Friberg 
(14) quotes Cvetkova as having reported that women working in a cadmium 
accumulator factory in Russia produced lower birth weight male and female 
children than did the population generally. In addition some offspring 
(47) 
suffered from ricketts or delayed dentition. 
f) Pancreatic Function  
Although high concentrations of cadmium are found in the pancreas in the 
occupationally exposed, little work has been done on the effect of cadmium 
on pancreatic function. Friberg (14) quotes Murata as recording a de-
crease in pancreatic activity in Itai-Itai disease. 
g) Mutagenesis  
Conflicting reports have appeared in recent literature on the mutagenicity 
of cadmium compounds. Cadmium can bind to the phosphates and bases of 
Desoxy-ribonuclecic acid and as such could induce genetic alteration. 
Plants e.g. peas and beans treated with cadmium do show chromosomal 
abnormalities. However, neither the fruit fly, Drosophila nor the paras-
itic wasp, Habrobraeom produced mutations when given large doses of cadmium. 
Shiraishi and Yosida (82) reported an increased frequency of cells with 
chromosome abnormalities in Itai-Itai patients. The-Hung Bul et al 1975 
(83) could not find any evidence of chromosome damage in 4 cases of Itai-
Itai disease or in 5 Swedish workers with a higher blood cadmium level 
than Itai-Itai patients. Very few genetic studies either in animals or 
humans have been performed. Many more studies are needed before it can 
be established that environmental cadmium is a health hazard. 
The high concentration of cadmium in the silt and waters of the River 
Derwent and in the surface soil of some areas around Hobart has caused 
considerable speculation as to whether the health of the public is at risk 
because of this. One pointer might be the health of workers closest to the 
source of this environmental contamination. 
(48) 
CHAPTER 7 
A Health Survey of Workers Exposed to Cadmium in Hobart  
At its Risdon plant, on the Derwent River, Tasmania, the Electrolytic 
Zinc Company of Australasia recovers cadmium from a cadmium copper 
precipitate by-product of the purification stage of zinc. 
Twenty seven men working on a three, eight hour shift per day basis are 
employed in the recovery operation which is conducted in a small multi-
storied building. 
In brief the recovery operation consists of:- (Anderson 1949 (84)) 
1. Oxidation and grinding of cadmium copper precipitate 
2. Leaching and filtering 
3. Precipitation of cadmium 
4. Oxidising and grinding of the precipitated cadmium 
5. Leaching oxidised cadmium precipitate and purification of the 
leach solution 
6. Electrolysis of cadmium sulphate solution 
7. Melting, casting and packing 
Men working in this plant are exposed to cadmium both as dust and fume. 
Concentration of each of these varies considerably over the working day 
and throughout the various areas of the plant. Eight hour sampling of 
the working environment indicates that the average concentration of 
cadmium varies from 17 to 31 micrograms per cubic metre. 
(49) 
Situated close to the cadmium plant is a small building housing a compressed 
air station. Eight men are employed in this building working on a three, 
eight hour shift per day basis. The working environment of the building is 
subject to some fall out from the cadmium plant, mostly cadmium dust. An 
eight hour sampling of the atmosphere within the station reveals a concent-
ration of 1 microgram per cubic metre. 
Another section of the plant produces super phosphate by mixing acid with 
ground up phosphate rock. The phosphate rock may come from several world 
sources and can contain up to 200 parts per million of cadmium. The number 
of men working in this plant and the number of shifts worked per week fluct-
uates considerably depending on the demand for superphosphate. An eight 
hour sampling of the working environment of this section of the plant revealed 
a concentration of between 0.15 micrograms per cubic metre to 0.85 micrograms 
per cubic metre. 
Each section of the plant at Risdon is visited by a medical officer at least 
once every six months. At each visit the working environment is examined. 
The company has given considerable attention to industrial hygiene and the 
past decade has seen the introduction of measures aimed at improving both 
working conditions and protection from excess exposure to cadmium. 
The waters of the River Derwent and the sediment in the river show a high 
concentration of heavy metals including cadmium - Bloom (85). Soil in some 
areas around Hobart also reveals a higher cadmium content than others (86). 
This has been attributed to atmospheric pollution at least in part by the 
plant and subsequent wind dispersion. Commercial oysters in the river show 
a high cadmium content - Thrower (87). 
(50) 
In September, 1975, I conducted a health survey amongst workers in those 
areas where cadmium is a possible occupational hazard, and a control group 
from a general office well removed from cadmium sources. 
The survey received the encouragement and backing of the Electrolytic Zinc 
Company. Company records, both employment and sickness were made available 
to me. Widespread promotion through Unions, Union representatives, employee 
social groups, and individual employees allayed any fears or misapprehension 
those who would be involved might have. Clerical staff were made available 
to facilitate the organisation and logistics of the survey. Employees 
taking part were given time off in working hours and transported by 
company vehicle to the various centres for the medical examination, radiology 
and pathology required. 
With this background I wrote to every employee exposed to cadmium and a 
group of clerical workers for controls inviting them to participate. 
Twenty two of the twenty seven men in the cadmium plant volunteered, four 
of the eight men working in the compressed air station and eight of the 
seventeen men working in the superphosphate plant - in all, a total of 
thirty four exposed workers. There is a slight bias towards younger men 
in the control group - thirty four office staff. (Figure 6, Page 76 ) 
Objectives of the Survey  
1. To elicit any individual or pattern of symptoms which could be attributed 
to working with cadmium. 
(51) 
2. To elicit any clinical signs or groups of signs which could be ascribed 
to cadmium effect. 
3. To compare the overall health of workers exposed to cadmium with a non 
exposed control group with particular references to:- 
(a) the skin 
(b) the central nervous system 
(c) liArer function 
(d) gastro-intestinal function 
(e) renal function 
(f) blood pressure 
(g) myocardial function 
(h) coronary and peripheral arterial disease 
(i) respiratory function 
(j) bone marrow function 
(k) gonadal function 
(1) 	bone structure and density 
4. To examine a series of easily performed biochemical and radiological 
investigations which may indicate a covert cadmium effect on tissue or 
cellular function. 
5. To examine any correlative effect of other industrial metals, e.g. zinc, 
lead, mercury. 
6. To compare the findings of this survey with similar surveys elsewhere. 
(5 2) 
7. To investigate the significance of extra occupational cadmium absorption 
from diet, smoking, residence. 
8. To develop a simple screening procedure which would indicate to the 
employer, employee and examining medical officers that body cadmium 
was at the danger level. 
The Survey  
Each participant completed, at his leisure, a questionnaire designed to give:- 
a) Information about possible background cadmium exposure from: diet, prev-
ious occupation, smoking habits, residence past and present. 
b) Information concerning past and present health. 
c) An indication of symptoms suggesting effects of either acute or chronic 
exposure to cadmium on all bodily functions. 
Later all received an extensive medical examination. At the time of the 
examination the completed questionnaire was discussed in detail. Answers 
were confirmed and clarified where necessary. Further information was also 
sought, particularly in the area of gonadal function (it was thought prudent 
not to include this in the written questionnaire). In addition those exposed 
occupationally to cadmium were questioned about workmates who had left or 
retired. The objectives of this was to see if a retrospective survey of the 
health of these men would prove worthwile. A sample questionnaire follows:= 
(Pages 53 - 62) 
(53) 
MEDICAL IN CONFIDENCE 	 (1) 
SURNAME: 
GIVEN NAMES: 
c, 
Present Address: 	 How many years have you 
lived there: 
Previous Address(es) in Australia 	How many years did you 
(If any): 	 live there: 
Date of Birth: 
Country of Birth: 
Years in Australia: 
Where have you lived before coming to Australia: How many years did you live 
there: 
Years in Hobart: 
Years worked at the Electrolytic Zinc Company: 
Where: 
Where have you worked 	What did you do there: 	For how long did 
previously: you work there: 
Small 1 
1 1 1 
F 	I Small Moderate 
Diet: 
Sea fish 
Shell fish 
Meat 
Big eater 
Big eater 
Big eater 
Moderate 
Small 	1 	1 Moderate 
(54) 
MEDICAL IN CONFIDENCE 	 (2) 
Personal history  
Single/Married: 
Exposure to fertiliser/pesticides  
Never 	Sometimes 	Often At home: 
   
I 
         
On farm: 
  
Never 
  
Sometimes 1 
  
Often 
           
Smoking history  
Started: 	Stopped: 	cigarettes/day 
pipes/day 
	cigars/day 
Alcohol intake  
	beers/day 	nips/day 
(55) 
MEDICAL IN CONFIDENCE 	 ( 3) 
PERSONAL PREVIOUS MEDICAL HISTORY 
Illnesses - requiring hospital treatment 
Illnesses - requiring a week or more off work 
Operations - 
Medical Treatment, if any, at present - 
Names of drugs taken previously - 
(56) 
MEDICAL IN CONFIDENCE 	(4) 
FAMILY MEDICAL HISTORY 
Good Health Poor Health: Dead When Cause 
Father: 
Age 
Mother: 
Age: 
Brothers: 
Age: 
Sisters: 
Ages: 
Children: 
Ages: 
1 (, 
(57) 
MEDICAL IN CONFIDENCE 
Please tick appropriate box  
In the past five years: 
(5) 
1. Has your weight - 
2. Has your appetite -  
Increased by five pounds of more 
Increased, but less than five pounds 
Remained just about the same 
Decreased, but less than five pounds 
Decreased by five pounds of more 
Increased quite a bit 
	I Increased slightly 
Remained just about the same 
Decreased slightly 
Decreased quite a bit 
3. Diet - 
Have you been following any special diet 
Yes No 
Do certain foodstuffs, or types of cooking upset you 
Yes 
If so, what foods and why 
1 	No 
Fatty or fried foods 
Spiced dishes 
Exotic cooking 
Any other foods 
(58) 
MEDICAL IN CONFIDENCE 
4. Existing habits 
Do you eat three normal meals a day 
(6) 
Yes No 
Do you forgo meals each day 
Consistently 	Spasmodically 	Seldom 
5. In general, has the frequency of your bowel movements - 
Decreased 
6. Has the size of the movement, in general - 
7. Has the colour of the movements, in general - 
I 	I 
8. Have you passed any black, tarry looking stools - 
Increased 
Increased 	I 	I Decreased 
Increased 	Decreased 
Not changed 
Not changed 
Not changed 
Not at all Several times 
9. Do you have:- 
Abdominal Pain -  
Only once of twice 
None Sometimes Often 
Or Cramps - 
None Sometimes Often 
10. Wind or belching - 
None Sometimes Often 
When - 
(59) 
	
MEDICAL IN CONFIDENCE 	 ( 7) 
11. Have you had a cough - 
That continues rather regularly 
That shows up only once in a while 
Not at all 
12. Have you coughed up any blood - 
Several times 	Only once or twice 	Not at all 
13. Do you have shortness of breath - 
Yes 	No 
14. Do you wheeze - 
No 	I 	1 Sometimes 	Constant 
15. Do you have sputum production - 
Slight 	Moderate 	Plenty 
16. Do you have colds or bronchitis - 
Never 	Sometimes 	Often 
17. Have you had a sore throat - 
Several times 	Only once or twice 	Not at all 
18. If you have a sore throat is it usually - 
of a fairly long duration 
of rather short duration 
(60) 
MEDICAL IN CONFIDENCE 	(8) 
19. Have you had any progressive or recurring hoarseness that was not 
associated with a cold - 
II Several times 
20. Sense of smell - 
21. Chest pain - 
None 
At rest 
Only once or twice 
Good 
Slight 
On exertion 
Not at all 
Poor 
Severe 
When: 
22. Have you had dizzy spells - 
Were they:  
Yes 
Severe and frequent 
Severe but not frequent 
Mild and frequent 
Mild and not frequent 
No 
23. Have you had any headaches that were - 
Severe and frequent 
Severe but not frequent 
Mild and frequent 
Mild and not frequent 
Do not have headaches 
24. In general, has the frequency with which you urinate during the day - 
Increased Decreased Not changed 
(61) 
MEDICAL IN CONFIDENCE 
25. Has the frequency with which you urinate at night - 
(9) 
Increased Decreased Not changed 
26. Do you have blood in urine - 
Yes No 
27. Do you have scalding - 
Yes 
28. Do you have pain in kidneys 
I Yes 
29. Do you have groin pain - 
Yes 	I 	I 	No 
30. Do you have any noticeable swelling of your ankles or legs - 
No 
No 
Not at all Several times 
31. Do you have bone pain - 
Only once 
or twice 
No Yes 
Where: 
32. Do you have joint pain - 
Yes 
Where: 
No 
33. Have you ever had any - 
Fever 
Chills 
Unusual 
sweats 
I 	I Several times 
Several times 
Several times 
I 	I 
I 	I 
34. Have you had any - 
Earaches 
Ringing inl 	I 
your ears 
Several times 
Several times 
Several times 
Several times 
Several times 
Diminishe 
hearing 
Paralysis 
Nervous 
trouble 
Only once or 
twice 
Only once or 
twice 1 
	I None 
I None 
Only once or 	None 
twice 
Only once or 
twice I 	I None 
Only once or 
twice I 	 None 
Only once or 
twice I 	I 
Only once or 
twice 
Only once or 
twice 
Only once or 
twice 
I 	I 
Only once or 
twice 
Only once or 
twice I 	I 
SIGNATURE 
Eyes 	I 	I Several times 
Ears 	Several times I 
Nose 	Several times 
Mouth 
	 Several times 
Rectum 	Several times 
Genitalia 	Several times 
None 
None 
None 
None 
None 
None 
(62) 
MEDICAL IN CONFIDENCE (1 0) 
Only once or pl 	1 None twice 
Only once or 	None 
twice 
Only once or 	None 
twice 
35. Have you had any discharge of blood or pus from your - 
(63) 
Alcohol  
Eighteen men in the exposed group answered that they rarely took alcohol; 
this represents 52.9% of this group. Five of these men admitted that they 
had averaged 80 grams per day in the past, but had not consumed alcohol 
for at least five years. In the control group 14.7% rarely drank alcohol. 
In both groups there were five men who consumed more than 80 grams of 
alcohol per day. It is generally accepted that there is a high risk of 
physical, social and mental damage if consumption exceeds 80 grams per day. 
Smoking  
No attempt has been made to distinguish pipe, cigar or cigarette smokers, 
nor to define smokers into light, medium or heavy. A non-smoker was defined 
as one who had not smoked for five years. Each group of non-smokers contain-
ed men who had smoked prior to 1970. These are identified where required. 
The majority of "non-smokers" in the exposed group were smokers at some 
stage of their lives. 
The examination included:- 
a) 	An E.C.G. 
b) 	An assessment of respiratory function:- 
i) Vital Capacity 	 ) measured on a Pulmotest 
ii) Forced expiratory volume at one second 	spirometer 
c) Routine urine testing using:- 
i) Bililabstic (Ames) 
(64) 
iii) A further examination for protein was made by boiling a measured 
quantity of freshly voided urine and adding acetic acid. 
Special Investigations  
a) Radiology 
i) Forearm through a water jacket to examine ulnar cortical density - 
Doyle 1961 (88). 
ii) Chest - if no recent chest film available. 
There examinations were carried out by Dr. B. Fazackerley of Hobart. 
b) Biochemistry 
i) Metals in urine (24 hour specimen). 
ii) Metals in blood. 
The concentration of cadmium, lead, mercury and zinc in both these fluids 
was determined by Chemlabs - Hobart. 
The description of their methodology, as supplied by the laboratory reads 
as follows:- (Pages 65 - 67). 
(65) 
HEAVY METALS 
Methods of analysis  
General  
The methods selected for analysis of blood and urine 
were selected after a review of methods used in similar 
surveys reported in the literature. It was noted that many 
surveys, led to results which could be partly attributed to the 
methods of analysis. Accordingly, we have in each instance 
used the method of addition of standards, together with 
correction for non-atomic background absorption effects, 
which are intended to take into account sample peculiarities 
which may either enhance or diminish the atomic absorption 
signal for each metal being measured. Each metal has been 
measured by atomic absorption spectrophotometric techniques. 
The reliability of these analyses has been confirmed by 
interlaboratory surveys in which different methods of 
analysis have been used, i.e. anodic stripping voltametry 
and atomic absorption flame and flameless techniques. 
Mercury in blood and urine samples was determined by 
digestion then measurement of generated mercury vapour by 
atomic absorption spectrophotometry. Many procedures have 
been recommended for digestion of organomercury compounds 
under reflux. However, to avoid the losses of volatile 
mercury compounds, the digestion was carried out in a cold 
sealed flask of acid-permanganate over a 48 hour period. 
Zinc was determined in both types of samples after perchloric 
acid digestion and suitable dilution. It is noted that many 
authors preferred in the case of urine to aspirate the sample 
directly into the flame. We preferred to remove all traces 
of organic matter from both types of samples to overcome the 
significant non-atomic absorption effects that would otherwise 
result. 
Cadmium and lead were determined in both types of samples 
after a preconcentration step, which isolated the metals 
from the effects of sample matrix interferences. These 
metals were chelated with a mixture of sodium diethyldithio-
carbamate and ammonium pyrollidine dithiocarbamate, at the 
appropriate pH, then extracted into a methyl isobutyl 
ketone organic phase which was subsequently aspirated into 
the flame. 
(66) 
Table (1)  
Limits of detection and accuracies for analytical methods used 
Detection 	Detection . 	, 
	
limit Accuracy 	limit 	Accuracy 
Urine Ugh 1 Blood 
1 triMooml; 
Mercury 	(0.2 	!0.1 at 0.5 	0.1 	!0.2 at 1.0 
+ 	 + Cadmium 	0.3 -0.2 at 1.0 	(0.2 	-0.1 at 1.0 
Lead 2.0 	! 4 at 40 	2.0 	! 1 at 20 
Zinc 	20 ! 10 at 500 	20 	! 10 at 500 
Table (2)  
Lead in blood - a comparative study 
Conch . in lig/100 ml 	 Solvent 
anodic stripping extraction 
Sample 	voltametry (ASV) 	Carbon rod AAS 	MS 
Univ. of Tas. 	Univ. of Tas. 	Univ. of Tas. 
1 	10 9.7 11 
2 12 9 12 
3 10 10.2 	6 
4 	8 	15.3 12 
5 20 20 18 
6 25 29 	28 
7 12 13 13 
8 	10 	16 10 
9 8 7 6 
10 28 24 	24 
Univ. of Tas. (ASV) Chemlabs 
M. Bowerman 	 30 	26 
J. Folder 14 13 
R. Edwards 13 16 
B. Watson 15 16 
K. Young 	 16 	16 
I. Richards 26 27 
(67) 
Table (3)  
Analysis of cadmium in urine, cited by Berman (1) using a solvent 
extraction procedure similar to that used in this project. 
Westerlund-Helmerson (2) has used this method successfully for 
analysing cadmium in blood down to 0.2 Ug/100 ml. 
No. of samples 
Cadmium 
added Ug/100 ml 
Cadmium 
recovered Ug/100 ml 
5 5 5-5.5 
5 10 10-11 
5 20 20-21 
5 30 29-32 
5 40 41-42 
5 50 49-54 
1. Berman, Eleanor (1967) "Determination of cadmium, thallium 
and mercury in biological materials by atomic absorption." 
At.Absorp.Newsl., 3(6), 57-60. 
2. Westerlund-Helmerson, Ulla "Determination of Lead and 
cadmium in blood by a modification of the Hessel method." 
At.Absorp.Newsl., 9(6), 133-134 
Table (4)  
Analysis of lead in blood in conjunction with Chemistry Department 
of University of Tasmania who participated in an International 
Survey 
Conch . Ug/100 ml 	Average conch . found by 
found by this different laboratories 
laboratory 	using a variety of methods  
59 	62.9 -9 Ug/100 ml by 
solvent extraction/flame 
atomic absorption 
(68) 
c) The following biochemical, haematological and bacteriological studies 
were performed by Dr. Parson's Laboratory, Hobart. Where appropriate 
a short description of the technique is given. The normal range for 
the laboratory is also presented. 
Serum bilirubin  
Determined by reaction with diazotised sulphanic acid in aqueous (conjug-
ated) or methanolic-aqueous (total) solution. Normal range is up to 1 
mg/100 ml. 
Alkaline phosphatase  
Measured by fixed-time hydrolysis of phenolphthalein phosphate at 37 ° . 
Normal range is 9 - 35 units. 
Serum glutamic pyruvic transaminase  
Determined by a kinetic method using a Boehringer kit. Normal values up 
to 27 u/l. 
Serum cholesterol  
Determined by the Liebermann-Burchard reaction. Normal values range from 
150 - 250 mg/100 ml. 
Serum triglycerides  
Triglycerides are separated from other lipids by partition between nonane: 
isopropanol and water. The triglycerides are saponified and the liberated 
glycerol determined by the Hantsch condensation. Normal fasting range is 
30 - 135 mg/100 ml. 
(69) 
Blood urea nitrogen  
Determined by urease-catolysed hydrolysis to ammonia, followed by reaction 
with phenol and hypochlorite. Normal range in this laboratory is 20 - 40 mg/ 
100 ml. 
Serum creatinine  
Determined by the Joffe reaction with alkaline picrate. Normal range in 
this laboratory is 0.8 - 1.3 mg/100 ml. The creatinine clearance (ml/min) 
can be calculated by the formula: 
Creatinine Clearance = U x V ml/minute 
where U = urine concentration (mg/100 ml.), V = urine vol. per minute, 
and S = serum or plasma concentration (mg/100 ml.) Normal value is 120 - 
130 ml/min. 
Serum sodium  
Determined by manual flame photometry. Normal range in this laboratory is 
136 - 149 mal/l. 
Serum potassium  
Determined by manual flame photometry. Normal range in this laboratory 
3.8 - 5.2 mal/l. 
Serum chloride  
Determined by titration with mercuric nitrate/diphenylcarbozone without 
deproteinization. Normal range in this laboratory is 98 - 108 ma1/1. 
Blood glucose  
Determined by reaction with 0 - toluidine plus acetic acid. Normal values 
in this laboratory are 70 - 220 mg/100 ml. 
(70) 
Blood uric acid  
Determined by reaction with phosphotungstic acid after deproteinization. 
Normal range is 2.5 - 7.0 mg/100 ml. 
Serum protein  
Total protein determined by EDTA-chelated biuret method. 
Electrophoretic pattern of serum proteins  
Proteins separated by electrophoresis on cellulose acetate at pH 8.6. 
Serum thyroxine  
Determined by the Oxford T4 - by Column Kit. Normal values are 3.0 - 
6.6 ug/100 ml. 
Serum calcium  
Determined by complexation with methylthymol blue plus 8 - hydroxyquinoline 
followed by colorimetry. Normal range for this method is 4.2 - 5.3 mEq/1. 
Serum Phosphous  
Determined by reduction of phosphomolybdic acid to molydenum blue. Normal 
range (as phosphorus) is 2.5 - 4.5 mg/100 ml. 
d) Sex hormones  
i) Serum testosterone 
ii) Serum luteinising hormone 
iii) Serum follicle stimulating hormone 
Measurements of these hormones were done at the Medical Research Centre, 
Prince Henry's Hospital, Melbourne, by Dr. H. Burger using radio-immuno 
assay. Normal ranges are shown in Figures 3, 4 and 5. Pages 71 - 73. 
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(74) 
e) Haematology  
Haemoglobin 
Packed cell volume 
White cell count 
Platelet count 
Relative viscosity 
Differential white tell count 
f) Urine  
Microscopy and culture 
Examination of 24 hour specimen 
Creatinine  
Determined by the Joffe reaction with alkaline picric acid. The normal values 
given in standard texts are: 
0.4 - 1.8 g/24 hr. (Wootton); 1.0 - 1.5 g/24 hr. (Boehringer); 
1.1 - 2.5 g/24 hr. (Merck); 1.0 - 2.0 g/24 hr. (Tietz). 
Amino acids screening test  
Determined by formation of a charge-transfer complex with benzoquinone - 
Lorentz, K. and Flatter, B. Clinical Chemistry, 20, 1553 (1974). These 
authors quote a range of 73 - 260 mg/24 hr. Most standard texts quote higher 
values: 200 - 700 mg/24 hr. (Tietz); 175 - . 530 mg/24 hr. (Merck). 
(75) 
The History  
After consideration of the written and oral replies it became apparent 
that only significant sources for body burden of cadmium would be occupat-
ional exposure and smoking. Diet and residence in a higher soil cadmium 
locality showed no significant variation between the groups. 
Many of the signs, symptoms and biochemical findings could have been 
effected by a high intake of alcohol. As both groups contain the same 
percentage of men with an excess alcohol consumption it was felt that any 
influence of alcohol on the statistical findings would be balanced and 
could be ignored. Accordingly the survey results were arranged and are 
presented in four groups as follows:- 
CONTROL GROUP EXPOSED GROUP 
No 34 No 34 
Smokers 22 Smokers 23 
Non-smokers 12 Non-smokers 11 
Figure 6, page 76 shows the years worked for each individual in each group. 
Figure 7, page 77 illustrates the smoking history. 
Statistical Analysis of Results  
Dr. D. Ratkowski from the Division of Mathematical Statistics, C.S.I.R.O., 
Hobart, analysed the survey findings. 
The survey data were subject to analyses of variance using the F test, 
correlation coefficients and X 2 tests of contingency. The text identif-
ies the method used to arrive at a conclusion. 
CORRECTION 
Page 76, line 9, Unexposed 
Smokers column, the figure 
32 should read 15. 
(76) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
1 8 
6 
5 6* 
8 5 
•. 11 
9 
3 	A 16 2 	C 16 
• 7** 
32 
A 23** 19 
5 	A 16 1 
• 4 	A 22 
15 	B 
3 	A 
• 11 	C 
7 	A 
11 	A 5 26 
9 	A 13 25 
23 	A 17 
• 9 	A 
11 	B 
24 	A 6 33 
28 	.0 46 20 	A 
10 * A 
15 	A 8 13A 37 
19 	C 11 23 * A 23 
• 38 
20 	A 9. 12 	C 
27 	C 40 8 * C 
24 	A 18 * A 
37 	A 37 * B . 19* 
26 	A 22 * A 
27 	A 
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YEARS WORKED 
AT THE ELECTROLYTIC ZINC COMPANY 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 6  
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
4 - 
11 
10 - 	* 
13 - 
• 12 
• 11 
16 	A 16 - 	C - 
• 14** 
15 
19 	A 20** - 
18 	A 23 - 
21 	A 23 
25 	B 
18 	A , 22 	C 
19 	A _ 
29 	A 24 - 
15 	A 26 - 
32 	A 26 
30 
27 	B 
30 	A 27 16 * A - 
26 	. C 25 - 	A - 
9 *A 
39 	A 35 - 	A - 
37 	C 38 37 * A - 
26 
26 	A 41 - 	C 
41 	C 38 30 * C 
41 	A 32 * A 
40 	A 42 * B - 	* 
41 	A 7 * A 
41 	A 
SMOKING YEARS 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 7 
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CHAPTER 8 
Body Burden of Mercury, Lead, Zinc and Cadmium  
The blood levels for these four heavy metals expressed as Ug/ml. and the 
amount excreted in a 24 hour urine collection expressed as Ug/litre were 
determined once for each participant. The findings were used as a guide 
to body burden. Additionally the findings were subject to further stat-
istical analyses to check whether the presence of lead, zinc or mercury 
might influence any possible cadmium effect. 
All blood specimens were collected in the laboratory. Exposed workers, in 
order to remove accidental occupational skin contamination showered before-
hand. The 24 hour urine specimen was collected at a weekend, or in the case 
of shift workers on their "days off" - again to remove possible occupational 
contamination. Each participant received two separate detailed instructions 
on the collection of a 24 hour specimen - one in writing and the other 
orally when they were given the specimen bottle. This was a glass 2 litre 
bottle cleaned with concentrated nitric acid and containing 10 mls. of 
hydrochloric acid as a preservative. Participants were warned not to use 
plastic material in the collection process. Arrangements were made to 
provide the laboratory with each specimen almost immediately after collection. 
Mercury  
Laboratory results for blood and urine levels are shown in figure. 8, page 80 
and figure 9, page 81 for each sub-group. Table 1, page 82 and table 2, 
page 82 indicate the mean, minimum and maximum concentration for each group. 
Statistically there is no significant difference between the groups using 
(79) 
an analysis of variance. Body burden of mercury is considered to be the 
same throughout the groups and will therefore be ignored as a possible 
influence on any cadmium effect. 
Lead 
Figure 10, page 83 shows individual results for blood lead for each group. 
No member of either group had a blood level above the accepted danger 
level for lead (70-80 Ug/m1.). There is a significant difference in blood 
lead levels between the combined exposed groups and controls - (table 3, 
page 85 ). The mean for this group, (23.65) is significantly higher than 
that of the combined unexposed group, (19.29), (p<0.05). This higher blood 
level was not expected when the survey was planned as lead in residue 
from the zinc plant is removed before the cadmium residue is treated in the 
cadmium plant. The possible association between lead, cadmium and haemo-
globin levels is discussed in a later section. Figure 11, page 84 shows the 
individual figures of a 24 hour lead excretion concentration. There is no 
statistical difference between the groups - (table 4, page 85). 
Zinc 
Figures 12, page 86 and 13, page 87 and tables 5, page 88 and 6, page 88 
show the results and statistical analyses for each group for this metal. 
Again statistically there is no significant difference between the groups. 
(80) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
1.2 0.3 
0.1 
nd. 0.4 * 
nd. 0.3 
0.3 
0.3 
nd. A 0.1 0.1 	C 0.4 nd. 	** 
0.1 
, 
nd. A nd. 	** 0.4 
0.4 A 0.4 nd. 
0.8 A 0.7 
0.3 B 
nd. A 
nd. C 
0.1 A 
0.4 A nd. 0.4 
0.1 A nd. nd. 
0.1 A nd. 
0.4 A 
0.3 B 
• 0.1 A n 	. 0.3 * A nd. 
nd. C 0.7 0.3 	A 
0.1 	* A 
n 	. A nd. 0.7 	A 0.1 
0.3 C 0.3 0.4 * A 0.9 
• 1.2 
nd. A 0.7 	C 
0.4 C nd. nd. 	* C 
0.9 A nd. 0.7 * A 
0.3 A nd. 	* B 0.9 * 
0.4 A 0.1 * A 
0.4 A 
BLOOD MERCURY (UG/100 MLS.) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE  8 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
1.6 3.7 
2.0 
2.8 4.6* 
0.3 _ 1.3 
• 2.0 
• 0.5 
0.7 	A 2.5 nd. 	C 2.6 
4.3 
1.0 	A 0.3 ** 2.1 
4.0 	A 4.6 nd. 
• 1.0 	A 1.5 
0.3 	B 
nd. 	A 
1.3 	C 
4.3 	A 
2.5 	A 1.3 1.0 
0.7 	A 0.7 1.3 
nd. 	A 0.7 
2.2.A 
0.3 	B 
0.2 	A 0.3 1.3 * A 1.3 
0.3 	•C 2.6 4.6 
, 0.3 * A 
0.4 	A , 2.0 1.0 	A 4.3 
3.6 	C 2.0 1.0 * A  nd. 
0.3 
0.4 	A , 0.7 8.9 	C _ 
2.6 	C 0.7 0.3 * C 
nd. 	A 6.7 * A 
2.4 	A 4.0 * 2.0 * 
nd. 	A 1.0 * A :0.2 	A 
UNDER 3 
25 - 30 
30 - 35 
35 - 40 
40 - 45 
45 - 50 
50-55 
55-60 
60 & OVER 
URINARY MERCURY (UG/LITRE) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C 	Superphosphate Plant 
FIGURE 9 
(82) 
Blood Hg - 	(Ug/100 mls.) 
Mean Min Max 
Unexposed smokers 0.245 0 1.2 
Unexposed non-smokers 0.342 0 0.9 
Exposed smokers 0.248 0 0.9 
Exposed non-smokers 0.309 0 0.7 
TABLE 1 
Groups not significantly different. 
Urine Hg - (Ug/litre) 
Mean Min Max 
Unexposed smokers 1.55 0.3 4.6 
Unexposed non-smokers 2.02 0 4.6 
Exposed smokers 2.92 0 4.3 
Exposed non-smokers 2.65 0 8.9 
TABLE 2 
Groups not significantly different. 
19 19 
16 
24 16* 
• 16 • 16 
16 
22 
' 24 A 13 30 	C 24 • 19** 
.13 _ 
27 A 22** 22 
22 A _ 22 16 
• 24 A 24 
16 B _ 
27 A 
• 22 C 
13 A 
56 A 16 27 
19 A 22 19 
16 A 16 
• 27 A 
16 B 
• 24 A 16 19 *A 30 
22 .0 22 24 	A 
• 22 * A 
27 A 13 22 	A - 19 
22 C 16 36 * A 22 
• 22 
13 A 16 24 	C _ 
• 22 C 19 16 * C 
19 A 22 * A 
22 A 33 * B 22* 
30 •A 24 * A 
22 A 
UNDER 25 
25 - 30 
30-35 
35 - 40 
40 - 45 
45 - 50 
50 - 55 
55-60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
BLOOD LEAD (UG/100 MLS.) 
* - Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 10 
24 16 
30 
26 20* 
• 11 _ 31 15 
26 
• 26 A 117 33 	C 41 
• 40** 
31 
39 A 2.9** 20 
20 A , 48 17 
• 33 A 22 
11 B 
26 A 
34 C 
31 A _ 
• 62 A 11 , 39 
26 A 51 31 
26 A 11 
• 53 •A _ 
26 13 , 
33 A 23 60 * A 43 
23 C <2 65 	A 
2.9* A 
17 A 110 83 	A 60 
2.9 C 20 30 * A 74 
17 
46 A 31 150 
• 14 C 0.8 2 * C 
14 A _ 43 * A 
30 A 43 * B 17 * 
77 A 22 * A 
17 A 
30 - 35 
50-55 
UNDER 25 
25 - 33 
35 - 40 
1111■111=MININNI01.111. 
40 — 145 
45-50 
. 55-60 
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Exposed 	Unexposed 	Exposed 	Unexposed - 
Smokers Smokers Non smokers 	Non smokers 
URINARY LEAD (UG/LITRE) 
- Previous smokers over five years 
** - Previous smokers under five years A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 11 
(85) 
Blood Pb - 	(Ug/100 mls.) 
Mean Min Max 
Unexposed smokers 18.36 13 24 
Unexposed non-smokers 21.00 16 30 
Exposed smokers 23.13 13 56 
Exposed non-smokers 24.73 16 36 
TABLE 3 
Significant difference between groups 	(p<0.05). 
Urine Pb - (Ug/litre) 
Mean Min Max 
Unexposed smokers 30.4 0 117 
Unexposed non-smokers 34.1 16 74 
Exposed smokers 29.9 3 77 
Exposed non-smokers 48.4 0 150 
TABLE 4 
Groups not significantly different. 
640 430 
490 
440 420* • 420 540 
• 630 
1,300 
• 540 A 520 _ 680 	C 480 
720 ** 
•550 . 
570 A 750 ** 550 
600 A 530 590 
530 A 450 
270 B 
670 A 
700 C 
550 A 
510 A 430 600 
650 A 740 510 
530 A 530 
500 A 
570 B 
450 A 470 680 * A 470 
480 .0 510 560 	A 
640 * A 
510 A 1.200 630 	A 600 
610 C 500 460 * A 620 • 570 
320 A 570 460 	C 
510 C 620 650 * C 
420 A _ 580 * A 
400 A 700 600 * 
510 A 470 * A 
— 	500 A 
UNDER 25 
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Exposed 	Unexposed 	Exposed 	• Unexposed 
Smokers Smokers Non smokers 	Non smokers 
BLOOD ZINC (UG/100 MLS.) 
* - Previous smokers over five years 
** - Previous smokers under five years A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 12, 
Exposed 
Smokers 
Unexposed 
Smokers 
Exposed 
Non smokers 
Unexposed 
Non smoker 
540 180 
670 
• 940 35Q* 
300 550 
• 110 _ 220 
' 770 A 515 190 	C 160 
• 270 ** 
300 
580 A 90 ** 275 
165 A 450 120 
• 390 A 690 
370 B 
95 
• 220 C 
300 A 
150 A 520 320 
85 A 550 350 80 A 370 
600 
1,100 B 
570 A 160 690 * A 590 760. C 580 780 	A 
200 * A 
670 A 400 540 	A 740 800 C 560 440 * A 50 
• . 	240 , 
370 A 790 310 	C 
320 C 380 960 * C 
200 A 1,000 * A 
410 A 380 * B . 700 * 140 A 
• 
620 * A 
 	:. 230 A 
LINDER 25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
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URINARY ZINC (UG/LITRE) 
* - Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 13 
(88) 
Blood zinc - Ug/100 mls. 
Mean 	Min 	Max 
Unexposed smokers 	617 	420 	1300 
Unexposed non-smokers 	534 	420 	620 
o 
Exposed smokers 	517 	270 	650 
Exposed non-smokers 	592 	460 	' 700 
TABLE 5 
No significant difference between groups. 
Urinary zinc - Ug/litre 
Mean 	Min 	Max 
Unexposed smokers 	438 90 	940 
Unexposed non-smokers 	365 	SO 	740 
Exposed smokers 	408 80 	1100 
Exposed non-smokers 	555 	190 	1000 
TABLE 6 
No significant difference between groups. 
(89) 
Cadmium  
Blood and urine cadmium levels are shown in figure 14, page 90 and figure • 
15, page 91. . 
Blood cadmium (Ug/100 mls.) - very highly significant differences were 
shown between the groups (pc0.001). The combined exposed group had a 
higher mean than the combined unexposed group, e.g. .727 micrograms per 
100 mls. compared with .129 micrograms per 100 mls. The mean, minimum and 
maximum for each group are shown in table 7, page 92. 
However, when blood cadmium, as an index of years of exposure, was examined 
by calculating the correlation Coefficient between these two variables, 
there was no significant correlation (table 8, page 92). 
A contingency table, (table 9, page 93) based upon whether people in the 
combined exposed group had more than 15 years of exposure or not and whether 
people had 1.0 microgram per 100 mls or more of cadmium in their blood was 
formed. This suggests that there is some evidence that some people exposed 
to cadmium for more than 15 years are more likely to have blood cadmium in 
excess of 1 microgram per 100 mls than people exposed for shorter periods. 
Urine Cadmium (Ug/litre)  
Again there was highly significant differences between the groups (p0.01) 
and the combined exposed mean 8.69 is higher than the mean for the combined 
unexposed group (1.79) (table 10, page 93). However, when a correlation 
coefficient between urine cadmium and years of exposure is formed there was 
no significant correlation. (Table 11, page 94). 
0.3 nd. 
0.2 _ 
0.5 (0.2* 
nd. nd. 
nd. 
nd. 
0.3 A 0.2 0.2 	C 0.2 • nd. ** 
0.2 
• 
2.0 A 0.2 ** (0.2 
0.3 A 0.2 nd. 
0.7 A 0.2 
0.2 B 
0.5 A 
<0.2 C 
0.2 A 
• 2.3 A nd. nd. 
0.9 A 0.5 0.2 
0.5 A 0.2 
• 0.9 A 
.nd. B 
0.7 A 0.2 <0.2 * A nd. 
nd. •C 0.2 1.1 	A 
0.4 * A 
0.3 A nd. 1.1 	A 0.2 
<0.2 C nd. 0.3 * A 0.3 
• <0.2 
2.0 A 0.2 0.2 	C 
0.2 C 0.2 0.2 * C 
1.1 A 1.6 * A 
.2.6 A nd. 	* B <0.2 * 
1.6 A 0.9 * A 
1.6 A 
UNDER 25 
25 - 30 
30-35 
35 - 40 
o -45 
45-50 
50-55 
55 - 60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
BLOOD CADMIUM (UG/100 MLS.) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C .; Superphosphate Plant 
FIGURE 14 
0.6 4.2 
2.0 	_ 
4.8 11. * 
• 0.6 0.6 
• _ 1. 2 _ 0.3 
• 1.4 A 2.8- 0.9 	C 1.6 
1.9 	** 
0.8 
27 A 0.3 ** 2.8 
6.0 A 3.2 0.8 
• 7.8 A _ 2.0 1.9 _ 1.9 A 
• 0.8 
0.8 A _ 
18 A 0.8 _ 3.7 3.6 A 1.7 0.3 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
URINARY CADMIUM (UG/LITRE) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C • Superphosphate Plant 
FIGURE 15  
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Blood Cadmium - (Ug/100 mls.) 
Mean Min Max 
Unexposed smokers 0.159 0 0.5 
Unexposed non-smokers 0.075 0 0.3 
Exposed smokers 0.822 0 2.6 
Exposed non-smokers 0.527 0 1.6 
TABLE 7 
Highly significant differences between groups (13(0.001). 
Blood Cadmium and Years of Exposure  
d.f. 
Unexposed smokers 	0•0095n5 	20 
ns Unexposed non-smokers 	0.4306 10 
.1 Exposed smokers 	0396ns 	21 
Exposed non-smokers 0.1997ns 	9 
All groups combined 	0.1926ns 	63 
Exposed groups combined 	0.2850ns 	31 
TABLE 8 
NOTE - ns means "not significantly different" 
d.f = degrees of freedom. 
(93) 
Blood Cadmium and Years of Exposure  
Blood Cadmium 
k1.0 	>1.0 
Years of 	<15 	16 	3 	19 
Exposure 	>15 	8 	7 	15 
24 	10 	34 
X2 = 3.849* 	(p<0.05; just significant) 1 
TABLE 9 
Urine Cadmium - (Ug/litre) 
Mean 	Min 	Max 
Unexposed smokers 	1.50 	0.3 	4.8 
Unexposed non-smokers 	2.33 	0 	11.0 
Exposed smokers 	8.22 	0.6 	28.0 
Exposed non-smokers 	9.67 	0.3 	29.0 
TABLE 10 
Highly significant differences between the groups (p<0.01). 
(94) 
Urine Cadmium and Years of Exposure 
Unexposed smokers 
Unexposed non-smokers 
Exposed smokers 
Exposed non-smokers 
Exposed group combined 
r 
-0.2035ns 
_0 • 3984 ns 
ns 0.3285 
0•2664n5 
0.3045ns 
d.f. 
20 
10 
21 
9 
31 
TABLE 11 
NOTE - d.f. means degrees of freedom 
ns = not significant 
Urine Cadmium and Years of exposure 
Urine Cadmium 
Z. 5 	-75 
Years of 	<15 13 6 19 
Exposure 	>15 6 9 15 
19 	15 34 
X2 = 2.746ns 1 
TABLE 12 
(95) 
Blood Cadmium - years of smoking 
r. 	d.f. 
Unexposed smokers 	-0.11991s 20 
Exposed smokers 02506ns 	21 
TABLE 13 
No significant relationship 
Blood and Urine - Cadmium and Zinc  
The following correlation coefficients have been calculated: 
d.f. = 66 	All subjects 
	
'Urine Cd 	Urine Zn. 	Blood Cd. 	Blood Zn. 
Urine Cadmium 	1.0 
Urine Zinc 0.13 	1.0 
Blood Cadmium 	0.80*** 	-0.02 	1.0 
Blood Zinc -0.21 	-0.11 	-0.24* 	1.0 
= 13(0.05; 	*** = 1)40.001 
TABLE 14 
d.f. = 32 	Using only the combined exposed group 
Urine Cd. 	Urine Zn. 	Blood Cd. 	Blood Zn. 
Urine Cadmium 	1.0 
Urine Zinc 0.13 	1.0 
Blood Cadmium 	0.78*** 	-0.14 	1.0 
Blood Zinc -0.26 	0.03 	-0.37* 	1.0 
= 1340.05; 	*** = pi0.001 
TABLE 15 
(96) 
Examination of a contingency table based upon urine cadmium greater than 
5 micrograms per litre and greater than 15 years exposure showed no signif-
icant difference. (Table 12, page 93). 
Blood Cadmium and Years of Smoking  
Table 13, page 94 shows the correlation coefficients based on years of 
smoking and blood cadmium levels. From these results there is no evidence 
of a relationship between the two. 
Body Burden of Zinc and Cadmium and Mercury  
Zinc and cadmium are closely related in nature and in body metabolism. 
Although blood and urine zinc levels were not significantly different in 
the control and exposed groups, correlation coefficients between the blood 
and urine levels of these two metals were formed (table 14, page 95 and 
table 15, page 95). These reveal a high positive correlation between blood 
and urine cadmium levels and a significant negative correlation between 
blood zinc and cadmium levels. 
There was no significant correlation between blood and urinary zinc or 
urinary cadmium and zinc. 
Statistically, therefore, body burden of mercury and zinc as measured by 
blood and urinary levels would not affect any findings. 
Blood Lead 
The higher blood lead levels found in the exposed group should not, on 
todays accepted knowledge of lead and body metabolism, affect any of the 
(97) 
clinical or biochemical parameters measured. This will be examined 
further in a later chapter, (chapter 15). 
Conclusions  
(1) Body content of mercury, zinc and lead were not significantly 
different between the exposed and control groups and therefore should 
not affect any findings. 
(2) Blood cadmium and urinary cadmium measurements were not good markers 
of body burden. 
Discussion  
It has been shown in previous chapters that cadmium accumulates in the 
human body over the life span. The body content is, because of a low and 
seemingly fixed excretion rate unrelated to intake, a good index of total 
exposure. Several workers have constructed mathematical biological 
models which relate total cadmium accumulation to exposure from all sources. 
There is no general agreement as to the exact body burden of a 70 year old 
man. However, figures produced by these models range from 15 to 120 'mgm. 
It has also been pointed out in earlier chapters that daily exposure is 
increasing and there is a critical renal concentration beyond which perman-
ent renal damage occurs. There are also differing figures suggested for 
this critical figure by other models. 
Comparison of atmospheric levels and urinary excretion figures from this 
survey and those performed elsewhere (chapter 7) would suggest a lower body 
burden for my group than most other surveyed. This group of exposed 
workers, therefore, would appear to be representative of a middle group . 
(98) 
between those environmentally exposed to low body burden and those 
occupationally exposed to high levels. The survey should, therefore, 
provide useful information on just how much cadmium can be tolerated 
before adverse effects appear. This, in turn, could help in deciding 
controls for environmental contamination. 
It was not possible to attempt to answer the question posed by many 
investigators - "does zinc have a protective effect against cadmium?". 
One can only speculate on the importance, if any, of the fact that in 
this small group of workers exposed to both zinc and cadmium there is a 
negative correlation between the blood levels of both metals. 
(99) 
CHAPTER 9  
Cadmium and General Health  
The Medical Examination 
The questionnaire and physical examination revealed a wide variety of 
medical and surgical conditions amongst the members of each sub-group of 
exposed and control workers. There was no common pattern to either group 
or sub-groups or group difference except in the area of respiratory 
function - vide chapter 10. Figure 16, page 100 illustrates the findings 
of previous or existing medical conditions either treated or receiving 
treatment. 
The medical questionnaire was designed particularly to elicit symptoms 
referable to organs or systems particularly involved in the metabolism 
of cadmium. There was no difference in symptomatology between the control 
group and the exposed group in answers to questions referable to:- 
(a) The alimentary system including liver and pancreas 
(b) Genito-urinary system 
(c) The skin 
(d) The central nervous system 
(e) The cardiovascular system 
Participants in the survey were asked to judge their own sense of smell. 
Six exposed workers thought their sense of smell was poor and five controls 
did likewise. 
All participants were also asked if they had bone or joint pain. Those 
who answered yes to this question were asked further details at the time 
EXPOSED 
Hypertension 	2 
Coronary artery 1 
disease 
Renal calculus 	2 
(diagnosed and treated 
before exposure to cad-
mium in both cases.) 
CONTROL  
5 
3 (Confirmed) 
1 (Not confirmed) 
0 
Prostatomegaly 
Papillomaofthebladd 
Peptic ulcer 
Hiatus-hernia 
Acute pancreatitis 
Gout 
Diabetes 
Chronic airways disease 
including asthma 
Silicosis 
2 
4 
1 
1 
3 
1 
2 
1 
(diagnosed and treated 
before exposure to cad-
mium). 
0 
1 
3 
2 
0 
1 
0 
2 
(100) 
FIGURE 	16 
Previous or existing medical conditions either treated or receiving 
treatment. 
(10 1 ) 
of the examination. In many cases a cause was found, e.g. post traumatic, 
gout, spondylitis etc. In the case of eleven exposed workers no obvious 
cause for the bone pain was found, and thirteen controls also had inexp-
licable bone pain. 
At the time of the medical examination all participants were questioned 
about their sexual function. There were no questions referable to this in 
the questionnaire. One exposed worker had been investigated for infert-
ility. No worker, either in the control group or the exposed group had 
sought treatment for any sexual problem and no worker in either group had 
. expectations of a higher than his present sexual function. 
The Clinical Examination  
A wide variety of minor and major physical abnormalities were found in 
both groups. Some were to be expected in view of the previous or existing 
medical history. Some however, were unmasked. Again, as with symptoms, 
there was no common pattern to the group or group differences. 
1. Skin - No skin tumors, ulcers, rashes or pigmentary changes were found 
in any individual. Some members of both groups had mild acne and the 
usual minor skin conditions e.g. warts, moles etc. 
2. Nasal mucosa and sputum - One member of the exposed group had a perfor-
ated nasal septum and another had a very crusted nasal mucosa. With 
these two exceptions, no difference was noted between the exposed and 
the control group. 
(102) 
3. Teeth and gums - No pigmentary changes were noted in the gums of any 
individual in any group. No staining or colouring on the teeth was 
noticed in either the exposed or the control group. 
Four members of the group of exposed smokers had considerable dental 
caries or gingivitis. No major dental abnormalities were noted in the 
control group or the group of exposed non-smokers. 
4. Cardio vascular system - One man in the sixty to sixty five age group, 
an exposed smoker, had moderate peripheral vascular disease. No other 
cases of unknown arterial disease were found. Excluding those known 
to have coronary artery disease, the only electrocardiographic abnormal-
ities found was one case of right bundle branch block in the exposed 
group and ventricular extrasystoles in three members of the exposed 
group and three members Of the control group. 
Effects of acute exposure to high concentration  
Many workers in the cadmium plant could remember occasions when high 
concentration of either dust or fumes caused them to stop work temporarily 
until the working environment returned to normal. Four workers suffered 
anorexia, nausea, dyspnoea and cough and subsequent night sweats after 
these episodes. None found it necessary to seek medical attention and all 
were back to work at the next shift. 
One worker with grade 4 dyspnoea, though able to return to work immediately 
after acute exposure, believed his dyspnoea was worse for three to four 
(103) 
days afterwards. He is receiving treatment for obstructive airways 
disease. 
The "time lost" records for each exposed worker in the cadmium plant were 
examined. These records show time lost through sickness, with diagnoses, 
injury, or without reason since he started work. The mean time lost for 
this group of 24 from sickness or unknown reason is 20 days with a minimum 
of no days to a maximum of ninety four. Similar records are not available 
for the control group but plant workers elsewhere have as much, or more, 
time off for non injury reasons than this group of exposed workers. 
Because the work force in the cadmium plant has always been small in 
number and the turnover small also compared with other Company activities 
it was possible to obtain a considerable amount of information on the 
health of ex fellow workers from present day long term workers at the 
time of their questionnaire interview. An attempt at a retrospective 
survey of the health of workers who had left the cadmium plant was made 
using Company records supplemented by the memories of the long term 
present day workers. As Company records did not allow an accurate analysis 
and human memory is fallible, this survey could not produce data on which 
scientific or statistical conclusions could be based. The following is 
a summary of the material that this small survey produced. 
Deaths in Tasmania related to Cadmium  
The Deputy Commonwealth Statistician, who is responsible for recording 
and coding the causes of death in Tasmania, was unable to retrieve 
material which would precisely link cadmium with the cause of death. 
(104) 
However, one of the coders in the Department, whose experience spanned 
twenty five years, was certain that he never saw a death certificate 
with any mention of cadmium. Other coders with shorter experience agreed 
with this. 
Mortality amongst ex workers' 
A sample of 22 new names of ex cadmium workers who had left Company emp-
loyment in the last twelve years was given to the Registrar of Births, 
Deaths and Marriages. Only 3 of these 22 were registered as deaths. All 
had died from cardio-vascular disease. 
Of other ex workers known to be dead to their fellow workers, only one 
was known to have a malignancy; carcinoma of the lung. According to 
their fellow workers most appeared to have died from cardiovascular disease. 
Morbidity amongst ex •workers  
(a) An insignificant number of men had to be either retired or trans-
ferred from the cadmium plant as the result of the findings made at 
the compulsory biennial medical examination over the years. No 
specific cause could be identified for these. 
(b) Long term ex workers are invited back to the Company for a reunion 
annually. According to present day workers, many ex workers enjoyed, 
or still are enjoying a long retirement. 
(c) The long term workers, particularly, believe that renal disease, 
(105) 
malignancy, serious lung disease had not figured prominently amongst 
the maladies of the ex colleagues. They anticipate a long and 
reasonably health retirement basing their expectations on the exper-
iences of their ex colleagues. 
Conclusion  
No individual symptom or pattern of symptoms or signs could be identified 
as due to working with cadmium. 
Discussion  
Several surveys (chapter 5) have suggested that vague ill health - insom-
nia, anorexia and fatigue are the lot of a worker exposed to cadmium. 
This survey found no evidence of this. No worker expressed any desire 
for a different job nor any reluctance to resume after aholiday. 
Company records indicate there is little labour turnover in the cadmium 
plant where most exposure occurs. This is confirmed by analysis of the 
length of service in the plant, (figure 6, page 76). This would suggest 
that both, on an individual and collective basis,there is no employee 
recognition of a health problem working with cadmium. 
(106) 
CHAPTER 10 
Cadmium and the Respiratory System  
The questionnaire sought information on the following symptoms:- 
(a) cough and sputum production 
(b) exertional dyspnoea 
(c) wheeze 
(d) frequency of colds or bronchitis 
At the time of medical examination the subjective symptoms were graded 
according to the patients estimate of severity. 
Cough with sputum production - (Figure 17, pagel°7) 
This was graded roughly according to the daily volume of sputum. Eighteen 
members of the exposed group complained of cough and sputum, fourteen were 
smokers and four non-smokers. Thirteen were graded as grade one, one grade 
two and four grade three. Twelve members of the control group, nine 
smokers and three non-smokers complained of these symptoms, eleven were 
graded one and one was graded two. Table 16, pagel°9compares the findings 
of the various groups. 
Exertional dyspnoea -(Figure 18, page 108) 
This was graded in accordance with the Medical Research Council formula. 
Twenty two exposed workers complained of dyspnoea; six grade one, thirteen 
grade two, two grade three and one grade four. Eleven controls complained 
of dyspnoea, eight grade one, three grade two. All those graded three or 
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Exposed 
Smokers 
Unexposed 
Smokers 
Exposed 
Non smokers 
Unexposed 
Non smokers 
COUGH WITH SPUTUM PRODUCTION 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 17  
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
o 0 
1 
0 o* 
0 0 
0 
0 
1 	A 0 0 	C 1 O** 
0 
0 	A 0 ** 1 
0 	A 0 0 
2 	A 1 
1 	B 
1 	A 
• 0 	C 
1 	A 
3 	A 0 0 
1 	A 0 0 
2 	A 0 
• 2 	A 
0 , 	B 
• 0 	A 0 0 * A 1 
1 	. C 0 2 	A 
0 * A 
2 	A 2 2 	A 2 
0 	C 1 2 * A I, 
• 1 
3 	A 0. 	. 0 	C 
2 	C 0 2 * C 
A * A 
4 	A 2 * B 2* 
2 	•A 
2_ 	A 
U4DER 25 
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EXERT1ONAL DYSPNOEA 
- Previous smokers over five years 
*# - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 18 
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Cough with Sputum Production 
Mean Min Max 
Unexposed smokers 0.409 0 1 
Unexposed non-smokers 0.333 0 2 
Exposed smokers 0.913 0 3 
Exposed non-smokers 0.545 0 3 
TABLE 16 
Groups are not significantly different, although the means for the 
exposed group of workers are somewhat higher. 
Exertional Dyspnoea 
Mean Min Max 
Unexposed. smokers 0.27 0 2 
Unexposed non-smokers 0.67 0 2 
Exposed smokers 1.30 0 4 
Exposed non-smokers 1.09 0 2 
TABLE 17 
Highly significant differences between the groups (1)(0.01). The combined 
exposed group of thirty four had a mean score of 1.23 where as the unexposed 
group of thirty four people had a mean score of 0.41. There was no sign-
ificant difference due to smoking. 
(110) 
below did not feel seriously inconvenienced by dyspnoea and were able to 
work and enjoy recreational activity without any distress. One man graded 
four was inconvenienced by his dyspnoea, both at work and at leisure. 
Table 17, page 109 shows the statistical analysis of this symptom. 
Respiratory Infection - (Figure 19, page 111) 
These were graded according to the number of attacks per year. Grade 0, 
one or two attacks, grade one, three attacks, grade two, four attacks per 
year. Twelve exposed workers, ten smokers and two non-smokers were graded 
one, whereas, three control workers, two smokers and one non-smoker were 
graded one. Table 18, page 113 compares the findings of the group. 
Wheeze - (Figure 20, page 112) 
This was graded according to the estimate of severity by the individual. 
Grade one - wheeze on moderate exertion, grade two - wheeze at rest. 
Thirteen of the exposed workers complained of wheeze, eleven smokers, two 
non-smokers, three controls had this symptom, two smokers, one non-smoker. 
Table 19, page 113 analyses this symptom. 
Respiratory Function - (Figures 21 and 22, pages 114 and 115) 
Each applicant's vital capacity and forced expiratory volume at one second 
was tested using a Pulmotest spirometer until there was 5% or less diff-
erence between the two highest readings. These measurements were repeated 
after bronchodilation with salbutamol inhalation. The vital capacity is 
expressed as a percentage of the predicted vital capacity as expected from 
height and age. A figure of 80% or less for this result is considered 
abnormal. 
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Exposed • 	Unexposed 	Exposed 	Unexposed Smokers Smokers Non smokers 	Non smokers 
WHEEZE 
* - Previous smokers over five years ** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 20  
(113) 
Respiratory Infection  
Mean 	Min 	Max 
Unexposed smokers 	0.091 	0 1 
Unexposed non-smokers 	0.083 	0 	1 
Exposed smokers 	0.435 	0 1 
Exposed non-smokers 0.182 	0 	1 
TABLE 18 
Significant differences between the groups (1)(0.05). The exposed 
smokers have a higher mean than the two unexposed groups. 
Wheeze 
Mean Min Max 
Unexposed smokers 0.091 0 1 
Unexposed non-smokers 0.083 0 1 
Exposed smokers 0.522 0 2 
Exposed non-smokers 0.182 0 1 
TABLE 19 
Highly significant differences between groups p<0.01. The exposed 
smokers have a higher mean than the unexposed workers. 
. 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
110% 102% 
84% 
98% 104% * 
88.6% 100% 
• 97.1% 
• 88.6% 
84% A 90% 82% 	C 97% 
• 105% ** 
113% 
98.8% A 97.5% ** 125% 
97% A 92% 104% 
•104% A 104% 
87% B 
86% A 
110% C 
105% A 
88% A 90% 105% 
115% A 120% 108% 
109.3% A 97% 
92% A 
105% B 
86% A 113% 78% * A 125% 
86% •C 126% 83% 
87% * A 
108% A 94% 86% 	A 105% 
107% C 100% 82% * A 102% 
86% 
84% A 63% 132% 	C 
111% C 91% 88% * C 
105% A 113.8% •* A 
72% A S 108% * B 102% * 
92% A 111% * A 
100% A 
VITAL CAPACITY 
PREDICTED VC 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 21 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
84% 88% 
78% 
100% 82% * 
92% 80% 
86% 
90% 
86% A 84% ** 93.75% 	C 81% 
42% 
46% 
75% A 96.9% ** 80% 
67.5% A 68% 84% 
69.8% A 83% 
44% B 
93% A 
• 77% C 
78% A 
50% A 73.6% 82% 
74% A 74% 83% 
75% A 94% 
• 80% 
66.6% B 
• 81% A 81% 73% * A 72% 
75% C 71% 83% 	A 
84% * A 
75% A 73% 87% 	A 72.92% 
61% C 78.9% 71% * A 67.57% 
• 80.6% 
71% A 58% 64% 	C 
94% C 96% 52% * C 
71% A 61% * A 
38.5% A 59% * B 75% * 
40% A 69% * A 
68% A 
FEVi 
VITAL CAPACITY 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 22 
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Two members of the exposed group, one a smoker and one a non-smoker were 
below this figure while one member of the control group, a smoker, did not 
reach this figure,. The forced expiratory volume at one second was expres-
sed at a percentage of the actual vital capacity. A figure of 75% or lower 
for this is considered abnormal Nineteen exposed workers, twelve smokers 
and seven non-smokers failed to reach this figure whilst eleven of the 
unexposed workers, eight smokers and three non-smokers also did not reach 
this figure. 
There was no correlation between the abnormal respiratory function test 
findings and symptoms. Some with marked or moderate reduction in the 
FEVVVC% had no complaints of dyspnoea or wheeze whilst others who did 
complain had no reduction in this figure. 
Statistically there is no significant difference between the exposed and 
the control group when respiratory function was measured objectively. - 
Tables 20 and 21, page 117. 
On clinical examination ten exposed workers, eight smokers, two non-smokers 
exhibited rhonci in the lung fields on auscultation. Two members of the 
control group, (both smokers) did also. This clinical sign is not consid-
ered to be of any significance in this study. 
Radiology 
1. Chest Film - 
Each participant in the survey has had a chest x-ray every two years. This 
is a compulsory requirement under an act governing employment in the mining 
(117) 
VC/Pred VC% 
Mean Min Max 
Unexposed smokers 97.6 63 126 
Unexposed non-smokers 106.6 97 125 
Exposed smokers 97.0 72 115 
Exposed non-smokers 95.5 78 132 
TABLE 20 
Groups not significantly different. 
FEVIJVC% 
Mean Min Max 
Unexposed smokers 78.6 42 100 
Unexposed non-smokers 79.0 68 88 
Exposed smokers 70.0 39 94 
Exposed non-smokers 72.4 52 94 
TABLE 21 
Groups not significantly different although mean for the combined exposed 
group (70.78) is somewhat lower than the mean for the combined unexposed 
group (78.74) Statistically there is no significant difference between 
the exposed and the control group when respiratory function was measured 
objectively. 
(118) 
industry in Tasmania. These films are examined by the same radiologist 
who reports either linear or nodular abnormalities suggestive of a 
pneumoconiosis or progress, or otherwise, of any changes notified prev-
iously. Only one exposed worker had changes consistent with silicosis and 
these changes were present on entry into the workforce. These were 
acquired whilst mining in Europe. Apart from this worker, no radiological 
abnormalities were reported in either group. 
Conclusion 
Individuals working with cadmium are more likely to complain of dyspnoea, 
cough, repeated respiratory infections and wheeze than non exposed individ-
uals. 
Although these workers had more respiratory symptoms than the non exposed 
there were no clinical signs or groups of signs or changes in simple 
measurements of respiratory function that could be definitely ascribed 
to cadmium effect. 
Discussion 
The literature (vide chapter 5) contains many surveys of respiratory 
function and disease of cadmium workers. Although some, like this one, 
failed to find objective evidence of a pulmonary effect of cadmium it is 
generally accepted that chronic airways disease with significant loss of 
function is produced by this metal. The unresolved questions are just 
how much, in what form and for how long cadmium must be present to have an 
(119) 
effect. Most Western countries accept a threshold limit value of 200 Ug/ 
cubic metre of dust and 100 Ug/cubic metre of fume. Some workers, e.g. 
Lauwerys (65) believes these figures should be halved. If workers are 
to avoid subjective symptoms this study indicated that a figure below 30 
Ug/cubic metre of dust should be the aim of the occupational hygienist. 
It was not possible to ascertain the effect of intermittent exposure on 
symptoms as there are no employees whose job provides a rotation through 
the cadmium contaminated plants and elsewhere. It would be of interest 
and value to study the effects of job rotation on those workers who do 
have symptoms. I have suggested this to the Company but there are problems 
to be overcome, e.g. job training, inter union co-operation, team variation, 
etc. 
Most employees when questioned about their symptoms after an absence 
from exposure for holidays did not appear to notice any change. A study 
of pre and past holiday symptoms and signs would provide evidence of the 
health value of job rotation. 
(120) 
CHAPTER 11  
Cadmium and Blood Pressure  
Blood pressure was recorded standing and after being recumbent for a 
quarter of an hour. Using the figure of 140 on 90 as the upper limit of 
normal for any age group, fourteen members of the exposed group had an 
elevated blood pressure not already diagnosed compared with thirteen 
members of the control group - Figure 23, page 122. Statistical analysis 
of both the systolic and diastolic pressures is shown in tables 22 and 23, 
page 123. 
Conclusion 
There is no relationship between body burden of cadmium and blood pressure 
levels in exposed workers. 
Discussion 
This is an important and significant finding. Several workers, e.g. 
Schroeder (71), Carrol (70), have linked hypertensive disease to environ-
mental cadmium - (Chapter 5). Morgan, (73) and Hammer (74) have produced 
evidence refuting such a link. Many advocates with both medical and non 
medical backgrounds frequently use the alleged association between the 
two as one of the fundamental reasons for stricter controls on environmental 
cadmium. •The media also portray the linkage as an established fact. The 
public in general as a consequence now seem to believe that there is a 
cause and effect relationship between the two. 
(121) 
It has been suggested that the occupationally exposed are protected from 
hypertension by the concomitant exposure to zinc. If blood and urinary 
zinc levels can reflect body burden of zinc this would not appear to be 
the case in the groups of workers for there is no difference between the 
exposed and controls. None of the surveys recorded in chapter 5 revealed 
any suggested link between cadmium and hypertension. Many involved work-
ers who were exposed to cadmium only so there could be no suggestion that 
occupationally acquired zinc might be a protective. Hypertension is 
frequently associated with chronic renal disease. Cadmium may produce 
chronic renal disease. In chapter 12 the results of renal function 
studies will be analysed. No cases of chronic renal disease were found. 
There was no correlation between blood pressure and years exposed. If 
there is a relationship between cadmium and hypertension there is no 
evidence from this survey of a direct dose or an increasing dose effect. 
However, the possibility of a relationship between the presence of cadmium 
in a sensitive individual and hypertension is not negated by this survey. 
This sensitivity could be based on individual enzyme structual differences, 
differing immunological complexes or protective actions by other 
substances in trace proportions. Environmental cadmium per se is not 
likely to be a cause of hypertension. Therefore other factors must also 
be involved. 
(122) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
140/80 • 140/80 
170/80 
160/95 150/100 * 
130/80 130/75 
• 150/90 
• 130/80 .., 
• 130/80 	A 170/90 140/85 	C 150/100 
120/85 ** 
140/85 
150/100 A 140/75 ** 
. 
150/100 
140/90 	A 140/90 130/85 
• 180/80 	A 190/100 
130/80 	B 
150/80 	A 
140/85 	C 
130/85 	A 
190/100 A 140/100 120/80 
120/85 	A 130/,80 160/100 
140/85 	A 110/80 
• 130/85 	A 
160/90 	B 
140/95 	A 130/90 140/100* A 140/100 
130/80. C 120/90 170/115 	A 
, 150/85 * A 
150/110 A 140/85 130/80 	A 150/95 
130/80 	C 130/80 120/80 * A 140/90 
110/70 
160/90 	A 140/90 170/100 	C 140/95 * 
l30/: 200/110 150/10* C 
130/75 	A 180/105* A 
140185 	A *190/90 * 
180/90 	A 180/90 * A 
.  	130/80 	A - 
HIGHEST BP READING 
- Previous smokers over five years 
** - Previous smokers under five years A - Cadmium Plant 
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C . Superphosphate Plant 
FIGURE 23  
UNDER 3 
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60 & OVER 
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Blood Pressure (Sys) - mm Hg. 
Min Max Mean 
Unexposed smokers 	142.3 110 200 
Unexposed non-smokers 	141.7 120 160 
Exposed smokers 	143.9 120 190 
Exposed non-smokers 156.4 120 190 
TABLE 22 
Groups not significantly different. 
Blood Pressure (Dias) - mm Hg. 
Mean Min Max 
Unexposed smokers 	86.4 70 110 
Unexposed non-smokers 	91.5 75 100 
Exposed smokers 	86.8 75 110 
Exposed non-smokers 92.1 80 115 
TABLE 23 
Groups not significantly different. 
(124) 
CHAPTER 12 
Cadmium and Renal Function 
Cadmium accumulates in the kidney and its accumulation there contributes 
significantly to body burden. A raised body burden of cadmium, in 
both experimental animal studies and observations on humans occupationally 
or environmentally exposed, is frequently associated with impaired renal 
function particularly tubular function. (Vide chapters 3, 4, 5, 6) 
In this study the following investigations were used to assess various 
aspects of renal function. 
1. Tests for proteinuria  
(a) Bililabstix (Ames) 
(b) Boiling fresh urine followed by the addition of trichldracetic 
acid. 
Only two exposed workers showed proteinuria, with both the Ames Bililabstix 
test and boiling followed by the addition of acetic acid. These men 
were exposed to low concentrations of cadmium outside the cadmium plant 
itself. One had a 24 hour excretion of 0.3 micrograms per litre whilst 
the other had an excretion of 1.4 micrograms per litre. No proteinuria 
• was detected in the urine of men who had a high (greater than 20 micrograms 
per litre) excretion of cadmium. (Figure 24, page 125) 
2. Microscopy of Urine  
Red cells in significant numbers were found in the urine of two exposed 
workers. No obvious clinical explanation was found to account for these. 
(125) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
nil • nil 
nil 
nil nil * 
nil nil 
nil 
nil 
' nil A nil nil 	C nil 
nil ** 
nil 
nil A nil ** nil 
nil A nil nil 
nil A nil 
nil .B 
nil A 
nil C 
nil A 
nil A nil nil 
nil A nil nil 
nil A nil 
nil A 
nil B 
nil A nil nil * A nil 
nil .0 nil nil 	A 
nil * A 
nil A nil nil 	A nil 
nil C nil nil * A nil 
nil 
nil A nil nil 	C 
nil C nil 60mgm*C 
nil A _ nil 	*A 
nil A 50mgm*B nil * 
nil A nil 	*A 
nil A 
PROTEINURIA 
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C - Superphosphate Plant 
UNDER 25 
25-30 
30 - 35 
35 - 40 
40-45 
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50-55 
55-60 
60 & OVER 
FIGURE 24 
(126) 
in other workers from both the exposed and control groups an occasional 
red cell was reported. No worker showed a significant leucocyte count, 
epithelial cells or casts and all urines were negative on culture. 
(Figures 25, 26, 27, 28, pages 127, 128, 128 and 130). 
3. Urinary pH - (Figure 29, page 131) 
The mean, mimimum and maximum pH values are shown in table 24, page 133. 
There is no significant difference between the groups. 
4. Blood Urea - (mgm/100 ml. Normal range 20 - 40) 
Five exposed workers, three smokers and two non smokers exceeded the 
normal level. One control had a raised level. (Figure 30, page 132). 
Statistically, (table 25, page 133) there was a significant difference 
between the groups. The combined exposed group had a higher mean (35.35) 
than the combined unexposed group (30.82). The clinical significance of 
this finding will be considered in a later discussion. 
5. Blood Creatinine - (mgm/100 ml. Normal 0.8 - 1.3) 
The groups were not significantly different, although the mean for the 
combined exposed group (1.156) is somewhat higher than the mean for the 
combined unexposed group (1.076). (Figure 31, page 134 and table 26, 
page 140). 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
RED BLOOD CELLS IN URINE 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 25 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers - - 
- 
occas. occas. 	* 
- _ 
• occas. 
- 
occas. A 15 occas. C occas. 
- ** 
occas. A - ** _ 
A - - 
• - A - 
- B 
- A 
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- A 
occas. A occas. - 
A - - 
occas. A occas. 
- 
- B 
A 1 * A - 
• occas. C - - A 
1 *A 
A - - A - 
occas. C - - *A - 
- 
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2 A - *A 
A - *B - 	* 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
_ 
occas. - * 
_ 
occas. 
occas. A occas. - C - _ 	** 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
neg neg 
neg 
neg ne• 
neg neg 
neg 
neg 
• neg. A neg neg 	C neg neg ** 
neg 
neg A neg ** neg 
neR A neg neg 
neg A neg 
- B 
neg A 
neg C 
neg. A 
neg A neg neg 
neg A neg neg 
neg A neg 
neg A 
neg B 
neg A neg neg * A neg 
neg .0 neg neg 	A 
neg * A 
neg A neg nq 	A neg 
neg C neg neg * A neg 
• neg 
neg A neg neg 	C 
• neg C neg neg * C 
neg A neg * A 
• neg A neg * B neg * 
neg A neg * A 
neg A 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
6.8- 6.6 
5.3 
5.6 54* 
5.7 5.6 
• 6.6 
5.6 
• 6.9 A 6.2 6.3 C 6.7 
5.2 ** 
5.9 
7.5 A 6.2 ** 6.7 
5.2 A 8.1 5.4 
6.4 A 6.6 
5.4 B 
6.0 A 
5.4 C 
6.0 A 
7.8 A 6.0 6.1 
6.9 A 5.8 - 
5.4 A 5.4 
5.0 A 
5.4 B 
5.6 A 5.6 5.2 * A 6.6 
5.3 •C 7.7 5.8 A 
7.0 * A 
5.4 A 5.2 - A 6.5 
5.5 C 6.2 - *A 6.5 
• 5.0 
5.4 A 6.6 5.3 C 
• 5.4 C 5.3 5.4 * C 
5.5 A 5.3 * A 
6.3 A 5.5 * B _ 	* 
5.9 A 6.3 * A 
• 6.8 
URINARY pH 
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Exposed Unexposed Exposed Unexposed 
Smokers Smokers Non smokers Non smokers 
36 29 
36 
30 33* 
26 30 
• 29 
30 
• 37 A 25 34 C 33 
29 ** 
21 
31 A 38** 20 
27 A 37 28 
• 31 A 24 
25 B 
31 A 
34 C 
25 A 
22 A 25 33 
24 A 35 34 
50 A 42 
• 36 
39 B 
37 A 28 35 * A 28 
35 . C 36 22 A 
47 * A 
47 A 38 29 A 29 
40 C 28 36 * A 36 
33 
40 A 23 35 C 
• 26 C 35 36 * C 
33 A 62 * A 
35 A 39 * B 31* 
47 A 37 * A 
38 A 
UNDER 25 
25-30 
30-35 
35- 40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
BLOOD UREA 
* - Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 30 
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Urinary pH - 
Mean Min Max n 
Unexposed smokers 	22 6.027 5.0 8.1 
Unexposed' non-smokers 	10 6.210 5.4 6.6 
Exposed smokers 	23 5.930 5.0 7.8 
Exposed non-smokers 	9 5.790 5.2 7.0 
TABLE 24 
No significant difference between the groups. 
Blood Urea - 
Mean Min Max 
Unexposed smokers 31.09 21 42 
Unexposed non-smokers 30.33 20 36 
Exposed smokers 34.35 22 50 
Exposed non-smokers 37.45 22 62 
TABLE 25  
Significant differences between groups (13(0.05). The combined exposed 
group has a higher mean (35.35) than the combined unexposed group (30.82). 
(134) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
L20 0.9 
1.1 
1.0 1.1 * 
0.9 1.1 
1 
1.10 
' 1.10 A 0.9 1.0 C : 1.00 
1.0 ** 
0.8 
0.95 A 1.2 ** 1.0 
1.1 A 1.2 1.05 
1.00 A 1.2 
1.0 B 
1.0 A 
1.10 C 
1.00 A 
0.9 A 1.0 1.1 
1.0 A 1.20 1.2 
1.50 A 1.30 
1.20 A 
1.20 B 
1.20 A 1.1 1.4 * A 1.0 
1.20 C 1.1 1.00 A 
1.2 *A 
1.3 A 1.25 1.00 A 1.00 
1.0 C 1.0 0.9 * A 1.1 
1.1 
1.35 A 0.9 1.30 C 
• 1.1 C 1.3 1.2 * C 
0.9 A 1.5 *A 
• 1.05 A 1.6 1.10 * 
1.40 A 1.3 * A 
1.2 A 
BLOOD CREATININE 
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** - Previous smokers under five years 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
1.73 1.4 
2.77 
1.46 1.74 * 
1.87 1.80 
• 1.75 
1.58 
2.09 A 1.16 2.0 	C 1.11 
1.98 ** 
•1.90 
1.15 A 1.62 ** 1.57 
0.89 A 2.00 1.17 
• 2.48 A 1.43 
1.54 B 
1.48 A 
• 2.86 C 
1.49 A 
0.58 A 2.22 2.24 
0.94 A 1.79 1.64 
0.92 A 1.69 
• 1.92 
2.10 B 
3.22 A 2.00 1.92 2.42 
2.21 C 1.20 2.04 	A 
2.00 * A 
1.70 A 2.15 1.83 	A 1.64 
2.46 C 1.58 1.85 * A 1.41 
• 1.74 
2.40 A 1.47 2.42 	C 
• 2.09 C 2.10 2.34 * C 
1.38 A 2.15 	* A , 
2.28 A 1.72 2.0 * 
0.98 A 1.75 * A 
1.57 A 
URINE CREATININE (GM/24 HR.) 
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** - Previous smokers under five years 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
880 • 1,700 
1,750 
800 1,860 * 
850 1,060 
• 1,670 
• 1,970 
960 A 1,700 2,500 C 2,030 
• 1,800 ** 
1,250 
1,050 A 2,050 ** 920 
940 A 1,760 1,060 
• 1,380 A 1,170 
770 B 2,550 *A 
1,950 C 
1,460 A 
1,670 A 930 2,050 
3,600 A 1,700 830 
2,300 A 1,140 
• 920 A _ 850 B 
1,840 A 1,910 920 * •A 1,850 
1,170 . C 1,330 950 
1,620 * A 
1,480 A 1,670 1,410 A 1,080 
1,250 C 1,100 1,850 * A 3,000 
• 1,340 
950 A 900 1,240 C 
1,280 C 1,800 1,650 * C 
2,300 A 1,630 * A 
940 A 2,100 * B 980 * 
• 1,440 A 870 * A 
- 1,850 A 
24 HOUR VOLUME URINE Onls) 
- Previous smokers over five years 
** - Previous smokers under five years 
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FIGURE 33 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
0.61 1.18 
1.22 
0.56 1.29 * 
0.59 0.74 
1.16 ' 
1.37 
0.67 A 1.18 1.74 	C 1.41 
• 1.25 ** 
0.87 
0.73 A 1.42 ** 1.33 
0.65 A 1.22 0.74 
• 0.96 A 0.81 
0.53 B 
1.77 A 
1.35 C 
1.01 A 
1.16 A 0.65 1.42 
2.50 A 1.18 0.58 
1.60 A 0.79 
0.64 A 
0.59 B 
• 1.28 A 1.33 0.64 1.28 
0.81 C 0.92 0.60 	A 
1.13 * A 
1.03 A 1.16 0.98 	A 0.75 
0.87 C 0.76 1.28 * A 2.08 
0.93 
0.66 A 0.63 0.86 	C 
0.89 C 1.25 1.15 	* C 
1.60 A 1.13 * A 
0.65 A 1.46 0.68 * 
1.0 A 0.60 * A 
1.28 A 
URINE (mlsimin.) 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
197. 86.47 
158.2 
182.5 93.55 * 
220. 169. 
104.7 
80.2 
217.7 A 68.23 80 	C 54.67 
110. ** 
152. 
109.52 A 79.02 ** 81.7 
94. A 113. 110.37 
• 179. A 122. 
200. B 
58. A 
146.6 C 
102.5 A 
34.73 A 238. 118. 
26.1 A 105.29 260. 
40. A 148. 
208.69 A 
248. B 
• - A 104.7 208.69 * A 110 
188. C 90.2 214.7 	A 123.4 	* A 
114.86 A 128.7 129.78 	A 151.85 
196.8 C 143.6 100. 	* A 47 
• 129. 
252.6 A 163. 195.16 	C 
163.28 C 116. 141.8 	* C 
60. A 131.9 	*A 
242. A 81.90 * B 204.08 * 
68.05 A 201.1 	* A 
84.6 A 
URINE CREATININE (mg/100m1s) 
- Previous smokers over five years ** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
100. 113.37 
175. 
- 	101.38 109.85 * 
144.2 113.6 
121.53 
99.74 
' 131.9 A 89.5 138.8 	C 81.14 
137.5 ** 
164.9 
84.15 A 93.74** 108.45 
56.18 A 115. 71.3 
172. A 82.75 
106.9 B 
102.7 A 
180. C 
103.4 A 
44.75 A 154. 152. 
65.2 A 103.5 125. 
42.5 A 89. 
• 111.1 A 
122.1 B 
186 A 126.26 95.2 * A 168. 
127.8 C 75.7 141.66 	A 
115.74* A 
90.8 A 149.3 127. 	A 151.85 
110. C 109.1 142.7 * A 89.0 • 109.7 
123.45 A 113.42 129.27 	C 
131.9 C 112.17 135.4 * C 
106.48 A 99.53* A 
150. A 149.3 *B 126.26 * 
48.6 A . 93.48* A 
90.85 A 
CREATININE CLEARANCE (nlsimin) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 36 
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60 & OVER 
(140) 
Blood Creatinine -(mgm/100cc. Normal 0.8 to 1.3 mgm /100 ml.) 
Mean 	Min 	Max 
Unexposed smokers 1.086 0.8 1.3 
Unexposed non-smokers 1.058 0.9 1.2 
Exposed smokers 1.126 0.9 1.5 
Exposed non-smokers 1.218 0.9 1.6 
TABLE 26 
Groups not significantly different, although the mean for the combined 
exposed group (1.156) is somewhat higher than the mean for the combined 
unexposed group (1.076). 
Creatinine Clearance - (Normal value is 
Mean 
120 - 	130 ml/min.) 
Min Max 
Unexposed smokers 116.7 75.7 175.0 
Unexposed non-smokers 117.5 71.3 168.0 
Exposed smokers 108.2 42.5 186.0 
Exposed non-smokers 124.4 93.5 149.3 
TABLE 27 
No significant difference between the groups. 
(141) 
6. Creatinine Clearance - (exprezedas mls/minute. Normal 120 - 130) 
Figures 31, 32, 33, 34 and 35, pages 134 - 138 depict the survey data on 
which the creatinine clearances (figure 36, page 139) were determined. 
Eighteen exposed workers had a value less than 120 mls/minute whilst twenty 
one control workers failed to reach this figure. As this test is generally 
regarded as one of the best if not the best indicator of glomerular func-
tion, several statistical exercises were carried out on the results. 
Table 27, page 142 shows the mean, minimum and maximum figures for each 
group. There is no significant difference between these groups. 
Table 28, page 142 is a contingency table considering clearances above and 
below 120 mls/minute. Again there was no significant group difference. 
In table 29, page 142 the calculation was repeated using 100 mls/minute 
as the cut off figure. Again there is no significant difference. 
7. 24 Hour Amino Acid Nitrogen - (mgm/24 hours. Normal 200 - 700) 
No worker in any group had an abnormal level. (Figure 37, page 143). Stat-
istically (table 30, page 147) there is no difference between the groups. 
8. Serum Electrolytes  
Renal tubular function was also evaluated by determining serum sodium, pota-
ssium and chloride, (figures 37, 38, 39, pages 144 - 146). Tables 31, 32, 
33, pages 147, 148 indicate there is no statistical difference between the 
groups. 
(142) 
Creatinine Clearance 
>120 	<120 
Unexposed smokers 8 14 
Unexposed non smokers 5 7 
Exposed smokers 9 14 
Exposed non-smokers 7 4 
13 21 34 
16 18 34 
29 39 68 
X2 = 0.54ns 1 
TABLE 28 
n.s. - not significant 
The calculation was repeated using 100 ml/mm as the cutoff value: 
>100 <1 0 0 
Unexposed smokers 16 6 
Unexposed non-smokers 9 3 
Exposed smokers 15 8 
Exposed non-smokers 8 3 
25 9 34 
23 11 34 
48 20 68 
X2 = 0.28ns 1 
TABLE 29  
n.s. - not significant 
(143) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
380 70 
600 
290 410 * 
310 310 
• 440 
350 
• 330 A 360 470 	C 190 • 470** 
475 
310 A 250 ** 415 
190 A 510 420 
385 A 290 
210 B 
240 A 
400 C 
240 A 
130 A 270 406 
340 A 240 240 
295 A 380 
390 A 
280 B 
610 A 450 252 * A 320 
300 C 460 400 
365 * A 
460 A 430 510 	A 470 
336 C 270 390 * A 210 
• 255 
440 A 390 410 	C 
• 280 C 320 330 * C 
410 A 336 * A 
• 480 A 310 * B 630* 
225 A 420 * A 
305 
AMINO ACID NITROGEN (mg/24 H 
Normal 200 - 700 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 37 
UNDER 25 
25 - 30 
30 - 35 
35 - 40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
( 144) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
130 142 
138 
142 136 * 
136 136 
139 
140 
• 140 A 136 134 C 135 135 ** 
140 
140 A 140 ** 135 
136 A 140 136 
138 A 137 
138 B 
137 A 
142 C 
129 A 
139 A 140 134 
142 A 136 135 
137 A 139 
136 A 
140 B 
140 A 135 142 137 
135 • C 136 138 A 
138 * A 
134 A 137 141 A 134 
135 C 138 140 * A 139 
• 136 
144 A 138 139 C 
• 141 C 140 137 * C 
141 A 135 * A 
140 A 135 * B 140 * 
140 A 135 * A 
136 A 
SERUM SODIUM (meg/100 mls) 
Normal 136 - 149 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 38 
UNDER 25 
25-30 
30-35 
35 - 40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
3.6 3.8 
. 	3.5 
4.2 3.8 * 
3.9 - 4.0 
• 3.7 
• 3.6 
' 3.7 A 3.6 3.9 	C 4.0 
3.3 ** 
3.5 
3.7 A 4.1 	** 4.0 
4.2 A 3.7 3.6 
4.0 A 4.1 
4.0 B 
3.6 A 
4.6 C 
4.7 A 
• 3.7 A 4.4 3.8 
3.6 A 3.4 4.0 
4.1 A 4.5 
• 3.5 A 
3.9 B 
4.2 A 3.7 3.5 4.1 
3.5 C 3.7 3.7 	A 
4.0 * A 
3.3 A 4.0 4.2 	A 13.6 
3.8 C 3.6 4.1 	* A 3.8 
4.0 
4.2 A 4.0 3.7 	C 
• 4.0 C 3.2 3.9 	* C 
4.5 A 4.3 * A 
4.0 A 3.2 	* B . 	4.0 * 
• 3.9 A 4.2 	*- A 
3.4 A 
SERUM POTASSIUM (meg/100 mls.) 
Normal 3.8 , 5.2 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 39 
UNDER 25 
25 - 30 
30 - 35 
40 - 45 
45 - 50 
50-55 
55 - 60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
96 102 
99 
104 101 	* 
102 105 
103 
104 
• 107 A 105 100 	C _ 98 ** 
106 
106 A 103 ** 102 
101 A _ 101 
102 A 100 
104 B 
103 A 
102 C 
99 A 
101 A 108 - 104 A 101 101 
98 A 102 
• 102 
103 B 
• - A 100 102 * A 103 • 98. C 104 102 	A 
- 	*A 
100 A 102 - 	A 99 104 C 105 105 * A 104 
• 101 
103 A 103 - 	C 
- C 105 99 * C 
102 A 103 * A 
103 A 98 103* 
102 A 111 * A 
103 A 
SERUM CHLORIDE (meg/100 mls.) 
Normal 98 - 108 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 40 
UNDER 25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
(147) 
24 hour Amino Acid Clearance - (mgm/24 hrs. Normal 200 - 700 mgm) 
Mean Min Max 
Unexposed smokers 372 240 600 
Unexposed non-smokers 341 70 630 
Exposed smokers 330 130 610 
Exposed non-smokers 381 252 510 
TABLE 30 
Groups not significantly different 
Sodium - (Normal range in the laboratory is 
Mean 
136 - 149 mal/1) 
Min 	Max 
Unexposed smokers 137.64 130 142 
Unexposed non-smokers 136.58 134 142 
Exposed smokers 138.26 129 144 
Exposed non-smokers 137.64 134 142 
TABLE 31 
Groups not significantly different 
(148) 
Potassium - (Normal range in the laboratory 3.8 - 5.2 mEq/1) 
Mean Min Max 
Unexposed smokers 3.786 3.2 4.5 
Unexposed non-smokers 3.875 3.6 4.1 
Exposed smokers 3.917 3.3 4.7 
Exposed non-smokers 3.882 3.2 4.3 
TABLE 32 
Groups not significantly different 
Chloride - (Normal range in the laboratory is 98 - 108 mal/1) 
n Mean Min Max 
Unexposed smokers 21 102.43 96 108 
Unexposed non-smokers 10 102.10 99 105 
Exposed smokers 21 102.24 98 107 
Exposed non-smokers 8 102.50 98 111 
TABLE 33 
Groups not significantly different 
( 149) 
Other indices of tubular and glomerular function; glycosuria, serum 
calcium and phosphorus, serum proteins, were measured and are discussed 
in later chapters. The results of these investigations support the 
following conclusion. 
There was no difference in renal function of the control and exposed 
groups using the parameters discussed above. The statistical signif-
icance between the actual blood urea levels of the groups is considered 
clinically unimportant and has been ignored because the more sensitive 
and more reliable indication of glomerular function, the creatinine 
clearance, did not correlate with this finding. It is generally accepted 
that a raised blood urea, in isolation, is a little value in assessing 
renal function. 
Discussion 
There is abundant evidence that a large percentage (33% or more) of body 
burden of cadmium is stored in the cells of the renal tubules. 	It is 
also clear that once a critical cellular concentration is reached permanent 
irreversible damage occurs resulting in both increased excretion of 
cadmium and clinical and biochemical manifestation of tubular damage. 
Urinary cadmium levels therefore do not reflect either renal concentration 
or total body burden. But it may be of value in detecting or assessing 
current exposure and intake as it rises and falls with exposure 
Levels of 30 microgram/litre or more are necessary before early signs, 
e.g. transient proteinuria, of altered renal function appears. Because this 
(150) 
figure has been consistently associated with signs of renal damage an 
arbitrary figure of 25 micrograms/litre (where there is no evidence of renal 
damage) has been suggested as an indication of excessive exposure. This 
survey confirms the suggestion that renal damage does not occur with a 
urinary excretion of less than 30 Ug/litre but does not provide evidence 
for or against the selection of 25 Ug/litre as an indication of excessive 
exposure. 
Urinary cadmium estimation are tedious and subject to many possible sources 
of error from incorrect sample collection to errors in actual assay. Some 
body burden of cadmium can be tolerated by renal tissues without producing 
damage therefore. How can the clinician decide when this burden has been 
reached? 
Unfortunately the only markers of renal tubular dysfunction at present 
easily recognisable are those which indicate irreversible damage. What 
is needed is an easily identifiable indicator of high renal tubular cad-
mium which in itself is not the result of irreversible cadmium toxicity. 
Considerable experimental work is going on at present to determine 
whether increased excretion of certain enzymes in the urine will provide 
the answer to this problem. This survey showed that the usual tests of 
renal function either singly or in groups were not useful markers of non 
toxic renal tissue burden of cadmium. 
The survey result must offer considerable consolation to the general 
public who, from mathematical modelspredictions,have been led to believe 
that critical renal levels will be reached before middle age if current 
exposure trends continue. If workers occupationally exposed to high 
(15 1) 
concentrations of cadmium for long periods do not reach the danger 
level there must be far less chance of the general population doing so 
from environmental exposure. 
(152) 
CHAPTER 13 
Cadmium and the Digestive System  
The intestinal mucosa and pancreas have an important role in the absorp-
tion,storage or excretion of cadmium. My survey looked at possible signif-
icant functional changes in these structures due to their involvement in 
cadmium metabolism. 
1. The Pancreas and Alimentary Canal  
Because elaborate or extensive investigations were deliberately excluded 
from the survey, digestive, absorptive and excretory function was assessed 
by history and clinical examination. However, certain investigations 
e.g. blood sugar, serum protein, lipids, triglycerides, cholesterol, 
uric acid, though performed primarily for other reasons discussed in later 
chapters were of assistance in finalising conclusions based on the above 
premises. 
Acute exposure following accidental plant malfunction and short term high 
atmospheric contamination produced nausea and vomiting in several workers 
on occasions. These symptoms were of short duration and no participant 
admitted either in the questionnaire or at the subsequent interviews to 
being seriously incapacitated by them. No worker could remember having 
to lose time from work because of an "overdose" and no medical certificates 
presented for any lost time by any employee implicated the working environ-
ment as a cause of illness. In high enough doses cadmium appeared to be 
an emetic of temporary duration. 
The questionnaire was designed to highlight symptoms associated with 
digestive disorders, malabsorption and altered intestinal motility. In 
(153) 
all these areas there was no differences in the response pattern between 
the groups. As mentioned previously there was no significant difference 
in the incidence of diagnosed gastro-intestinal conditions between the 
groups. 
Physical examination of the abdomen revealed no abnormalities in any 
group. No member of any group exhibited associated stigmata of malab-
sorption, e.g. finger clubbing, pallor, cachexia. 
Several workers e.g. Princi (56), Horstowa et al (62) have reported a 
yellow staining of teeth in the occupationally exposed. No member of the 
exposed group showed staining of natural teeth. There was no significant 
difference in the number in each group with either partial or full 
dentures. 
Four workers in the exposed group, three smokers and one non smoker had 
marked caries and gingivitis. No member of the control groups had any 
serious dental condition. The company provides an on-site dental clinic 
and these findings may simply reflect both the easier access and hygiene 
conscience of clerical workers in contrast to the problems of access of a 
shift worker and a laboure2s standards of hygiene; 
Conclusion 
No differences in the functioning of the digestive system of exposed 
workers and controls were found. 
(154) 
Discussion  
Some investigations have linked vague ill health, anaemia, nausea and 
disordered digestion or intestinal motility with chronic cadmium intake. 
There is good and abundant experimental evidence that both the pancreas 
and the gut, as well as salivary glands are very actively involved in 
handling body cadmium. It is not surprising therefore that such a 
linkage has been frequently suggested. No worker has proven that cadmium 
concentration in the cells of these organs is responsible for the symptoms. 
No worker has found pathological changes in these organs that could be 
correlated with cadmium in the cells. 
The symptoms generally ascribed to cadmium are often associated with 
disease elsewhere in the body. Perhaps renal or pulmonary disease in the 
cadmium exposed workers was responsible for the production of these symp-
toms and not cadmium itself. 
(155) 
CHAPTER 14 
Cadmium and Liver 
The liver plays an important role in the transport and storage of cadmium. 
A large percentage of body burden - possibly 20 - 25% is stored in here. 
Metallothionein - the protein responsible for cadmium binding in the 
tissues and transport in the circulation is produced in part if not in 
toto by hepatic cells. 
The following list of tests of liver function were employed to investigate 
possible hepatic dysfunction:- 
(a) Total Bilirubin 
(b) Conjugated Bilirubin 
(c) Serum Protein 
(d) Serum Albumin 
(e) cC 1 Globulin 
(f) 00 2 Globulin 
(g) 'V Globulin 
(h) ic Globulin 
(i) Alkaline Phosphatase 
(j) Serum Glutamic Pyruvic Transaminase 
(k) Serum Cholesterol 
(1) Serum Triglycerides 
(a) Serum Bilirubin - No member of either the exposed or the control 
group had a serum bilirubin higher than 0.5 mgm per 100 ml. Figure 41, 
page 156. 
(b) No member of either group had any conjugated bilirubin in the specimen 
of serum analysed. Figure 42, page 157. 
(156) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
0.5 0.5 
0.5 
0.5 0.5 * 
0.5 0.5 
0.5 
0.5 
0.5 A 0.5 0.5 	C 0.5 
0.5 ** 
0.5 
0.5 A 0.5 ** 
_ 
0.5 
0.5 A 0.5 0.5 
0.55 A 0.5 
0.5 B 
0.5 A 
0.5 C 
0.5 A 
0.5 A 0.5 0.5 
0.5 A 0.5 0.5 
0.5 A 0.5 
0.5 A 
0.5 B 
0.5 A 0.5 0.5 0.5 
0.5 C 0.5 0.5 	A 
0.5 * A 
0.5 A 0.5 0.5 	A 0.5 
0.5 C 0.5 0.5 * A 0.5 
0.5 
0.5 A 0.5 0.5 	C 
0.5 C 0.5 0.5 * C 
0.5 A 0.5 * A 
0.5 A 0.5 * B 0.5 * 
0.5 A 0.5 * A 
0.5 A 
TOTAL BILIRUBIN 
mgm /100 ml. 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 41 
UNDER 25 
25-30 
30-35 
35-L 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
(157) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
nil nil 
nil 
nil nil * 
nil nil 
. nil 
• nil 
• nil A nil nil C nil 
• nil ** 
nil . 
nil A nil ** nil 
nil A • nil nil 
, nil A • nil 
nil B 
nil A 
• nil C 
nil A 
nil A nil nil 
nil A nil nil 
nil A nil 
• nil A. 
nil B • 
• nil A nil . nil nil 
nil C nil nil 
nil * A 
nil A nil nil A nil 
nil C nil nil * A nil 
. 	nil 
nil A nil , nil C 
• nil C • nil . nil * C 
nil A nil * A 
: nil A nil * B nil * 
mil A nil * A 
.7.1i1 A 
UNDER 25 
25 - 30 
30-35 
35 - 40 
40-45 
45 - 50 
50-55 
55 - 60 
60 & OVER 
CONJUGATED BILIRUBIN % 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 42 
(158) 
(c) Serum Protein - Four members of the exposed group, three smokers 
with lengthy exposure to cadmium and one non-smoker with limited 
exposure to cadmium had a total protein below the laboratory normal 
of 6.5 grams per 100 mls. One member of the control group did not 
reach this level. However, when subject to statistical analysis, 
there was no significant difference between the groups as a whole. 
(Figure 43, page160,table 34, page 166) 
(d) Serum Albumin - The four members of the exposed group with a low 
serum protein all recorded a level of albumin less than 3.5 
grams per 100 mls. (lower normal for the laboratory). In addition 
another member of the exposed group with limited exposure to cadmium 
also failed to reach this figure. The only member of the control 
group with low serum protein also had a low serum albumin. Again, 
however, statistically there is no difference between the groups. 
(Figure 44, page 161, table 35, page 166). 
(e) 0:1 Globulin - No member of either the exposed group or the control 
group showed a value lower than the laboratory normal, (normal 
0.l-/0.4 Gm. 100 mls.). (Figure 45, page 162, table 36, page 167). 
(f) cc 2 Globulin - Twelve members of the exposed group, eight smokers and 
four non-smokers had a level of0C2 globulin higher than 0.8 grams 
percent (the laboratory normal). Six members of the control group 
exceeded this figure, three smokers, three non-smokers. However, 
statistically there was no significant difference between the groups. 
(Figure 46, page 163, table 37, page 167).. 
(159) 
(g)p Globulin - Seven members of the exposed group had a level greater 
than 1.0 grams percent, four smokers and three non-smokers. Three 
members of the control group also had elevated figures, two smokers 
and one non-smoker. However, statistically there was no difference 
between the groups. (Figure 47, page 164, table 38, page 168). 
(h) 15 Globulin - Five members of the exposed group, two smokers and three 
non-smokers had an elevated level compared with three in the control 
group, two smokers and one non-smoker. Again statistically there is 
no significant difference between the groups. (Figure 48, page 165 
table 39, page 168). 
(i) Alkaline Phosphatase - (Normal 9.35 IU/Litre). Three members of the 
exposed group had a level higher than the laboratory normal of 35 
units/litre; all were smokers. Two members of the control group 
had elevated figures also. Statistically there was no difference 
when all the levels were considered between the groups. (Figure 49, 
page 169, table 40, page 171). 
A contingency table formed from people with values above and below 
the level of 35 IU showed that these numbers with raised levels were 
not significant. (Table 41, page 171). 
(j) Serum Glutamic Pyruvic Transaminase - (Normal range< 27 units per 
litre). (Figure 50, page 170,table 42, page 172). Thirteen people, 
four unexposed and nine exposed had a level higher than the laboratory 
normal. A contingency table to examine this was formed. (Table 43, 
page 172). Again these numbers were not significant. 
6.80 7.20 
7.10 
7.50 7.70 * 
7.20 6.90 
• 7.20 
• 6.70 
' 7.30 A 7.70 5.80 C 7.00 
7.50 ** 
7.60 
6.70 A 7.00 ** 7.50 
7.30 A 7.80 6.90 
7.10 A 6.80 
7,20 B 
7.40 A 
7.60 C 
7.20 A 
7.30 A 7.60 7.10 
7.70 A 7.60 6.30 
7,0 A 7.40 
• 7.0 A 
7.20 B 
• 6.70 A 6.90 7.50 * A 7.30 
7.40 •C 6.80 7.20 A 
7.90 * A 
7.00 A 6.50 6.90 A 6.70 
7.20 C 7.00 7.30 * A 6.50 
• 6.80 
7.50 A 6.00 6.70 C 
7.10 C 7.20 6.50 * C 
6_30 A 7.60 * A 
6.00 A 7.20 * B 7.20 * 
6.70 A 6.90 * A 
6_40 A 
UNDER 25 
25 - 30 
30-35 
35 - 40 
40-45 
45-50 
• 50-55 
55 - 60 
60 & OVER 
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Exposed Unexposed Exposed Unexposed 
Smokers Smokers Non smokers 
	
Non smokers 
TOTAL PROTEIN (gm PER 100 ml,) 
(Normal 6.5 - 8) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 43 
4.20 4.30 
4.61 
5.27 4.76 * 
4.44 4.35 
• 4.05 
4.26 
• 4.52 A 5.15 ** 2.91 	C 4.04 
4.79 
4.86 
4.28 A 3.97 ** 4.24 
3.90 A 4.79 3.74 
4.25 A 4.02 
4.60 B 
4.29 A 
4.69 C 
4.03 A 
4.35 A 4.40 4.76 
5.10 A 4.63 3.76 
3.79 A 4.71 
• 3.63 A 
4.51 B 
• 4.09 A 4.33 4.05 * A 4.58 
4.03 •C 5.32 4.10 	A 
4.27 * A 
4.26 A 4.38 3.89 	A 4.08 
3.91 C 3.80 4.46 * A 3.99 
• 3.54 
4.65 A 3.49 4.17 	C 
• 3.72 C 4.54 3.35 * C 
3.44 A 4.85 * A 
3.24 A 4.46 * B 4.22 * 
4.19 A 4.39 * A 
3.43 A 
UNDER 25 
25-30 
30-35 
35 - 40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed " 
Smokers Smokers Non smokers 	Non smokers 
SERUM ALBUMIN (gm/100 ml.) 
(Normal 3.5 - 5.2) 
* - Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C .- Superphosphate Plant 
FIGURE 44 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
0.20 0.13 
0.15 
0.15 0.10 * 
0.26 0.19 
• 0.24 
• 0.24 
' 0.21 A 0.17 0.18 	C 0.15 
0.16 ** 
0.20 
0.15 A 0.12 ** 0.19 
0.19 A 0.33 0.22 
0.18 A 0.21 
0.22 B 
0.29 A 
0.18 C 
0.20 A 
0.16 A 0.17 0.30 
0.20 A 0.16 0.17 
0.18 A 0.10 
• 0.21 A 
0.22 B 
• 0.14 A 0.18 0.12 * A 0.15 
0.30 C 0,11 0.18 	A 
0.22 * A 
0.20 A 0.12 0.15 	A 0.17 
0.24 C 0.20 0.21 * A 0.12 
0.22 
0.17 A 0.30 0.09 	C 
0.45 C 0.13 0.18 * C 
0.23 A 0.18 * A 
• 0.18 A 0.11 	* B 0.19 * 
0.25 A 0.13 * A 
0.18 A 
cl,C 1 GLOBULIN (gm /100 ml.) 
(Normal 0.1 40.4) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 45 
UNDER 3 
25-30 
30-35 
35 - 
40-45 
45-50 
50-55 
55-60 
60& OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
0.80 0.73 
0.70 
0.58 0.58 * 
0.70 0.66 
• 0.91 
0.77 
0.68 A 0.55 ** 0.74 	C 0.81 
• 0.76 
0.67 
0.65 A 0.93 ** 0.90 
0.94 A 0.76 0.88 
• 0.68 A 0.77 
0.68 B 
0.72 A 
0.79 C 
0.69 A 
0.68 A 0.80 0.48 
0.65 A 0.71 0.63 
0.84 A 0.60 
• 0.84 A 
0.72 B 
0.81 A 0.67 0.87 * A 0.76 
0.95 C 0.59 0.85 	A 
0.84 * A 
0.76 A 0.50 0.80 	A 0.75 
0.91 C 0.73 0.76 * A 0.68 
• 0.73 
0.69 A 0.39 0.59 	C 
• 0.61 C 0.86 0.90 * C 
0.83 A 0.58 * A 
0.82 A 0.67 * B 0.70 * 
0.69 A 0.65 * A 
0.74 A 
UNDER 25 
25-30 
30-35 
35 - 40 
40-45 
45-50 
50-55 
55 - 60 
60 & OVER 
ce 2 GLOBULIN (gm /100 ml.) 
(Normal 0.4 -> 0.8) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 46 
(164) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
0.80 0.97 
0.76 
0.67 0.94 * 
0.88 0.83 
• 1.04 
• 0.77 
' 0,93 A 0.96 1.06 	C 1.00 
• 0.85 ** 
0.82 
0.79 A 0.85 ** 1.01 
0.94 A 0.96 0.95 
• 0.90 A 0.90 
0.76 B 
0,95 A 
• 0.93 C 
1.08 A 
0.91 A 0.91 0.68 
0.85 A 0.98 0.79 
1,05 A 0.92 
1.09 A 
0.72 B 
• 0.88 A 0.86 1.14 * A 0.89 
1.06 •C 0.83 0.97 	A 0.98 * A 
0.76 A 0.75 0.95 	A 0.85 
0.91 C 0.85 0.75 * A 0.68 
• 1.15 
0.86 A 0.74 0.78 	C 
• 0.91 C 0.86 1.14 * C 
0.87 A 0.86 * A 
0.82 A 0.98 * B 1.00 * 
0.73 A 0.77 * A 
0.81 A 
I) GLOBULIN (gm/ 100m1. ) 
(Normal 0.5 - 1.0) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 47  
UNDER 25 
25 - 30 
30 - 35 
35 - 40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
. (165) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
• 	 0.80 1.07 
0.88 
0.83 1.32 * 
• 0.92 0.87 
0.94 
• 0.66 
0.96 A 0.87 0.91 	C 1.00 
0.94 ** 
1.05 
0.83 A 1.13 ** 1.16 
1.33 A 0.96 1.11 
1.09 A 0.90 
0.94 B 
1.15 A 
1.01 C 
1.10 A 
1.20 A 1.32 0.88 
0.90 A 1.12 0.96 
1.14 A 0.97 
• 1.23 A 
0.98 B 
0.78 A 0.86 1.32 * A 0.92 
1.06 C 0.95 1.10 	A 
1.49 * A 
1.02 A 0.75 1.11 	A 0.85 
1.23 C 1.42 1.13 * A 1.03 
• 1.16 
1.13 A 0.88 1.07 
1.41 C 0.90 0.93 * C 
0.93 A 1.13 * A 
0.94 A 0.98 * B 1.09 * 
0.84 A 0.86 * A 
1.24 A 
is GLOBULIN (gm/ 100m1. ) 
(Normal 0.6 - 1.3) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 48 
UNDER 25 
25 - 30 
30-35 
35 - 40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
(166) 
Serum Protein -(Normal 6.5 - 8 Gm/100 ml.) 
Mean Min Max 
Unexposed smokers 7.123 6.0 7.8 
Unexposed non-smokers 7.025 6.3 7.7 
Exposed smokers 7.057 6.0 7.7 
Exposed non-smokers 7.045 5.8 7.9 
TABLE 34 
No significant difference between the groups. 
Serum Albumin - (Normal 3.5 - 	5.2 Gm/100 ml.) 
Mean Min Max 
Unexposed smokers 4.434 3.49 5.32 
Unexposed non-smokers 4.235 3.74 4.76 
Exposed smokers 4.126 3.24 5.10 
Exposed non-smokers 4.082 2.91 4.85 
TABLE 35 
No significant difference between the groups. 
(167) 
°el Globulin - (Normal 0.1 - 0.4 Gm/100 mls.) 
Mean Min Max 
Unexposed smokers 0.187 0.10 0.33 
Unexposed non-smokers 0.173 0.10 0.30 
Exposed smokers 0.214 0.14 0.45 
Exposed non-smokers 0.159 0.09 0.22 
TABLE 36 
No significant difference between the groups. 
ciC 2 Globulin - 	(Normal 	0.4 ->0.8 Gm/100 ml.) 
Mean Min Max 
Unexposed smokers 0.713 0.50 0.93 
Unexposed non-smokers 0.713 0.48 0.95 
Exposed smokers 0.755 0.61 0.90 
Exposed non-smokers 0.685 0.58 0.90 
TABLE 37 
No significant difference between the groups. 
(168) 
$ Globulin - 	(Norma10.5 - 1.0 Gm/100 ml.) 
Mean Min Max 
Unexposed smokers 0.869 0.67 1.15 
Unexposed non-smokers 0.882 0.68 1.01 
Exposed smokers 0.892 0.72 1.09 
Exposed non-smokers 0.944 0.75 1.14 
TABLE 38 
No significant difference between the groups. 
V Globulin _ (Normal 0.6 - 1.3 Gm/100 ml.) 
Mean Min Max 
Unexposed smokers 0.964 0.66 1.42 
Unexposed non-smokers 1.022 0.85 1.32 
Exposed smokers 1.063 0.78 1.41 
Exposed non-smokers 1.094 0.86 1.49 
TABLE 39 
No significant difference between the groups. 
(169) 
Exposed 	One 	Exposed 	Unexposed 
Smokers Smokers 	Non smokers 	Non smokers 
20 14 
Z8 
25 19* 
31 20 
25 
18 
21 	A 26 17 	C 14 
22 ** 
23 
53 	A 29** 32 
13.7 A 15 27 
27 	A 15 
25 	B 
20 	A 
25 	C 
31 	A 
58 	A 19 21 
25 	A 31 36 
19 	A 22 
20 	A 
33 	B 
• 15 	A 27 34 18 
30 	C 29 24 	A 
15 * A 
20 	A 22 15 	A 14 
25 	C 22 - 	*A 27 
• 15 
118 	A 76 17 	C 
• 23 	C 24 24 * C 
21 	A 27 * A 
25 25 * B 15* 
21 	A 15 * A 
18 
ALKALINE PHOSPHATASE IU/LITRE 
(Normal 9 -35) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 49 
UNDER 25 
25 - 30 
30-35 
35 - 40 
40-45 
45-50 
50-55 
55 - 60 
60 & OVER 
(170) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
20 9 
33 
11 7 * 
18 20.25 
27 
36 
4 	A 13 18 	C 108 
25 ** 
7 
61 	A 17** 27 
9 	A 4 9 
9 	A 7 
8 	A 
11 	B 
6 	C 
20 	A 
34 	A 13 13 
12 	A 16 14 
36 	A 7 
• 20 
11 	B 
• 227 	A 9 43 
20 	C 13 28 
6 * A 
13 	A 37 22 	A 11 
45 	C 11 7 * A 13 
• 18 
16 	A 22.5 18 	C 
• 11 	C 16 40.5*C 
20 	A 11 * A 
29 	A 7 * B 27* 
20 	A 9 * A 
9 
SERUM GLUTAMIC PYRUVIC TRANSAMINASE 
(Normal 27 Units/Litre) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 50 
UNDER 25 
25-30 
30 - 35 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
(171) 
Alkaline Phosphatase - (Normal 9 - 35 IU) 
Mean Median Min Max 
Unexposed smokers 25.45 23.5 15 76 
Unexposed non-smokers 22.17 20.5 13 36 
Exposed smokers 29.65 24.0 13 118 
Exposed non-smokers 21.00 20.5 14 34 
TABLE 40 
No significant difference between the groups. 
Number of people with Alkaline Phosphatase values above and below 35 IU/litre  
(35 >35 
Unexposed 32 2 34 
Exposed 30 3 33 
62 5 67 
X2 = 0.25ns 1 
TABLE 41 
n.s. = not significant 
(172) 
Serum Glutamic Pyruvic Transaminase 	(Normal range 27 units per litre.) 
Mean Median Min Max 
Unexposed smokers 16.57 16 4 37 
Unexposed non-smokers 22.33 13.5 6 108 
Exposed smokers 29.26 20 4 227 
Exposed non-smokers 19.09 18 6 41 
TABLE 42 
No significant difference between the groups. 
Number of people with Serum Glutamic Pyruvic Transaminase values higher  
than normal 
<27 >27 
Unexposed 30 	4 34 
Exposed 25 9 34 
55 	13 68 
X 21 = 2.38ns 
TABLE 43 
n.s. = not significant 
(173) 
(k) Serum Cholesterol - (Normal range 150 - 250 mgm/100 mls.) 
Thirteen members of the control group, six smokers and seven non- 
smokers had a cholesterol level over than 250 mgm percent. Seventeen 
of the control group had a higher level, eleven smokers and six non-
smokers. (Figure 51, page 174). There is no statistical signif-
icance between the groups (table 44, page 176). 
(1) Serum Triglycerides - (Normal 30 - 135 mgm/100 mls.) Twenty four 
members of the exposed group, sixteen smokers and eight non-smokers 
had an elevated level. Twenty eight members of the control group, 
eleven non-smokers and seventeen smokers had a raised level. 
(Figure 52, page 175). However, table 45, page 176 shows there is no 
' 	significant difference between the groups. 
Conclusion 
There is no evidence from this study to indicate any significant 
clinical variation in liver function between exposed workers and 
controls. 
Discussion 
The results of the serum protein and its components, serum alkaline 
phosphatase and serum glutamic pyruvic acid showed some departures 
from normal values. As has been pointed out there was no statistically 
significant variation between the groups. However, these abnormalities 
are worthy of comment. They could be dismissed as a manefestation of 
infectious hepatitis which was epidemic in Southern Tasmania at the 
time. From specific questioning and clinical examination, I could not 
Exposed 
Smokers 
Unexposed 
Smokers 
Exposed 
Non smokers 
Unexposed 
Non smokers 
• 	160 215 
267 
274 . 257* 296 290 
253 
• 148 
' 233 A 298 282 C 261 
192 ** 
212 
204 A 200 ** 186 
242 A 309 202 
226 A 208 
260 B 
232 A 
219 C 
234 A 
212 A 215 220 
250 A 277 296 
253 A 221 
202 A 
200 B 
• 290 A 258 364 * A 276 
286 C 267 242 A • 252 * A 
268 A 248 268 A 186 
177 C 222 260 * A 212 
304 
296 
/ 
A 198 210 C 
236 C 298 277 * C 
202 A 200 * A 
216 A 331 * B 254 * 
209 A 193 * A 
192 A 
UNDER 25 
25 - 30 
30-35 
35 - 40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
(174) 
CHOLESTEROL (mgm . /100 
(Normal 150 - 250) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 51 
(1 75) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
136 125 
209 
149 275* 
135 179 
• 209 
149 
• 163 A 530 1,380 C 145 
• 159 ** 
250 
129 A 133 ** 136 
381 A 209 170 
179 A 168 
210 B 
95 A 
106 C 
560 A 
252 A 210 145 
340 A 163 499 
173 A 80 
• 422 A 
126 B 
527 A 55 210 * A 173 
379 •C 254 109 A 
145 * A 
145 A 665 172 A 138 
119 C 205 181 * A 136 • 436 
310 A 119 109 
154 C 450 219 * C 
90 A 132 * A 
146 A 385 * B 312* 
236 A 163 * A 
99 A 
TRIGLYCERIDES ( mgm/100 ml.) 
(Normal 35 - 135) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
UNDER 25 
25 - 30 
30-35 
35 - 40 
40-45 
45 - 50 
50-55 
55-60 
60 & OVER 
FIGURE 52  
(176) 
Serum Cholesterol - 	(mgm./100 ml. 	- Normal 150 - 250) 
Mean Min Max 
Unexposed smokers 242.0 148 309 
Unexposed non-smokers 237.9 186 296 
Exposed smokers 232.1 177 296 
Exposed non-smokers 261.7 193 364 
TABLE 44 
No significant difference between the groups. 
Serum Triglycerides - (Normal 30 - 135 mgm/100 mls.) 
Mean Min Max 
Unexposed smokers 231 55 665 
Unexposed non-smokers 203 125 499 
Exposed smokers 232 90 560 
Exposed non-smokers 291 109 1380 
TABLE 45 
No significant difference between the groups. 
(177) 
link any survey participant with either the disease or close contact 
with known sufferers. As the hepatitis virus is almost certainly more 
widely distributed throughout the community than the number of 
diagnosed cases would suggest, altered tests of liver function could 
be produced by sub-clinical infection. Unfortunately there is no 
specific test for this condition. 
Another explanation could be they reflect the drinking habits of the 
individual. There is a close correlation between heavy drinking and 
some abnormal results in the non exposed groups but not all heavy 
drinkers in either exposed or control groups showed one or more 
abnormal results. Two almost teetotal controls showed an abnormality 
in one or more tests compared with eleven almost teetotal exposed 
workers. 
These figures have not been subject to statistical analysis for several 
reasons. The majority of abnormal results were not very different 
from normal and could well be laboratory error. Also there is no 
consistent pattern to the variation. Most were a single deviation only. 
But three of the "teetotal" exposed group showed three or more abnormal 
tests and these men had long periods of exposure, (25 years or more). 
As a similar picture emerged when haemoglobin levels were examined. 
(Chapter 15) correlation matrices were calculated to see if there was 
any correlation between blood lead, blood cadmium,haemoglobin,total 
protein,albumin0C2 globulin and years of exposure for the twenty two 
men in the cadmium plant only. (Tables 46, 47, 48, pages 180 - 181. 
The statistician reports as follows - 
(178) 
"The most significant correlation coefficients between the measured 
variables and years of exposure are those for haemoglobin and total 
protein, both of these showing a highly significant decline (p(0.001) 
for workers in the cadmium plant (the exposed non-smokers group is too small 
for significance to be easily detected). Blood cadmium is positively 
correlated with years of exposure (p<0.05). Albumin is significantly 
depressed (p<0.05) in the exposed smokers group, but not in the non-smokers 
group. The total protein, haemoglobin and albumin are highly intercor-
related in the exposed smokers group. There is no evidence, however, that 
2 globulin is significantly raised, the correlation coefficient 0.2831 
being far from significant. 
An interesting result is the highly significant correlation between ce2 
globulin and haemoglobin (r = 0.8873) for the exposed non-smokers. This 
would tend to rule out any possibility that an increase in eC 2 globulin 
would be expressed as a result of long exposure in the cadmium plant. 
However, the sample size is too small to be emphatic about any conclusions; 
this is unfortunate because any effect observed in the exposed smokers 
groups may be due to smoking rather than due to exposure to cadmium." 
My investigations were directed towards the health hazards of cadmium and 
I have concluded that there is no harmful effects on liver function to 
those with body burdens of the range my group of exposed workers have 
attained. It would be of interest, however, to investigate protein metab-
olism in a much bigger group of workers with long and higher exposure and 
therefore higher body burdens to see if there was a significant variation 
from normal in this group. Metallothionen is a protein apparently 
(179) 
specifically associated with heavy metals and changes in the serum prot-
eins might reflect its formation and tissue levels thus providing an 
easily identifiable marker for cellular cadmium levels. 
(180) 
a) For the exposed smokers group (d.f. 
Yrs. 	Exp. 	1.0 
Blood Pb 	-0.1449 	1.0 
Blood Cd 	0.5406* 	0.3596 	1.0 
Haem. 	-0.8889*** 	0.2430 	-0.4201 
Tot. Prot.-0.7539*** 	0.0443 	-0.4187 
Albumin 	-0.5514* 	0.1060 	-0.1612 
ce2 Glob. 	0.2831 	-0.1923 	-0.2276 
= 	15): 
1.0 
0.7624*** 
0.5469* 
-0.1795 
1.0 
0.8127*** 
-0.3363 
1.0 
-0.6667** 1.0 
Yrs. Exp. Blood Pb Blood Cd Haem. 	Tot. Prot. Albumin d:2 Glob 
TABLE 46 
b) For the exposed non-smokers group (d.f. = 5): 
Yrs. 	Exp. 	1.0 
Blood Pb 	0.6818 	1.0 
Blood Cd 	0.4800 	-0.1831 	1.0 
Haem, 	-0.5503 	-0.1960 	-0.3990 	1.0 
Tot. 	Prot.-0.4423 	-0.1672 	-0.2787 	0.1837 
Albumin 	0.4741 	0.2829 	0.3709 	-0.6858 
'X 2 Glob. 	-0.5575 	-0.1199 	-0.6376 	0.8873** 
1.0 
0.3523 
0.1405 
1.0 
-0.8237* 1.0 
Yrs. Exp. Blood Pb Blood Cd Haem. 	Tot. Prot. Albumin c17 2 Glob 
TABLE 47 
* p <0.05 	** p40.01 	 *** p 0.001 
(181) 
c) 	For the combined exposed group (d.f. 
Yrs. 	Exp. 	1.0 
Blood Pb 	-0.0357 	1.0 
Blood Cd 	0.5145* 	0.2810 	1.0 
Haem. 	-0.7890*** 0,1485 	-0.4054* 
Tot. 	Prot.-0.6421*** 0.0102 	-0.4324* 
Albumin 	-0.3828 	0.1240 	-0.1201 
0C2 Glob 	0.0667 	-0.1664 	-0.3326 
= 	22): 
1.0 
0.5765** 
0.2636 
0.2102 
1.0 
0.7455*** 
-0.1521 
1.0 
-0.6402*** 1.0 
Yrs. Exp. Blood Pb Blood Cd Haem. Tot. Prot. Albumin ce2 Glob 
TABLE 48 
* p<0.05 	**p< 0.01 	*** p0.001 
Relative Viscosity - (Normal 1.5 - 1.72 centrepoises) 
Mean 	Min Max 
Unexposed smokers 1.689 1.56 1.84 
Unexposed non-smokers 1.734 1.59 1.94 
Exposed smokers 1.702 1.58 1.85 
Exposed non-smokers 1.738 1.56 1.91 
TABLE 49 
No significant difference between the groups. 
(182) 
CHAPTER 15 
Cadmium and the Haemopoetic System  
Cadmium is found in both serum and red cells, Perry et al (17), Lucis 
et al (18). Some investigations have found anaemia amongst cadmiuM 
workers, others have not. (Vide Chapter 5). Eosinophilia also has been 
described - Nicaud et al (55), Princi (56). Friberg (14) examined the 
bone marrow of nineteen cadmium workers in 1950 and noted no pathological 
changes. 
In this survey the following investigations into the haemopoetic system 
were carried out. 
(a) Relative viscosity 
(b) Haemoglobin 
(c) Packed cell volume 
(d) White cell count 
(e) Platelet count 
(f) Examination of blood film 
(g) Differential white cell count 
(h) Uric acid estimation 
1. Relative viscosity - (Figure 52, page 186) This test was performed as 
an alternative to the erythrocyte sedimentation rate. It is a non-specific 
test which accurately and quickly reflects changes occurring in the plasma 
proteins. The normal range for the laboratory is 1.5 to 1.72 centrepoises. 
It was thought that this might reflect changes that are reputed to occur 
in proteins as the result of cadmium triggering off the production of 
metallothionen. 	Seventeen of the exposed group, ten smokers and seven 
(183) 
non-smokers had an elevated figure compared with thirteen controls, five 
non-smokers and eight smokers. However, statistically there was no 
significant difference between the groups. (Table 49, page 181). A 
contingency table (table 50, page 188) examines these results also. 
2. Haemoglobin - (Normal range 13.5 - 18 Gm/100 mls.) 
Six members of the exposed, four smokers and two non-smokers, all with 
lengthy exposure to the most contaminated atmosphere had a haemoglobin 
level less than 14 grams percent. Two members of the control group, one 
a non-smoker and the other a smoker had a low level. (Figure 53, page 
187). However, there is no significant difference in actual levels 
between groups. (Table 51, page 188). 
Several statistical exercises were carried out in relation to the number 
. of men with haemoglobin above and below 14 Gm and years of exposure. A 
contingency table (table 52, page 189) considers all workers with 20 
or more years exposure and shows there is a significant link between 
exposure time and low levels. A similar table (table 53, page 189) 
considering only those working in the most contaminated atmosphere rein-
forces the idea of a definite relationship between high body burden and 
lower haemoglobin levels. 
Examination of a correlation coefficient between years of exposure and 
• haemoglobin suggests that an added factor, smoking,may be of significance 
in the relationship. 
d.f. 
Exposed smokers 	-0.8014*** 	21 
Exposed non-smokers 	-0.1896ns 	9 
(184) 
The correlation coefficient between haemoglobin levels and years of 
exposure, r = -0.6940 (d.f. 21) is highly significant as is years of 
smoking and years of exposure r = 0.7966 (d.f. 21). Both years of 
exposure and years of smoking are highly confounded with age. 
Removing the effect of years of exposure using a partial correlation 
coefficient between haemoglobin and years of exposure produced the 
following: r = -0.5711 xx (d.f. 20). A similar calculation giving a 
partial correlation coefficient between haemoglobin and years of smoking, 
removing the effect of years of exposure showed r = 0.1538 ns (d.f. 20). 
It therefore can be correlated that haemoglobin is negatively correlated 
with years of exposure even after the effect of smoking as accounted for 
whereas the correlation between haemoglobin and years of smoking does not 
stand after years of exposure have been equalised. 
Tables 46, 47 and 48, pages 180 - 181 show the relationship between blood 
lead and haemoglobin. They do not provide any evidence for a significant 
correlation between the two. 
Conclusion 
Workers with at least 20 years of exposure have a significantly lower 
haemoglobin level than those employed for 20 years or more in unexposed 
areas. 
3. Packed cell volume - (Normal 40 - 54 percent) 
Figure 54, page 192 and table 54, page 190 indicate there isrlo significant 
difference between the groups. 
(185) 
4. White cell count - (Normal, 4,000 - 11,000 per cubic m.m.) Figure 
55, page 193 and table 55, page 190 indicate no statistical significant 
difference between groups. 
5. Platelets - (Normal 150,000 - 450,000 per cubic m.m.) Figure 56, 
page 194 shows no member of any group had an abnormal platelet count. 
• 6. Differential white cell count - Figures 57, 58, 59, 60, 61, pages 
195 - 199. There is no significant group variation. 
7. Blood film examination - With three exceptions, all of whom subseq-
uently were found to have a positive screening test for infectious 
mononucleosis, all blood films were essentially normal. 
8. Uric acid - (Normal level 2.5 - 7 mgm per 100 mls.) Figure 62, page 
200. Serum uric acid was measured for all participants. This examination 
primarily a marker of purine metabolism can also be used as an aid to assess 
bone marrow function or renal function. Although only four members of the 
survey, three in the exposed and one in the control group 'gave a history of 
being treated for clinical gout, twenty two participants in the survey had 
an elevated uric acid level. (Seven exposed smokers, four exposed non-
smokers, two unexposed non-smokers and nine exposed smokers). Statistically 
there was no difference when the groups were analysed. Table 56, page 201. 
Conclusion  
Some abnormality of haemoglobin synthesis is associated with increased body 
burden of cadmium. No other bone marrow effect is evident in this survey. 
(186) 
Exposed Unexposed Exposed Unexposed 
Smokers Smokers Non smokers Non smokers 
1.56 1.66 
1.79 
1.64 1.83 * 
1.61 1.68 
• 1.65 . 
• 1.58 
• 1.66 A 1.72 1.80 C 1.94 
• 1.65 ** 
1.81 
1.65 A 1.66 ** 1.85 
1.85 A 1.71 1.59 
1.59 A 1.66 
1.58 B 
1.80 A 
1.71 C 
1.71 A 
1.83 A 1.73 1.74 
1.66 A 1,84 1.92 
1.80 A 1.65 
• 1.68 A 
1.62 B 
1.75 A 1.59 1.80 * A 1.67 
1.80 . C 1.69 1.76 A 
1,91 * A 
1.75 A 1.69 1.67 A 1.66 
1.80 C 1.68 1.77 * A 1.61 
1.76 
1.67 A 1.68 1.65 C 
. 
1.70 C 1.81 1.74 * C 
1.63 A 1.66 * A 
1.60 A 1.80 * B 1.66 * 
1.67 A 1.56 * A 
1.64 A 
RELATIVE VISCOSITY 
(Normal range 1.5 - 1.72 centrepoises) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 52 
UNDER 25 
25-30 
30-35 
35 - 40 
40 - 45 
45-50 
50-55 
55-60 
60 & OVER 
(187) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
15.7 14.4 
15.6 
14.9 15.6 * 
14.2 14.5 
• 14.8 
• 15.0 
16.0 A 13.9 15.4 	C 16.0 
14.3 ** 
15.3 
15.5 A 14.9 ** 15.1 
15.9 A 16.2 13.5 
• 15.4 A 14.8 
14.0 B 
16.4 A 
• 15.2 C 
14.5 A 
15.4 A 14.3 14.8 
15.6 A 15.7 15.1 
14.8 A 15.4 
16.0 A 
16.0 B 
• 13.2 A 15.8 16.5 * A 15.0 
15.0 C 15.5 16.5 	A 
14.9 * A 
14.9 A 15.1 15.2 	A 15.8 
15.0 C 15.4 14.5 	* A 13.0 
• 14.7 
14.0 A 15.7 14.7 
• 14.3 C 15.1 14.6 * C 
12.4 A 13.3 * A 
12.7 A 15.7 * B 15.6 * 
13.5 A 12.3 * A 
12.5 A 
HAEMOGLOBIN 
(gm/percent) 
Normal 13.5 - 18 
* - Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 53 
MEER 25 
25 - 30 
30-35 
35-40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
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Relative Viscosity 
Contingency Table - Prepared from those above and below the normal range. 
Normal Above Normal 
Unexposed smokers 16 6 
Unexposed non-smokers 7 5 
Exposed smokers 15 8 
Exposed non-smokers 4 7 
Unexposed 23 11 34 
Exposed 19 15 34 
42 26 68 
= 	1.00ns 
No significant difference. 
TABLE SO 
Haemoglobin - (Gm/100 ml. Normal 13.5 - 18) 
Mean Min Max 
Unexposed smokers 15.10 13.9 16.2 
Unexposed non-smokers 14.87 13.0 16.0 
Exposed smokers 14.75 12.4 16.4 
Exposed non-smokers 14.87 12.3 16.5 
TABLE 51 
No statistical difference 
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Haemoglobin Level  
Workers with twenty of more years exposure - 
Unexposed smokers 
Unexposed non-smokers 
Normal 
6 
4 
Below Normal 
9 
1 
Exposed smokers 4 5 
Exposed non-smokers 3 1 
Unexposed 10 1 11 
Exposed 7 6 13 
17 7 24 
2 X 1 = 3.96* 	( p0.O5 - significant) 
TABLE 52 
Workers with twenty or more years exposure in the most contaminated 
atmosphere - 
Unexposed 10 	 1 11 
Exposed 5 6 11 
15 	7 22 
X2 = 5.24* 	( p<0.05 - significant) 
TABLE 53 
(190) 
Packed cell volume - (Normal 40 - 54 percent) 
Mean Min Max 
Unexposed smokers 44.91 41 48 
Unexposed non-smokers 44.25 39 47 
Exposed smokers 44.00 38 52 
Exposed non-smokers 44.18 40 49 
TABLE 54 
No significant difference between the groups. 
White cell count - 
Mean Min Max 
Unexposed smokers 8000 6000 13000 
Unexposed non-smokers 7000 5000 13000 
Exposed smokers 8304 5000 12000 
Exposed non-smokers 7364 6000 10000 
TABLE 55 
No significant difference between the groups. 
(191) 
Discussion 
Although none of the exposed group with lower haemoglobin levels could 
clinically be regarded as anaemic an attempt was made after the survey was 
completed to investigate this small group in greater detail. Only one 
member presented for further examination after invitation. It was not 
possible to place him in any of the recognised categories of anaemia from 
the serum iron level, iron binding capacity, and repeat blood film. One 
explanation could be a cadmium effect on haemoglobin synthesis rather than 
iron metabolism. No attempt was made to pursue this line of thought. 
Investigation of a larger group of long exposed individuals with lower 
haemoglobin levels may provide the answer to this abnormality which has 
been a finding in other surveys also. 
• 	46 43 
47 
45 46* 
42 43 • 46 
43 
• 49 A 41 44 C 47 
44 ** 
46 
45 A 45** 46 
47 A 48 42 
45 A 45 
41 
52 A 
• 47 C 
41 A • 
46 A 42 44 48 A 47 44 45 A 46 
• 46 A 
47 B 
39 A 47 48 * A 44 
43 .0 45 49 A 
45 * A 
45 A 43 43 A 46 44 C 46 44 * A 39 
• 43 
41 A 47 42 C 43 C 44 44 * C 40 A 40 * A 
39 A 46 * B 47* 41 A 41 * A 
38 A 
UNDER 25 • 
25 - 30 
30-35 
35 - 40 
40-45 
45-50 
50-55 
55 - 60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
PACKED CELL VOLUME/PERCENT 
(Normal 40 - 54%) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 54 
7,000 5,000 
10,000 
• 6,000 8,000 * 
6,000 6,000 
• 7,000 
6,000 
11,000 A 6,000 8,000 C 13,000 
7,000 ** 
12,000 
7,000 A 6,000 ** 7,000 
10,000 A 12,000 6,000 
• 8,000 A 7,000 
9,000 B 
9,000 A 
6,000 C 
12,000 A 
7,000 A 7,000 7,000 
9,000 A 11,000 6,000 
8,000 A 13,000 
• 11,000 A 
11,000 B 
10,000 8,000 7,000 * A 6,000 
9,000 C 8,000 6,000 A 
8,000 * A 
7,000 A 7,000 8,000 A 8,000 
5,000 C 6,000 8,000 * A 5,000 - 
• 7,000 
5,000 A 10,000 6,000 C 
• 7.000 C 7,000 10,000 * C 
9.000 A 7,000 * A 
6.000 A 7,000 * B 7,000 * 
8.000 A 6,000 * A 
7.000 A 
UNDER 25 
25 - 30 
30 - 35 
35- Lb  
40 - 45 
45-50 
50-55 
55-60• 
60 & OVER 
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Exposed Unexposed Exposed Unexposed 
Smokers Smokers Non smokers Non smokers 
WHITE CELL COUNT 
(Normal 4,000 - 11,000 per cubic mm) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 55 
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Exposed Unexposed Exposed Unexposed 
Smokers Smokers Non smokers Non smokers 
241,600 158,400 
245,000 
206,000 344,000 * 
170,000 237,600 
• 208,000 
• 194,000 
' 285,000 A 209,000 240,000 C 212,000 
240,000 ** 
322,000 
243,000 A 240,000 ** 240,000 
248,000 A 276,000 296,000 
273,000 A 264,000 
272,000 B 
264,800 A 
175,000 C 
317,600 A 
143,000 A 248,000 192,000 
173,000 A 288,000 190,000 
240,000 A 296,000 
248,000 A 
308,000 B 
283,000 A 216,000 200,000 * A 225,000 
256,800 C 250,000 280,000 A 
196,000 * A 
220,000 A 224,000 308,000 A 206,000 
150,000 C 252,000 260,000 * A 240,000 
• 328,000 
123,200 A 312,000 224,000 C 
228,000 C 272,000 252,000 * C 
310,000 A 220,000 * A 
344,000 A 259,000 * B 208,000 * 
328,000 A 228,000 * A 
224,000 A 
PLATELETS 
(Normal 150,000 - 450,000 per cubic mm) 
* - Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 56  
UNDER 25 
25-30 
30-35 
35-Lb 
40-45 
45-50 
50-55 
55 - 60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
52 59 
60 
54 56* 
56 52 
55 
53 
• SO A 62 71 	C 72 
55 ** 
69 
61 A 47 ** 71 
60 A 65 47 • 57 A SO 
59 B 
66 A 
50 C 
58 A 
67 A 44 54 
58 A 64 61 
50 A 56 
70 A 
64 B 
63 A 62 70 * A 53 65 C 72 55 	A 
35 * A 
71 A 42 67 	A 63 
57 C 49 52 * A 69 
56 
62 A 55 56 	C 53 C 55 53 * C 54 A 67 * A 
59 A 64 * B 56* 56 A 53 * A 58 A 
NEUTROPHILS PERCENT 
(Normal 25 - 75) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 57 
UNDER 3 
25 - 30 
33 - 35 
35-40 
40 - 45 
45-50 
50-55 
55 - 60 
60 & OVER 
10 7 
4 
6 3* 
2 4 
2 
4 
• 1 A 1 - 	C 2 6 ** 
- 
- A 2** - 
1 A 1 7 
3 A 1 
1 B 
4 A 
1 C 
- A 
- A 5 4 
4 A 3 1 
2 A - 
• I A 
2 13 
• 2 A 2 - * A 
1 .0 3 1 	A 
1 * A 
1 A 3 2 	A - 
1 C 2 2 * A 1 
8 
2 A 4 3 	C 
• 2 C - 	S 2 * C 
4 A 3 * A 
4 A 2 * B 2* 
• 3 A 1 * A 
2 A 
UNDER 25 
25-30 
30-35 
35 - 40 
40-45 
45-50 
50-55 
55 - 60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
•EOSINOPHILS PERCENT 
(Normal .4 - 4.4) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant . 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 58 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smoker 
- - 
- 
- - 	* 
- - _ 
_ 
- 	A - - 	C - _ 	** 
_ 
- 	A _ 	** - - 	A - - 
• - 	A - 
- 	B 
- 	A 
- 	C 
- 	A 
• - 	A - - - 	A - - 
- 	A - 
• - 	A 
- 	B 
- 	A - - - - 	.0 - A - *A 
- 	A - - 	A - 
- 	C - - *A - _ 
- 	A 1 . - 	C 
- 	C - - * C 
1 	A  
- 	A - * B - 	* 
- 	A 0 - *A 
- 	A .. 
-BASOPHILS PERCENT 
(Normal 0 - 1) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 59 
UNDER 25 
25-30 
30 - 35 
35 - 40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
34 29 
- 30 
38 38* 
39 42 
35 
38 
' 43 A 33 26 	C 22 
33 ** 
24 
33 A 45** 27 
32 A 30 33 
35 A 41 
35 B 
26 A 
43 C 
40 A 
28 A 43 42 
35 A 27 36 
42 A 37 
21 A 
32 B 
27 A 31 29 * A 37 
32 C 33 39 	A 
61 * A 
25 A 52 20 	A 34 
34 C 42 44 * A 26 
• 32 
28 A 34 35 	C 
42 C 41 39 * C 
38 A 23 * A 
26 A S 31 * B 32* 
40 A 41 * A 
32 A 
LYMPHOCYTES PERCENT 
(Normal 15 - 35) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 60 
UNDER 25 
25-30 
30-35 
35 - 40 
40-45 
45-50 
50-55 
55 - 60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
4 5 
6 
2 3* 
3 2 
8 
5 
6 	A 4 3 	C 4 
6 ** 
7 
6 	A 6** 2 
7 	A 4 13 
5 	A 8 
5 	B 
4 	A 
• 6 	C 
2 	A 
5 	A 8 - 3 	A 6 2 
6 	A 7 
• 6 	A 
2 	B 
• 8 	A 5 1 * A 11 
2 	C 2 5.A 
3 * A 
3 	A 3 11 	A 3 
8 	C 7 2 * A 4 
4 
2 	A 6 6 	C 
• 3 	C 4 6 * C 
3 	A 7 * A 
11 	A 3 * B 10* 
1 	A 5 * A 
8 	A 
MONOCYTES PERCENT 
(Normal 2 - 6.5) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 61 
UNDER 25 
25 - 30 
30 - 35 
35 - 40 
40 - 45 
45-50 
50-55 
55 - 60 
EC & OVER 
9.5 6.9 
6.2 
• 7.2 8.5 * 
6.1 6.9 
• 6.4 
• 8.5 
5.6 A 6.5 3.6 	C 6.5 
6.4 ** 
6.5 
4.9 A 5.3 ** 6.3 
6.0 A 7.2 2.8 
6.9 A 4.7 
5.7 B 
6.0 A 
6.8 C 
5.3 A 
7.9 . 7.0 4.4 
7.6 A 7.3 7.3 
5.4 A 6.0 
• 8.3 A 
4.6 B 
• 5.0 A 5.4 7.9 * A 6.8 
7.4 •C 8.7 5.0 	A 
7.3 * A 
8.3 A 7.6 6.3 	A 6.9 
7.9 C 6.9 5•5 * A 4.0 
6.4 
8.1 A 7.6 6.0 	C 
4.6 C 7.5 9.2 * C 
4.1 A 7.2 	* A 
• 5.1 A 6.9 	* 5.5 * 
3.0 A 4.4 * A 
4.6 A 
UNDER 25 
25-30 
30-35 
35- 40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
URIC ACID 
(mgm/percent) 
Normal 2.5 - 7 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 62 
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Uric Acid - (Normal level 2.5 - 7 mgm/100 mls.) 
Mean Min Max 
Unexposed smokers 6.86 4.7 9.5 
Unexposed non-smokers 6.07 2.8 8.5 
Exposed smokers 6.05 3.0 8.3 
Exposed non-smokers 6.30 3.6 9.2 
TABLE 56 
No significant difference between the groups. 
Serum Calcium - (Normal 4.2 - 5.3 MEQ/Litre) 
Mean Min Max 
Unexposed smokers 4.532 3.2 5.3 
Unexposed non-smokers 4.642 3.5 5.2 
Exposed smokers 4.643 3.8 5.2 
Exposed non-smokers 4.627 3.5 5.1 
TABLE 57 
No significant difference between the groups. 
(202) 
CHAPTER 16 
Cadmium and Bone Metabolism  
Animal experiments indicate that cadmium, unlike lead does not accumulate 
to any extent in bone. Kitamura et al 1970 (89) have shown that less 
than 1% of human body burden resides in osseous tissue and that there is 
accumulation with age. 
Bone metabolism was investigated in this survey by measuring:- 
1) Serum calcium 
2) Serum phosphate 
3) Serum alkaline phosphatase 
4) A radiological survey for bone density using the ulna bone 
1. Serum calcium - (Normal 4.2 - 5.3 meg/litre) Figure 70, page 204, 
table 57, page 201. All measurements are within normal range and there is 
no significant group difference. 
2. Serum phosphate - (Normal range 2.5 - 4.5) Figure71, page 205, table 
59, page 206. All measurements are within normal range and there is no 
statistical difference between the group. 
3. Serum alkaline phosphatase - (Chapter 14) Figure 49, page 169, table 
40, page 171. 
4. Radiology - This was performed by Dr. B. Fazackerly of Hobart. The 
ulna bone mineral content was examined using a method described by Doyle 
(88). Macroscopic cortical thickness measurements only have been reported. 
(203) 
A microdensitometer reading for these films was initially proposed but 
no desitometer available in Tasmania has proved suitable for the task. 
Dr. Fazackerly reports that there are no significant changes in any 
subject in any group. There - is no evidence of bony metabolic disease in 
any film. A significant number (24) participants in the survey complained 
of vague bone pain for which no obvious explanation could be found at the 
clinical examination. This group comprised eleven exposed workers and 
thirteen controls. 
Conclusion  
No evidence of disordered calcium metabolism was found. 
Discussion 
Several reports of bone changes in the occupationally exposed (Nicaud et 
al (SS), Bonnell (61), and the well documented changes in Itai-Itai disease 
are believed to result from renal tubular damage by cadmium in association 
with dietary deficiency of either calcium, vitamin D or both. 
Bone changes have not been a feature of other surveys, similar to this 
even when there has been evidence of altered calcium or phosphate metab-
olism. 
(204) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
4.5 4.8 
4.5 
4.1 4.5 * 
4.4 4.8 
• 5.0 
5.3 
4.5 A 4.5 4.9 	C 5.0 
5.1 ** 
4.6 
4.7 A 3.4 ** 5.2 
4.7 A 5.2 3.5 
5.2 A 4.8 
4.7 B 
5.0 A 
4.4 C 
4.9 A 
• 4.9 A 4.8 4.8 
4.3 A 3.2 4.9 
4.8 A 4.7 
4.7 A 
4.6 B 
4.9 A 4.4 4.5 * A 4.3 
50 C 4.6 3.5 	A 
4.7 * A 
4.2 A 4.7 5.1 	A 4.2 
3.8 C 4.6 4.5 * A 5.1 
• 4.7 
4.9 A 4.3 4.8 	C 4.6 * 
4.9 C 4.3 4.9 	* C 
4,6 A 4.6 * A 
3.9 A 4.7 * B 
4.3 A 4.7 * A 
4.9 A 
CALCIUM (meg/litre) 
Normal 4.2 - 5.3 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 70 
UNDER 25 
25 - 30 
30 - 35 
35 - 40 
40 - 45 
45 - 50 
50 - 55 
55 - 60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
4.0 	• 3.6 
2.7 
3.8 5.0 * 
4.1 2.8 
4.0 
• 2.0 
3.2 A 3.7 5.2 	C 3.6 4.0** 
2.8 
2.2 A 4.8 ** 2.9 
3.3 A 3.0 3.7 
2.7 A 4.5 
3.2 B 
4.1 A 
2.8 C 
3.0 A 
3.1 A 2.8 2.9 
3.2 A - 3.4 3.7 
4.5 A 3.5 
• 4.5 
4.5 B 
• 3.0 A 3.8 2.7 	* A 2.6 
2.5 	. C 3.4 3.2 	A 
3.3 * A 
4.0 A 3.6 3.2 	A 5.0 
4.5 C 3.3 4•7 * A 3.0 
• 4.2 
3.6 A 4.5 3.2 	C 
2.9 C 2.5 3.0 * C 
4.5 A 2.8 * A 
• 3.8 A 3.5 * B 3.7 * 
3.5 A 4.5 * A 
3.0 A _ 
DER 25 
25 - 30 
30 - 35 
35 - 40 
40-45 
45-50 
50-55 
55 - 60 
60 & OVER 
PHOSPHATE (mg/ml) 
Normal 2.5 - 4.5 mgm/100 ml 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 71  
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Phosphate -(Normal 2.5 - 4.5 Mgm/100 mls.) 
Min Max Mean 
Unexposed smokers 	3.564 2.0 4.8 
Unexposed non-smokers 	3.542 ' 2.6 5.0 
Exposed smokers 	3.461 2.2 4.5 
Exposed non-smokers 3.573 2.7 5.2 
TABLE 58 
No significant difference between the groups. 
T4 - 	(Normal 3.0 - 6.6 mg/100 mls.) 
Mean Min Max 
Unexposed smokers 	4.85 3.7 7.0 
Unexposed non-smokers 	5.47 3.8 7.4 
Exposed smokers 	5.29 4.0 6.7 
Exposed non-smokers 5.49 4.3 6.7 
TABLE 59 
No significant difference between the groups. 
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CHAPTER 17 
Cadmium and Endocrine Function  
The pancreas and gonads are well known storage sites for cadmium. Thyroid, 
adrenal, pancreatic and testicular function were also examined elinically'and 
biochemically as part of the survey. No clinical abnormality was found. 
1. Thyroid function - (Normal 3.0 - 6.6 Mg/100 mls.) 
This was measured by determining the serum thyroxine content. (Figure 
63, page 210). No member of the control or exposed group showed 
either a higher or lower level than the normal nor was there any 
significant difference between the groups when compared as a whole. 
(Table 59, page 206). 
2. Adrenal function - As measured by 17 Keto Steroids excretion/24 hrs. 
17 Keto Steroids - (Normal 5-25 mgm/24 hrs.) Figure 64, page 211. 
No member of either group exhibited an abnormal value for this test. 
Statistically there was no significant difference between the groups. 
(Table 60, page 212). 
3. Gonadal function - 
An estimation of serum testosterone, follicle stimulating hormone and 
luteinising hormone was made, (figures 65, 66, 67, pages 213 - 215). 
The laboratory normals for these groups vary with age. (Vide chapter 7). 
Two members of the exposed group, both smokers, had a testosterone 
level that was either low or border line for their age compared with 
three members of the control group. Five members of the exposed group, 
all smokers, had a slightly low or abnormally low follicle stimulating 
hormone level; only two of them worked in the most contaminated area. 
(208) 
One member, an exposed smoker, has an increased level. Three members 
of the control group, one a smoker and two non-smokers, have a raised 
follicle stimulating hormone level. Two members of the exposed group, 
both smokers, had a slightly raised LH level, as did two members of 
the control group. Only one member, a non-exposed worker had elevated 
FSH and LH with a low serum testosterone level, suggesting impaired 
testicular function. There was no correlation between blood cadmium, 
urinary cadmium excretion or length of exposure to cadmium with the 
abnormal results found. 
4. Pancreatic function - 
The endocrine function of the pancreas was assessed using a blood sugar 
level in association with a test for glycosuria. (Ames Bililabstix). 
Four exposed workers, two smokers and two non-smokers showed glycosuria 
as did two controls. (Figure 68, page 216). When these findings were 
examined in association with blood sugar levels (figure 69, page 217) 
only one, an exposed worker in a low cadmium environment area would 
definitely be regarded as new diabetic. One other exposed worker 
known to be a diabetic receiving treatment had a normal blood sugar 
reading. Two exposed workers and one control with a trace of sugar 
(0.01%) and a normal blood sugar reading were invited to have further 
investigation but did not accept. One control worker with 0.75% glycos-
uria was found, after a glucose tolerance test to have renal glycosuria. 
Conclusion 
There was no evidence of a harmful effect from cadmium on thyroid, adrenal, 
gonadal or pancreatic endocrine function. 
(209) 
Discussion 
Most surveys on cadmium and health have not reported investigations into 
endocrine function. This is surprising in the light of the knowledge that 
cadmium is stored in both gonadal and pancreatic cells. 
Cadmium does have a temporary or permanent sterilising effect. Parizek 
(79). At one time it was under investigation as a male contraceptive. 
This study would suggest that its use in this area would be ineffectual. 
Furthermore, adequate dosage for long periods would probably be associated 
with undesirable renal and haemopoeitic effects. Cadmium had no effect 
on sexual function of those exposed. 
(210) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
7.0 4.1 
5.3 I 
4.1 49* 
4.2 4.5 
• 6.0 
5.1 
• 6.0 A 3.8 4.3 	C 6.7 
• 3.9 ** 
4.4 _ 
5.4 A 5.0 ** 7.0 
5.8 A 6.4 4.1 
• 4.7 A 5.0 
5.7 B 
4.8 A 
5.6 C 
5.2 A 
5.1 A 5.0 5.5 
4.0 A 5.4 7.4 
4.8 A 4.2 
• 6.0 A 
- B 
4.9 A 3.7 5.2 3.8 
4.1 •C 4.8 5.5 	A 
5.3 * A 
5.7 A 3.9 6.1 	A 4.8 
5.2 C 6.3 5.0 * A 5.8 
• 3.8 
5.0 A 4.4 6.7 	C 
5.0 C 5.0 4.3 * C 
6.7 A 5.9 * A 
• 4.5 A 6.6 * B 7.1 	* 
5.8 A 5.5 * A 
6.4 A 
HORMONES 
THYROXINE (mg/100 m 
Normal 	3 - 6.6 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 63 
UNDER 25 
25 - 30 
30-35 
35 - 40 
L0 -45 
45-50 
50-55 
55-60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
6.0 9.5 
12.6 
7.0 7•5 * 
13.4 20.0 
• 10.5 
13.3 
' 13.2 A 6.7 10.6 	C 6.0 
• 18.0 ** 
9.4 
6.1 A 19.0 ** 7.0 
8.3 A 11.9 8.0 
10.4 A 5.9 
8.4 B 
7,4 A 
• 15.0 C 
9.2 A 
7.6 A 13.8 14.1 
11.3 A 11.3 9.4 
7.5 A 11.0 
• 11.0 A 
8.6 B 
4.1 A 16.1 10.0 * A 10.9 
7.2 • C 7.9 8.2 	A 
7.7 * A 
14.0 A 11.0 8.0 	A 14.1 
6.2 C 7.4 14.6 * A 9.3 
9.0 
9.4 A 6.6 8.0 	C 
9.8 •C 9.7 8.5 * C 
17.0 A 14.5 * A 
• 11.0 A 14.7 * B 9.0 * 
10.8 A 5.8 * A 
9.1 A 
HORMONES 
17 KETO STEROIDS 
(mg 24 hrs) 
Normal 5 - 25 
- Previous smokers over five years ** - Previous smokers under five years 
A - Cadmium Plant 
Compressed Air Station 
Superphosphate Plant 
FIGURE 64 
UNDER 25 
25 - 30 
30 - 35 
40-45 
45-50 
50-55 
55 - 60 
60 & OVER 
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17 Keto Steroids - 
n Mean Min Max 
Unexposed smokers 22 10.80 5.9 19.0 
Unexposed non-smokers 12 10.40 6.0 20.0 
Exposed smokers 21 9.68 4.1 17.0 
Exposed non-smokers 11 10.05 5.8 	. 14.7 
TABLE 60 
No significant difference between the groups. 
(213) 
Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
21.6 22.3 
11.7 
19.2 17.1 	* 
23.1 11 	0 
22.7 
24.5 
• 13.1 	A 15.9 16.8 	C 8.9 
17.8 ** 
21.3 
23.3 	A 18.6 ** 22.2 
21.6 	A 15.9 21.1 
• 11.8 	A 17.6 
insuff.B 
29.2 	A 
• 21.6 	C 
9.8 	A 
16.8 	A 25.3 14.3 
insuff.A 15.1 16.3 
16.3 	A 21.6 
• 19.2 	A 
17.2 	B 
• 14.7 	A 21.1 14.1 	* A 13.9 
12.4 	.0 18.6 17.0 	A 
15.2 * A 
18.6 	A 6.5 22.2 	A 11.4 	. 
24,9 	C 21.6 18.0* A 4.9 
11.7 
18.5 	A 26.1 13.4 
15.6 	C 11.4 13.0 	* C 
3.4 	A 20.5 * A 
21.3 	A 14.0 * B 16.4 * 
19.8 	A 12.7 * A 
26.4 	A 
HORMONES 
TESTOSTERONE(mol/L) 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 65 
UNDER 25 
25-30 
30 - 35 
35 - 40 
0-45 
45-50 
50-55 
55-60 
60 & OVER 
3.5 i 	0.2 2.5 
2.2 	t 0.2 
2.3 	t 	0.2 1.0 	t 	0.1 * 
2.3 	t 0.2 1.0 
1.7 	I 	0.1 
0.9 t 0.1 
2.0 t 0.2 A 3.4 ! 0.2 2.8 t 0.2 	C 1.4 	- 
+ 	0.1 
1.4 t 	0.1 ** 
2.0 	t 0.2 
2.1 	t 0.2 A 1.3 ** 2.7 t 	0.2 
1.4 	t 	0.1 A 2.1 	t 	0.2 3.5 
2.2 	± 	0.2 2.4 
0.4 B 
3.6 A 
6.4 C 
2.3 A 
1.6 	t 	0.1 A 3,6 2.0 	t 	0.2 
4.3 A 3.4 t 0.2 
+ 3.4 	- 	0.2 
1.4 	t 	0.1 A 2.9 t 0,2 
0.3 	t 	0.1 A 
1.0 B 
3.2 	t 	0.2 A 1.9 	t 	0,2 1.7 t 0.1 	* A 7.1 	t 0.4 
0.7 t 	0.1 C 1,6 t 	0.1 1.0 	A 
5.2 t 0.3 * A 
2.0 	t 	0.2 A 1.6 t 0.1 2.5 t 0.2 	A 2.4 	t 	0.2 
0.8 	t 0,1 C 1.2 1,5 t 0.2 * A 21.2 	t 	1.9 
• 3.2 	t 0.2 
4.5 A 1.4 3.6 t 0.4 	C 
0.8 C 1,8 	t 	0.1 4.0 t 0.3 * C 
2.7 	t 	0.2 A 3.9 t 0.3 * A 
2,8 	t 0.2 A 2.3 	* B 0.7 t 0.1 * 
3.6 A 5.6 t 0.5 * A 
0.2 	t 	0.5 
UNDER 25 
25 - 30 
30-35 
35 - 40 
40 - 45 
45-50 
50-55 
55 - 60 
CO & OVER 
Exposed 
Smokers 
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Unexposed 
Smokers 
Exposed 
Non smokers 
Unexposed 
Non smokers 
HORMONES 
FOLLICLE STIMULATING HORMONE 
ml U/ml 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 66 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
1.7 	* 	0.1 2.3 t 0.2 
1.5 * 0.09 
2.0 t 0.1 2.3 * 
1.8 	t 	0.1 1.5 * 0.1 
2.1 
• 1.6 
3.0 t 0.1 A 2.1 	t 	0.1 1.4 * 0.08 C 1.8 
1.8 	I 0.1 ** 
2.2 	t 	0.1 
1.7 A 2.4 ** 3.0 
2.5 	t 0.1 A 2.1 1.9 
1.5 A 1.9 
2.1 	t 0.2 B 
2.0 	t 	0.1 A 
3.4 	t 0.2 C 
1.8 	t 	0.1 A 
2.4 	t 0.1 A 2.3 t 0.2 1.3 ± 0.08 
2.7 t 	0.2 A 2.7 t 0.1 1.8 ± 	0.1 
2.7 t 0.1 A 2.5 
1.0 A 
1.6 	t 	0.1 B 
3.1 	t 	0.2 A 1.8 t 0.1 1.6 	*A 3.3 ± 0.2 
0.7 C 1.5 	t 	0.1 2.0 A 
2.4 t 0.2 *A 
1.9 	t 	0.1 A 1.4 	t 0.08 3.0 t 0.1 	A 1.9 ± 0.1 
1.2 C 2.6 	t 0.2 2.1 	*A 8.1 ± 0.5 
2.1 	t 	0.1 
4.9 t 0.4 A 1.5 2.6 	C 
1.9 C 1.5 2.8 t 0.1 	*C 
1.9 	t 	0.1 A 2.6 t 0.1 	*A 
2.6 A 2.2 1.0 * 
4.3 A 5.5 	t 0.3 	*A 
1.3 A 
UNDER 25 
25-30 
30-35 
35 - 40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
HORMONES 
LUTEINISING HORMONE 
ml U/ml. 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 67 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
nil 	• nil 
nil 
nil nil * 
nil nil 
• nil 
nil 
nil 	A pos'' nir--- ** 
nil 	C 	 nil  
nil • 
nil 	A trace ** nil 
nil 	A nil nil 
nil 	A nil 
nil 	B 
nil 	A 
nil 	C 
nil 	A 
nil 	A nil nil 
nil 	A nil nil 
nil 	A nil 
nil 	A 
trace B 
nil 	A nil nil * A nil 
nil 	• C nil nil 	A 
nil * A 
nil 	A nil nil 	A nil 
nil 	C nil nil * A nil 
• nil 
nil 	A nil nil 	C 
nil 	C nil nil * C 
nil 	A trace*A 
nil 	A +++ * g nil * 
pos" A nil * A 
nil 	A 
GLYCOSURIA 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 68 
UNDER 25 
25 - 30 
30 - 35 
35-40 
40-45 
45-50 
50-55 
55-60 
60 & OVER 
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Exposed 	Unexposed 	Exposed 	Unexposed 
Smokers Smokers Non smokers 	Non smokers 
84 77 
96 
81 69* 
110 90 
• 87 
80 
' 87 A 85 80 	C 78 
• 74** 
82 
100 A 100 ** 85 
96 A 73 89 
80 A 90 . 
97 B 
81 A 
• 76 C 
93 A 
107 A 123 85 
92 A 88 96 
93 A 90 
• 97 A 
91 B 
75 A 87 90 * A 95 
80 •C 85 92 	A 
83 * A 
96 A 108 86 	A 111 
82 C 100 100 * A 107 • 103 
102 A 79 117 
86 C 124 89 * C 
88 A 83 * A 
• 80 A 368 * B 85* 
100 A 88 * A 
103 A 
BLOOD GLUCOSE 
(mgm/100 ml) 
Normal 70 - 110 
- Previous smokers over five years 
** - Previous smokers under five years 
A - Cadmium Plant 
B - Compressed Air Station 
C - Superphosphate Plant 
FIGURE 69 
UNDER 25 
25-30 
30-35 
35-40 
40-45 
45-50 
50-55 
55 - 60 
60 & OVER 
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CHAPTER 18 
CONCLUSIONS 
Using blood cadmium and 24 hour urinary excretion levels as markers, 
workers in a cadmium contaminated environment at the Electrolytic Zinc 
Company of Australasia's plant at Risdon, Tasmania, exhibit evidence of 
a higher body burden of cadmium than do controls from other areas of the 
plant. This cadmium burden appears to be tolerated very well for they 
show no evidence of serious health problems when compared to the controls. 
Only minor abnormalities of cellular or organ function were found in a 
wide variety of clinical, biochemical and radiological investigations 
performed. These have been detailed in previous chapters. 
Pulmonary disease is a common finding amongst those occupationally 
exposed to cadmium (chapter 5). Bonnell et el (61) have reported that it 
may appear or increase in severity some years after removal from exposure. 
The cadmium workers had a higher incidence of subjective respiratory 
symptoms than the controls. However, simple screening tests of respiratory 
function showed no measurable difference between the two groups. Radio-
logically also there were no significant changes or differences in chest 
films. The first manifestations of chronic airways disease are those 
symptomswhich were more prevalent in my group of exposed workers - cough, 
wheeze, dyspnoea and repeated respiratory infections. I am therefore not 
excluding the possibility that this cadmium effect will appear later, 
although Bonnell reviewed a group who had worked with a much higher level 
of atmospheric cadmium than my group (270 micrograms/cubic metre compared 
to 31). 	Clincally there was no serious respiratory disease found as a 
consequence of working with cadmium. 
Most surveys show the other major hazard of a high body burden 
(219) 
of cadmium is impaired renal function. No evidence of an adverse 
effect on renal function from occupational exposure to cadmium has been 
demonstrated in this survey. As Bonnell also has reported that prot- 
einuria can occur after removed from exposure, I am not excluding a later 
appearance of this finding. 
Unlike most other surveys (chapter 5) I found no evidence of subjective 
or objective ill health arising from working with cadmium. Again this 
could be due to the low working environmental level. No figures are 
available for this level over the preceeding years but it should have 
been higher in the past when little attention was paid to industrial 
hygiene and many industrial practices now considered unsafe were in 
operation at Risdon. 
In particular hypertension, neoplasia, liver disease, disorders of bone 
metabolism, endocrine malfunction, renal calculi and bladder tumors 
were not found amongst the exposed. Animal experimental studies and 
epidemological surveys have implicated cadmium as a causative agent in 
these conditions. This in turn has led to speculation by environment-
alists that the general public are at risk from the increasing environ-
mental levels of cadmium. If these conditions are not more prevalent in 
those with a body burden of the order of the group of exposed workers one 
can postulate that either they are not dose related if they are produced 
by tissue cadmium and/or if there is a dose relationship it is extremely 
unlikely that the public are seriously at risk from present environmental 
levels. There is no evidence from the findings of both groups that 
environmental cadmium in and around Hobart has any deleterious effect on 
health. 
(220): 
The survey shows cadmium may produce changes in the synthesis of both 
haemoglobin and plasma proteins. These changes have been discussed in 
previous chapters. They were of no clinical significance in my group of 
workers. Their real ;significance may be furthering both knowledge of 
metabolism and assessment of body burden. This would require a study 
of a much bigger group over a longer period. Several other surveys, 
but not all, have found similar changes but there are no reports of a 
more detailed examination of these changes. 
No individual or group of symptoms and/or signs appeared from my invest-
igations which might assist in the diagnosis of a cadmium effect. No 
simple non invasive investigation procedure produced any evidence of a 
direct cellular effect. There appears to be no synergistic or antagon-
istic effect from other metals on the health of cadmium workers. No 
simple screening procedure appeared from the survey results as a satis-
factory indication of danger levels of body burden. Nevertheless the 
findings as a whole may be of assistance in deciding safe working levels. 
Further monitoring of both groups would provide valuable evidence for 
those who have the responsibility of determining a figure for a safe, no 
effect level of total body cadmium, tissue, particularly renal tissue, 
level; and more importantly total intake levels. Industrial hygienists 
are particularly concerned with working environmental levels and there is 
still debate on just what these levels should be. Working in concentra-
tion up to 31 micrograms at least for long periods has proved to be safe 
for the group of workers I examined. (Vide infra). 
The cadmium compounds normally encountered in industrial environments 
(221) 
may be divided into three categories in respect to the hazards to those 
exposed to them. 
1. 'Fume' usually submicron (less than 0.5 um diameter) agglomerates 
of small (less than 0.1 um diameter) cadmium oxide particles. Such fume 
may be classed as wholly 'respirable', that is capable of reaching and 
depositing in terminal bronchioles and alveoli, to give localised effects 
and possibly complete systemic absorption. 
2. 'Soluble dusts' defined as those soluble in N/10 HC1. They include 
cadmium oxide and chloride and cover all normal airborne sizes. It should 
be emphasised that with regard toits biological action, it is the solu-
bility of the deposited dust in body fluids which needs to be considered 
for this may be quite different from its solubility in water. Certain 
cadmium compounds such as cadmium oxide are virtually insoluble in water 
but their solubility in such acid conditions represents the behaviour in 
the body of compounds such as cadmium oxide more closely in this respect 
than solubility in water at neutral pH. While with such dusts only the 
respirable fraction will be avilable for alveolar deposition, some of the 
larger particles may go into solution on the surface of the upper respir-
atory tract and also be absorbed systematically. The remaining larger 
particles, together with the proportion of the particles deposited on the 
ciliated epithelium of the tracheobronchial tree which are translocated 
will, finally, be swallowed to give only a low contribution to the systemic 
absorption. 
3. Insoluble dusts, relatively incoluble in body fluids such as cadmium 
sulphides and sulphoselenides. 
(222) 
In 1971 the American conference of Government Industrial Hygienists 
recommended a Ceiling Value for cadmium oxide fume of 100 hg per cubic 
metre and a Threshold Limit Value of 200 Ug/cubic metre for cadmium metal 
dust and soluble salts. These figures have produced considerable debate 
and lower figures have been suggested or applied by others. 
Chronic lung disease, probably due to direct action from inhaled matter 
and renal disease from increasing renal concentration are generally 
accepted as the only major industrial hazards of cadmium. The setting of 
safe working limits to protect from these is complicated by the healthy 
kidneys ability to store cadmium, the small and relatively fixed cadmium 
excretion no matter what the renal tissue concentration and the increas-
ing background exposure from increasing environmental concentrations. 
Recent figures, based on certain assumptions of absorption, distribution 
and deposition of cadmium in the organism and the use of mathematical 
biochemical models have indicated that a renal concentration of 300 Ug/gm 
wet weight is associated with proteinuria. Friberg has suggested that 
200 hg be regarded as the tentative critical concentration for a no effect 
result. A 50 year old man would reach this level with either an ambient 
concentration of 2 hg/cubic metre over a 24 hour day or 20 Ug/cubic metre 
in the working environment over an eight hour day. 
The British Occupational Hygiene Society Committee on Hygiene Standards 
have recommended a figure of 50 Ug/metre as the figure for total respir-
able cadmium. My survey would suggest a figure of 30 hg is safe and it 
is not necessary to aim for the relatively low figure suggested by 
Friberg. 
(223) 
Statistical analysis of my results indicates that exposed workers who smoke 
are more likely to suffer the abnormalities found than those who do not. 
As has been detailed earlier, smoking - particularly cigarette smoking 
contributes significantly to body burden. Bruckman et el (90) from 
their model have suggested that a smoker (20 cigs/day) has a 50% increase 
in body burden at the age of 70 than a non-smoker. 
Independently, Friberg has concluded that a non-exposed 50 year old who 
smokes has probably exceeded a renal concentration of 200 Ug/gm wet 
weight. There is no evidence from my survey to suggest that the combin-
ation of smoking and exposure to cadmium produces serious effects. There 
is evidence that this combination is undesirable, for biochemical changes, 
as yet of no significance, are common with the combination. Further 
study of large numbers with this combination is required. It may be due 
to an additive effect of two different agents or an increased total burden 
of cadmium derived from two sources. 
Cadmium has produced death and disability in both the occupationally and 
environmentally exposed. It has no useful biological function and 
consequently it must receive strict biological and environmental monit-
oring. But there is evidence from this work that the body can tolerate 
it to some degree. This should provide a stimulus to further research 
into both allowable environmental levels and controls as 'well as 
tolerable body burden. 
(224) 
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